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my Parents, 
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PREFACE. 
To the uninitiated the conduct of Research implies a 
process_ whereby answers to_questions are obtained by definitive 
experimentation and analysis; after the completion of this work 
it woulj seem more appropriate to defi~e Research as the procAs s 
whereby questions are generated. Wr,ereas it is true that 
questions were set and experiments designed to prove or disprove 
these, in the final analysis it appeared that for every answer 
rrovided several new questions were found t .o have arisen an.d new 
experiments were rAquired to answer some of these: others have 
remai~ed ~s questions. 
The exp erimPnts described herein were performed during the 
tenure of the Hermann Blumgart Research Fellowship at Harvard 
~edical School and the Beth Israel Hos pital, Boston, Mass~chusetts. 
I wish to thank the Women•s Auxiliary of the Massachusetts Chapter 
of the American Heart Association for providing the surport for 
this Fellowship. 
These experiments were all performed and the data analysed 
by myself. Miss Joan M. Burke, B.s. pro_vided tecnnical help 
and performed the serum cholesterol determinations. Without her 
enthusiasm.and - unfailing help this work would never have been 
completed in the two years available. 
The programme-directors were Drs. A. Stone Freedberg and 
George S. Kurland of the Department of Medicine, Beth Israel 
Hospital, Boston. For their persistent support, advice and 
encouragement I shall always be grateful. In retrospect I wish 
to thank them both particularly for refusi~g to accept any of my 
ideas until they were conclusively proven by the experiments. 
This thesis has a consiierable proportion of it devoted 
to the descrjption of equipment, methods and statistical analysis. 
Since the methodology was of crucial imrortance, it was felt that 
it was justified to devote a section of the body of the teit to 
this rather than insert it in the Aipend1x. The statistical 
method chosen was an analysi.s of v3.r1ance; the versatility of 
the 1rocedure is illustrated also by a detailed treatment i~. the 
body of the text. In this regard my gratitude is expressed to 
Dr. Theodore S. Colten, Sc.D., Assistant Professor of Statistics 
at Harv3.rj School of Public Health for his unfailing patience in 
providing what amounted to an individually ·nstructed course in 
Biostatistics. 
Throuehout the test liberal use is made of grar,hic illustra-
tion of the haemodynamic prlnciples discussed. In order to 
achieve tris numerous figures from the work of other a11thors ha:i 
to be used, with apologif'S. The sources of all "borrowed" 
figures are 1ndicated. A word of thanks to !lr. Paul Sh:,wst:1rk 
of the Depq,rtment of Bio;ihotography of the Beth Israel f!osrital 
for rerforming the photography of the er~phs arising out of 
these experi~ents. 
A final word of t~anks to Miss L. Malan, who as tyrist, 
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~ "Die Methode 1st Alles" - ~ 
Carl Ludwig. 
The central role of the mammalian heart in the 
circulation was recognieed by Nei Chung when he wrote in 
his Third Book of the Yellow ~mperor's Classic of Internal 
Medicine (2698 - 2598 B.C.): 
Treatise on the Five Viscera in Relation t•:> their part 
in Perfecting Life, 
"The Heart 1s in accord ·with the pulse. The complexion 
of a per3on shows when the heart is in a splendid condition. 
The 11.eart r-ulea over the kidneys It ( l) . . . . . . . . 
The importance of assessing the functional state of the 
heart was realised even by the early Egyptifl.n physicid.ns in 
t~e 17th Century B.C. as described in the ~bers Papyrus:-
"The begi~ning of the physicii,.n~ secret : knowlPdge of 
the heart• a mov.emen ts and knowledge of the heart. There are 
vessels from it to every limb. As to this, when any physician, 
any surgeon, or any exorcist applies the hands or his fingers 
to the head, to the back of the head, to the hands to the place 
of the stomach. to the arms or to the feet, then he P-xamines 
the heart, because all his limbs possess its vessels, that is, 
the heart speaks out of the vessels of every limb".( 2) 
The role of left ventricular systole i~ the generation of 
force necessary to propel blood through the vascular tree, was 
appreciated by Stephen Hales in his observations on the rolee 
2. 
of systole and diastole in the determination of peripheral 
flow. ( )) 
The diversity of factors whi ·~h may act as determinants 
of left ventricular function was alluded to·by Jean PoiHeuille 
in· his "Researches upon the Force of the Left Ventricle": 
"The course of the blood is so subject t ·:> the action 
of the heart, th~t ~ew researches upon the force of 
this organ have seemed to us worthy of the entire 
interest of physiologists. 
One should say that the age, the se.x., the temperament, 
the 1di:>syncrasiea, the ata.te of consciousness, of 
sleep, of exPrcise, of rest. of health, of illnesses, 
the passions, modify more or less the force of the 
heart. We recognise the influence of these modifyine 
agents; but does thejr existence prescribe all effort 
wh · ch would have for its aim the determination of the 
limits of this force?"{ 4 ) 
A great jeal of interest has since focussed on the facto~s 
that may govern· not only the basal level of funct1.on of the 
heart but ~lso its ability to i~crease its energy output 
according to the requirements of stress. The mechanisms by 
which the heart can accomplish an increase i~ force and output 
have been defined. Not only can th.e heart function at an 
increased rate of contractions, but it can increase its output 
during each stroke by increasing the force of contraction. 
Both intrinsic and extrinsic factors have been shown to 
influence the state of performance, or contr3.ctility, of the 
myocardium. 
Although a definition of .:nyocardi.al "contractility" i.n 
terms of haemodynamic principles will be attempted l~ter, its 
meaning will be indicated at t~is stage by considering, in 
perspective, .its role 1~ the function of the heart as ~n entire 
organ. A fundamental char~cteristic of the heart is its 
ability to readily alter its ~t~te of ~erfJrtnance. Thls 
ability, whethP.r inducPd by increased frequency of contr~ction, 
increaRed sympdthetic background or altered fillt~g, provides 
for modulation of the ~ork and power of the heart nP.ces.rnry 
to ' function at a speed commensurate with the time av~il~ble. 
Whatever the manner in which it is u1t · mately brought about, 
it 1s an alteration n myoc1:1rdial .. contra.ctility" t!lat under-
lies the flexibility of the functional st!lte of tn~ heart. 
Little 1.s known about the contractile st:1te of the myo-
card:.1.um in clinical thyroid disease; whet:ier the altered 
ntj'Ocardial physiology is due to a primary action of the hormones 
or secondary to the peripheral vascular and metabolic actions; 
to assess this directly, left ventricular catheterisation is 
necessary but this is not justifiable in patients with thyroii 
disease. Thus far indirect assessment of contractility has 
had to be made from information obtained by means of arterial 
and venous cannulations. The purpose of this thesis is to 
review the factors known to influence myocardial contractility, 
to outline the estimation of this aspect·of myocardi~l function 
in the intact animal and to pres~nt evidence obtained by direct 
measurement of myocardial function in dogs with experimentally-
induced hypo- and hyperthyroid states that myocardial contrac-
.4 • 
tility varies according to the thyroid state of the ani!!lal. 
Intera.ctions between catecholamines and thyroid hormone on 
myocardial contractility are assessed and the direct effect 
of the hormone on the myocardium defined. Mechanisms of 
action of the hormone on the function of the heart are suggested. 
and the implicat·ions of the observations ol;>tained in these 
experiments in the genesis of thyrocard i ac disease states are 
discussed. 
2. FACTORS THAT DETERMINE T~E LEVEL OF MYOCARDIAL P~RFORMANCE. 
Exercise has customarily been used as a model stimulus 
for both the rate of action and the level of perfor-:nance of the 
heart. Most research into factors i~volved in the control of 
cardiac function in the intact animal has concerned itself with 
a detailed analys i s of the mechanisms responsible for the physio-
. 
logical alterations i nduced by exerc i se. 
A. EXTRI~SIC TO THE MYOCA RDIUM: 
(a) HUMORAL: 
(i) The Catechol~mines: Extrinsic humoral influences 
have been confined to possible roles played by the circulating 
catecholamines, epinephrine and norepinephrine. Increased 
secretion of catecholamines by the adrenal gland during exerciae 
has been generally assigned an important role in mediating the 
cardiac response to stress and exercise. However, . intravenous 
i nfusions of both physiological and pharmacological amounts of 
both 1-epi~ephrine and norep1nephrine, have failed to reproduce 
the left ventri cular re~ponse to exerci 3e both in terms of rate 
and force of contraction.{5) The onset of the response to 
these hormones was quite gradual, leading to a bradycardia rather 
than tachycardia as i nfusions were cont i nued. · In these same 
animals, conscious and unrestrai ned with indwelling monitoring 
equipment, exercise produced a response quite unlike that obtained 
wi th either epinephrine or norepinephrine. It is only in the 
isolated heart preparation( 6) and in the anaesthetized(S, 7 ) or 
vagal-blocked animal(B, 9 )that these hormones cause an increase 
in heart rate with the increase in contractile force. 
Urinary excretion of epinephrine and norepinephrine is 
6. 
nevertheless found to be increased during muscular work, even 
with the mere assumption of the erect posture.(lO) 
As a result of their extensive experimentation in conscious, 
unsedated dogs, Rushmer et al(ll) came to the conclusion tha.t 
the left ventricular responses induced by physiological levels 
of 1-epinephrine and norepinephrine are relatively unimportant 
in effecting the cardiovascular responses tp exercise. 
(ii) Glucagon: The demonstration by Farah and Tuttle(l 2) 
that glucagon had inotropic and chronotropic actions simil~r to 
those of epinephrine on isolated heart preparations, has raised 
the question of whether this hormone has a physiological myo-
cardlal action. The subsequent findings of Lucchesi(l3) and 
Glick et al(l 4 ) in the intact animal have established that the 
hormone acts very similRrly to the catecholamines by stimul~tion 
of the beta-receptor, but that its action can occur in the 
presence of beta-adrenergic blockade. The suggestion ha3 been 
made and confirmed that the hormone acts by directly stimula-
ting the adenyl cyclase system. ( 15 ) 
Distinct pharmacological actions have been demonstrated 
glucagon on cardiac function, but the role of the hormone as 




(iii) Electrolytes: The electrolytes composing the environ-
ment of the heart, especially sodium, pot~ssium and calcium 
ions, all have distinct effects demonstrable on cardiac muscle 
in vitro.< 16) In the intact animal, however the concentrations 
of these ions are maintained within relatively narrow li~its 
and it is unlikely that they play any significant role in the 
1. 
rep:u lat ion of my oca.rdie.l functton. 
(b) ~ETJHOGBNTC: 
Stimulation of the sympathetic nerv~s to the heart ~reduce~ 
cardio-ncceleration, more po11erful contractions and a reduction 
in d:..astoljc dime11A~ona,(.:::. 7 ) In contrast to th~ effects of 
epinephr1r_e or norepinephrir..e inftunonR, the eJevati.on of 
pressure is accompanied by a tachycardia rather than hy a 
bradycardia a~1 in the case of tJ1e former a.gents. The very 
~reat increase in the tf>nsion developed by the myocardi ;m 
durlng stimu]at~on of sympathetic nerves to the heart may re-
flect some of the potential qontrol wh ch can be exerted thrcugh 
the S)mpathetic nervous system. 
At temrts to assess the role of the pa.rasym-pe. thet i c nervous 
supply to the heart were made by stimulat:on of the ,,afT.l s 
nerves. ( 11 ) Both le·ft and right vagus nerves effected a 
reduct1on 1n heart ratP on being stiffiulated. This wa~ associ-
ated with a rPduction in contractile forcP, If, however, the 
reductic•n jn rate during vagal stimulation was avoided by 
artif i cial atrial pacing, no signif1cant alteration 1n left 
ventricular performance cou]d be shown. 
Stitr.ulation of hypothalamic and di encephalj c regions in 
the conscious dog by means of prev1ously implanted el~ctrodes 
placed stereotect1cally, was found to initiate cardiac responses 
wh~ch closelj mim1cked the responses to exercise.(lB) Changeo 
in heart rate ~nd in indices of contractj)jty were observed 
that commenced with an extremely . brief latent period. Such 
observations could be obtained by reflex mechanisms prior to the 
f L 
actual initiation of exercise. The conclusion of these 
autnors was that the traditionally accepted humoral ~nd 
mechanical factors may well operate, but that higher centres 
were more directly responsjble for the initiation of the 
cardiovascular reAponses to exerci9e. 
B. INTRINSIC MYOCARDIAL FACTORS: 
Of great interest has been th~ findi~g that in the intact 
an.1:n9.l d4'nervation of the heart does not render the animal in-
capable of respondi~g to the demands of muscular exercise.(lg) 
The mechan sms by which the denervated heH rt modulates its 
output differ from thoee operating in the intact ani~al. Such 
a heart, especially after adrenalectomy, ha~ to rely entirely 
on intrinsic mechanisms to control its output. 
(a) Humoral Factors: 
Mechanisms that may operate in primary fashion at a local 
myocardi~l level to effect an alteration in performance have 
been suggested. The release of neuro-transmitter substance(ZO) 
norep1nephr1ne and shifts of potassium ion( 2l) have been postu-
lated. Mo~roe et al obtained convincing evidence that norepi-
nephrine is released at a myocardial level during an increase 
in afterload in the isolated perfused heart preparation.< 2o) 
Sarnoff et al demonstrated a net potassium loss during increases 
in contractility associated with an increase 1n afterloa.d and 
rate, but pointed out that this phenomenon may be secondary to 
either local pH changes associated with the increased oxygen 
consumption or to alterations in time relations.< 21 > Less 
time became available during diastole for the inward flux of 
thi~ ion, so i~timately involved with depolarization and 
9 .. 
repolarization. 
( b-) Mechanochemi cal Factors: 
{i) Synchronicity of Fibres: Evidence has been presented 
that the degree of syn~rgy in muscle action is of i~portance in 
ventr~cular performance because of the interdigitati~g arrange-
ment peculiar to cardiac muscle. Stimulation of the surface 
of the - ventricle by an electrical impulde causes a decreased 
rate of pressure generation compared to a stimulus traversing 
the normal His-Purkinje conduction system.< 22 ) 
(11) Frank-Starling Mechanism: It was first shown by Frank 
in 1895 that an increase in filling of the isolated frog's heart 
. (23) 
· resulted in a more forceful contraction. Starling and his co 
workers related the phenomenon to an increase in fibre length 
as was evident by s.n increase in volume of their heart-lung 
preparation .. <24 ) 
With an increase in myocardial fibre length leading to an 
increase in· the force of contraction, the heart has available 
an adaptatory mechanism enabling it to eject what_ever volume is 
received on the input side. Serious doubt has, however, be~n 
cast on whether this relationship has any significant role in 
the intact animal, in contradistinction to the situation in the 
experimental prPparations in which it was first observed ~nd 
repeatedly demonstratea.< 25 ) These arguments are based mainly 
on the fact that the heart has been found to decrease rather 
than· increase in size during exercise in the face of the increased 
output, work and power. The Frank-Starling concept ts, however, 
firmly ground~d and consistent with the sliding-filament theory 
of muscle action.( 26) 
10. 
Recent work by Sonnenblick et al jn intact unanaestheti?ed 
man. however, invoked the mechanif1m as actjvely pa.rticipatjr,g 
in the response to exerciAe.< 27 ) These authors demonstrated 
that tachycardia inducP.d without exercise reduced cardiac 
dimeneions to a larger extent than tachycardia accompanying 
exerc:i He and therefore concluded that the mechar.ism must be 
operative in the exercise-response • The heart operates from 
. 
an increased fibre length compared to the fibre length determjned 
for the heart at any particular heart rate. The effect was not 
readily obvious by virtue of the fact tr.at the cardiac dimensions 
were reduced as a result of the mechafiism in opPration. 
(iii) Anrer Phenomenon: A second type of regulating mecha-
nism independent of alterations in fibre length and requiring 
at least a few heart beats to develop, was described first by 
Anrep who noticed that ventricular voluJLe at first increased 
but subsequently decreased following sudden elevation in aortic 
resistance in the heart-lung preparation.< 28 ) This mechanism 
has been extensively jnvestigated by Sarnoff and co-workers in 
the isolated supported heart preparation.< 29 ) These authors 
have postuluted that it permits the ventricJe, when beating at 
any given rate, to eject the same stroke volume against a wide 
rar.ge of resistances, without requiring an incr~ased end-
diastolic fibre length. Over certain ranges it therefore ac~s 
in a manner so as to conserve the heterometr·ic Frank-Starling 
mechaniRm for changes in stroke volume. The increase in 
contractility that it effects also serves to shorten the prop~r-
tion of the total cardiac cycle occupied by systole. This is 
of particular importance when the heart rate is increased, 
since the diastolic inte1~al, essential for both ventricular 
11. 
filling and coronary artery perfusion, is maintained at maximum. 
(iv) The Bowditch Effect: Bowditch first observed that an 
increase in stimulation frequency is associated with an increase 
in twitch tension in the isolated frog heart.(]O) Hajdu has 
ir,vestigated this phenomenon extensively and correlates the 
alteration in twi~ch tens ion with a shift of intracellular 
potassium ion to the extracellular space. The decreased in ra-
cellular potassium concentration, to a certain limit when 
sustained contracture ensues, is associated with an inc1·ease 
in contractile force. The cause of the potassium shift has 
been postul&ted to be related to either changes in pH or to 
the rel a ti ,,-rely decreased time available for shift of the potas-
sium in an intra.cellular direction because of the shortened 
diastolic interval. In the mammalian heart Sarnoff et al 
have been able to ·demonstrate not only the phenomenon of the 
staircase( 2g) but also the potassium shifts.( 2l) Manif~stations 
of the same mechanism are also found ir1 :r;ostextrasystol1c 
potentiation(3l) and after sustained postextraRystolic etimula-
tion e.g. paired electrical pacing(32 ) both of which situations 
are associated with an increase in contractility. 
The operative mechanism remains to be precisely defined; 
it has been suggested, 1n addition to the views of Hajdu(30) 
outlined above, that local release of norepinephrine(33) may 
have a role in the mediation of the phenomenon. Recent 
investigations into the changes of calcium ion flux across 
the cardiac muscle membrane by Langer and Brady(34 ) have 
strongly suggested that this ion and membrane permeability to 
it, are important factors in determining inotropic phenomena. 
12. 
According to these investigators, increased frequency of 
contraction initia~es a process of augmented calcium turnover 
with influx initially exceeding efflux. A distinct calcJum 
transport system ar,pears to be operative; this contention was 
supported by the work of Grossman and Furchgott who, at various 
calcium concentrations and stimulation frequencies in guJnea-
pig atria, demonstrated a positive relationship between calcium 
exchange and contractility.( 35 ) 
13. 
3. MYOCARDIAL CONTRACTlLITY AND ITS ASS"ESSM'ENT IN THP. IN'!.' P.CT 
ANIMAL. 
A. PHYSIOLOGY OF CONTRACTION IN I SOL/.. 'f~D MUS CL 'E: 
The performance of the heart has tradlt1011ally been described 
in terms of relat.ions between the end-diastollc volume, or f11)-
ing pressure, of the ventricles and their outpu"";,. e:ther c,f 
volume of blood or work performed .. ( 3b) While these measurements 
provide considerable insight into tt..e level cf cardiac performance, 
studie.s on the mechanics of isolated muscle and heart r,re:rarations 
have suggested that the contractile state of cardiac muscle, like 
that cf skelet~l muscle, can be characterized best in terms of 
the relation between instantaneous force, velocity of shortening 
and fibre length.CJ?) 
(1) Muscle Structure: 
Accordine to the Three-Co~ponent theory of muscle mor~hology 
the muscle. including cardiac muscle, behaves as if it were 
composed of three functional mechanical component s.(3E) 
(a) the active contractile element wh1ch can shorten a.nd 
develop tension. 
(b) a passive flerie.s elastic component, mechan · ca.1ly in 
series with the contractile element. 
(c) a passive elastic component, mechanically in parallel 
with the contractile element, the parallel elastic 
component. 
These are illustrated conceptually in Fig.l according to 
Jewell and Wilkie. 
"I • ... . 










{1") Length-force-velocity relationships iL striated musclP: 
The length and tension changes i~ the nmscle. as a whole, 
depend on the interactions among the three elements outljned 
previously. A comple~e description of the contractile state 
of a muscle, whether skeletal or cardiac. can be achieved by 
the use of four variables, all of which may, however, change 
simultaneously durjng the course of a single contractjon. 
These variables are: 
(i) the tension in the muscle. 
(ii) the velocity of shorten;ne of the contractile 
element. 
( ij . ) 
(iv) 
the length of the fibre. 
time relatjonships of tension development after 
activation. 
The interactions of these factors have been shown to obey 
certain constant mathematical relationships which can be 
expressed in · the form of curves, first described by A.V. Hill 
on the basis .of heat production, but more recently in terms of 
15. 
actually measured velocity and shortening.(39) The mechanical 
constancy of such relationships were emphasized by Ritchie and 
Wilkie who were able to predict the responses of muscle under 
varying states of fibre length and load. by demonstrating the 
close correlation between predicte.d and observed responses. ( 40 ) 
The curves required by the·se authors to fully describe the 
action of muscle were: 
(i) the force-extension curve of the series elastic 
component. · 
(ii) the curve relating the intensity of the active state 
of the fully_active muscle to muscle length. 
(iii) th~ force-velocity curve of the fully active muscle. 
(iv) the curve describing the change i~ the intensity of 
the active state with tlme after a single stimuluA. 
Since the second, thirj and fourth curves relate the 
fundamental behaviour of the contractile element, they may 
in fact be used to characterize thP. contractile state of the 
muscle. 
(iii) Isometric Length-Force-Velocity Relationships in 
Isolated Cardiac Muscle. 
These curves were described for skeletal muscle which 
could be tetanized in the fully active state and plateaux of 
force generation obtained. The identical relationships were 
shown to apply to cardiac muscle which, even though it cannot 
be tetanized, permits points obtained from successive contrac-
tione and representing a series of instantaneous curves, to be 
utilized instead. Using isolated cat papillary muscles, 
Abbott and Mom!'laerts( 4l) and S0nnenblick( 42 ) have shown that 
16~ 
the relation between the total load lifted by an isoton cally 
contracting after-loaded muRcle and the initial velocity of 
iP.otonic shortening is a curve ident ical to tr.at for skelet~l 
muscle. This is shown in Fig. 2 ( e.fter Sonnen bl i ck) . ( 42 ) 
FIG.2 
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In the ieometric twitch, cer~a1n characteristics of cardiac 
muscle are evident: 
( 1) As the initial length of the muscle fibre is increa3ed, 
the tension developed and the rate of tension development both 
increase, so that the interval from the onset of contraction 
to the peak of tension development remains constant, provided 
the frequency of contraction, temperature and ionic environment 















(2) When the initial muscle length is ircreased during the 
period of tension recording, both r esting tension and developed 
tension (he ight of tension curve) are increased. The behaviour 
of resting tension and developed tension on increase ir. i it 1 al 
lengtt. occurs according to the relationship shown in Fig.4, 
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(3) By increasing the frequency of contraction , both the 
rate of tension development and the developed tension are 
increased, illustrated in Fig.5, redrawn from Sonnenblick.( 42 ) 
500 1000 
FIG. 5 TIME ( msec) 
(4) InotrofiC Interventions: 
The add1t1on of inotropic agents e.g. norepinephrine or 
additional calcium ions, bring about certain specific alterations 
in the relationships of force, velocity and time. 
(i) Increase in calcium concentration results in an 
incr~ase in the rate of tension development and the 
peak developed. tension, with minimal reduction in 
the time-to-peak-tension period. 
(ii) Addition of norepinephrine results in an increase 
in the rate of tension development and peak developed 
tension with also a substantial shortening of the 
time-to-peak-tension period. 
(iv) Isotonic Force-Velocity Relationships in Cardiac Muscle: 
The same relationships were investigated in isotonically-
contracting cardiac muscle. ( 37 ' 42 ) A small adju·stable pre load 
was provided and the preloaded length-tension relationship 
obtained. The muscle was then allowed to develop tension 
against an afterload and overall shortening occurred once the 
afterload was lifted. The initial velocity of shortening on 
lifting the afterload was plotted against the total load; 
a curve sjmilar again to that of skeletal muscl·e was obtained. 
As the afterload was increased, the muscle developed increased 
force to meet this load, following which shortening occurred. 
As the afterload increased, the initial velocity of isotonic 
shortening and the extent of shortening progressively decreased, 
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The curve relating velocity of shortening to load is once again 
identical to the curves seen for skeletal muscle.(39,40J · 
The theoretical point, with no load on the muscle, or 
conversely, totally unopposed force generation, when velocity 
of ~hortening by extrapolation would be maximal, is labelled 
as 11 Vmax". ( c.f • Fig. 6) • Since in accordance with the 
resting length-tension relation of the papillary muscle, a 
significant ~reload is necessary to establish the initial 
length that will produce such a contraction, Vmax cannot be 
directly determined, but is obtainable only by extrapolation. 
20. 
Similarly if the afterload is increased to the point at which 
no shortening occurs and the contraction occurs isometrically, 
the isometric twitch-tension is obtained, "Po". 
is also indicated in Fig.6. 
This point 
(a) Effect of varying initial length on isotonic force-velocity 
relationships. 
If the initial length of the' muscle is · increased by increas-
ing the preload, with each increase in initial length a new 
cu'rve is obtained, yielding a series of force-velocity curves 
which, whfl'n extrapo.Lated to zero load, produce convergence to 
a common Vmax; this is illustrated in Fig.7 - redrawn from 
Sonnenblick.< 42 ) In this figure each individual curve represents 
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If the external work performed by the muscle (i.e. total load X 
distance of shortening) and its power (total load X velocity of 
shortening) are calculated, the relationships are as represented 
in Fig.8, redrawn from Sonnenblick.< 42 ) 
21 .. 
At any given initial muscle length, with constant 
frequency of contraction and chemical environment, the work 
and power of the muscle become necessary functions of the 
load. 
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FIG. 8 
As initial muscle length is increased, the maximal work the 
muscle would perform , as well as the load at which the maximal 
work i s performed, are both increased. At any one load, 
increasing initial muscle length, increases the work accomplished 
22. 
and the velocity of shortening; hence the power is increased 
as well. 
(b) Effect of inotro ic interventions and chan es of rate 
on force-veloci t y re at1ons. 
If pre-load, initial length and afterload are held constant, 
the rate of tension development (dT/dt) and the velocity of 
shortening (dl/dt) could be changed by varying the frequency 
of stimulation, by changing the environmental calcium conc en-
tration or by th e addition of an inotropic agent e.g. norepi-
nephrine. It can be shown that such inotropic interventions 
produce their effects without alteration in the elastic compon-
ents. Su'h effects are shown in Fig.9 (redrawn from Sonnen -
blick. <42 ) 
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In each instanc e the initial ~1scle length is held constant. 
In panel A it can be seen that as frequency of contraction is 
increased there is an increase in Vmax , with little or no 
increase in Po. When norepinephr1ne is added an increase in 
both Vmax and Po was observed (Panel B). When [Ca ++J is 
increased, there is also an increase in both Vmax and Po with 
a parallel shift in the curve (Panel C). 
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(v) Force-velocity relationships and intrinsic contractility: 
From the foregoing, it becomes evident that cardjac muscle 
will readily, under the influence of inotropic st·imu] i, alter 
its relationship between Po and Vmax i.e. its force-velocity 
relationships. It io thio readiness with which cardiac muscle 
will alter its force-velocity rela~jons ar:.d hencP itt: co1·t1·~ctile 
state, which proviJec a fundament~l functional distinctiJn 
betwee.'1. C>J.1.•J.iaG muscle and skeletal r::iuscle. Tn changing Vm':a.X, 
R.n inotropic intervention induces a change in the b'lsic state 
of the muscle a.nd an altered st'i.te of contr.-:a.ctility 13 engenJered. 
Inotropjc actions are :::1.ccompanie,l by shortt3ning of the dur::!.tion 
of contr~ction, hence changes in the r:1te of force development 
at a.11.y onp muscle length should reflect alterations in thP 
force-velocity relation alone without necessary alter~tion in 
length-tension relations. 
Two import:in t generalities about card:..ac muscle therefore 
become apparent: 
(i) an increJ:1.se in muscle length induces an increa3e in 
the force of contraction ( as in skeletal muscle). 
With increasing fibre length, the increase in force 
(Po) is engendered without a change in Vmax. 
Vmax therefore remains to defi'le and quantify the 
basic state of the muscle. 
(i i ) At a:iy one mu:1cle length increasing frequency of 
contrf.i.Ct ion or alteration in chemical envi r:)nment 
may readily alter the rate of force development or 
the peak force developed, without prolongation of. 
the duration of contraction. A change in Vmax will 
therefore have occurred. 
24. 
A s<.11.amary of these principles io provided in Fig.10 -
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In changing Vmax an inotropic interve1tio~ induces a change 
in the basic state of the muscle and hence changes its 
contr:ictility. 
(vi) Definition of Contractil1ty: 
After these considerations one may de.fine contractilit 
of card~ac muscle as follows: 
"Changes in myocardial cont ractili ty may be defined as 
changes 1n the performance of the muocle that arise from 
alterations in the relationship, during the active state 1 among 
force, velocity, f1bre length and the time-course after excita-
tion". 
Using these terms, changes in the performance of the 
heart resulting fro~.changes in the fundamental properties of 
the contr~ctile machinery of _ the muscle are said to repre3ent 
changes in myocardial contractility; changes in performance 
25. 
~rising secondarily from changes in physical conditions out-
side the .contractile elements e.g. increase in load or fibre 
length, are not. 
B. PHYSIOLOGY OF TH"E MYOCARDIUM IN THE INTACT H~ART, 
Prepar.!,ttions used J.n the study of isolated cq,r1iac muscle 
are necessarily depriv~d of blood and nervous supply and can 
therefore har1ly be considered as met~bolically nor~al. More-
over the responses of these electrically driven preparations 
need not necessarily reflect•the behaviour of the rhythmical y 
beat.lng heart. 
Aside from the Ldentity of the contr~ctile machinery, 
certai~ mechanical par~llels may be noted between the operation 
o! the papillary muscle anrt the i~tact heart. Its a gross 
approximation, the heart functions as an afterloaded muscle 
i.e. the heart has its initial fibre length established by a 
small preload (ventricular end-d iastolic pressure or effective 
filling pressure); with activation the ~nyocardium develops a. 
force equal to the afterlo~d (aortic pressure) after which 
shortening of the muscle occurs with ejection. 
(1) Length-Tension Relationships in the Intq.ct Heart. 
Frank, using the isolated frog's heart, demonstr~ted ~hat 
t~e height of isometric tension generated by the left ventricle 
depends on the initial filling of the ventricle.( 23) He 
interpreted his findings, though, as indicating that it is the 
initial tension in the muscle, rather than fibre length which 
acted as the factor determining the force of the Bubaequent 
contraction. Frank aleo succeeded in showing that the output 
of the ventricle increased as its filling was increased. 
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He did not, however, measure the volume of the ventricle and 
again interpreted his findi~gs as pointing to the initial 
tension in the muscle as the determinant of the increased output. 
Ueing the dog's heart-lung preparation, Patterson. Piper 
and Starling demonstrated that it was by increasi~g its volume 
and hence the length of its fibres that the heart increased its 
force of cont~action and stroke output.< 43 ) . These workers 
observed that the tension as assessed by intraventricular pressure 
recording! need not change at all in the presence of large 
increases in volume on increasing the output of their preparation. 
This led them to the conclusion that, "the output of the heart 
is a f 11nction of its filling, the energy of its contraction 
depends on the state of dilatation of the he3rt's cavities" 
which forms the basis of Starling's Law of the Heart.< 24 ) 
Subsequently others have concluded that it is the intra-
ventricular tension rather than fibre length( 44 ) or both 
factors( 45 ), end-diastolic fibre length and i~itial tension, 
that are responsible for the characteristics of the subsequent 
contraction. 
In a definitive study, Braunwald et a <46 ) measured 
simultaneously left ventricular circumference, usjng a mercury-
filled reaist~nce gauge, and intraventricular pressure. The 
relationship between left ventricular end-diastolic pregsure 
and end-diastolic circumference was examined under condition8 
of varying output and resistance to outflow. These investiga-
tors found that the relationship between left ventricular end-
diastolic pressure and end-diastolic vol~me remained constant 
when both aortic pressure and stroke output were varied over 
wide ranges. An increase in myocardial contractility was 
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accompanied by increased carjiac output while mai~taini ne the 
same end-diastolic pressure and volume. At the end of thei~ 
exp~riments, depreasion of myocardial· function was a_ways 
indicated by an increase i~ end-diastolic circumference at any 
given end-diastolic pressure. These observ~tions lend support 
to the view that in the intact heart it is the circumference 
rather than the intraventricular pressure that influences the 
force generated by the subsequent beat. as originally proposed 
by Patterson, Piper and Starling. 
Linden and M1tchell( 47 ) came to the same concl1 si::ms in 
their study of the relation between left ventricular diastolic 
pressure and myocardial segment length. These authors defined 
a curvilinear relationship between these two var~ablea in the 
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Two portions of the curve are apparent, one in which during low 
ventricular pressure, a small increase in pressure is accompanied 
by a large increment in myocardial segment length and one in 
which at high end-diastolic pressures a substantial increase 
in pressure is required to elicit a small increase 1~ segment 
length. 
The clinical implications of the se relationships have been 
discussed by Braunwald.(4B) 
28. 
Starling's Curve: 
The relationship between end-diastolic preasure, end-
diastolic volume and the output of the heart was considered by 
Frank( 23) and formed the basis of Starling• s Li nacre Leet-ire 
on the Law of the Heart.( 24 ) A curve was descr1 bed al(>ng which 
the heart behaves in terms of output ~s the inflow · a varied. 
The curve had three portions; an ascending portion, an ~p1cal 
flat portion and a descending portion, i~terpreted to indicate 
a state of failure of the heart to meet it~ demand~. Thi.!'5 
curve was based on work performed in the heart-lung prepar!:ition 
dnd serious doubt was cast on whether these relationships 
applied to the function of the intact ani~al's heart.( 25) 
Sarnoff and Berglund()b) using the intact dog, made a 
meticulous study of the applicability of Starling's Law of 
the Heart to their prepar~tion. These authors examined the 
relationships between filling pressure and ventricular stroke 
work rather than volume, under a wide range of physiologjcal 
circumstances. Sarnoff's curves were obtained by plotting 
the ventricular stroke work (in gram meters per ~troke) against 
the mean .atrial pressure on the eame side of the heart. 
A typical example is shown in Fig.12 - redrawn from Sarnoff a.nd 
Berglund.( 36 ) This curve showed an initial steep rise at low 
filling pressure and flattened off to a plateau with little or 
no decline even at high filling pressures. These authors could 
never demonstrate such a descending limb i.e. a fall in stroke 
work at high filling pressures in the normal heart with an 
intact pericardium. It could be demonstrated, however: 
(1) when left main coronary artery flow was compromised. 
(2) in the presence of severe anaemia. 
29. 
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These authors stressed further11ore the importance of using 
stroke work which takes into con8ideration the pre~sure 
agai~st which the output is delivered rather than output alone. 
They came to the conclusion that a s ... -igle Starling's curve 
cannot always satisfactorily describe the function of the heart, 
but that for a given heart there is a series or family of 
Starling curves, with the heart having the capacity to move 
from one curve to another depending on the functional stat;.e of 
its control Starling curve and begin to function on a n~w higher 
curve. 
On the basis of these observations Sarnoff has defined 
myocardial contractility as follows.( 49) 
"When from any given end-diastolic pressur,e or fibre length, 
the ventricle produces more external work or more external stroke 
power (stroke work per systolic second) an increa~e in ventricular 
contractility is said to have taken place". 
Implicit in this definition is an increased rate of 
development of tension when contractility increases. Specifically 
excluded is any increased work that may be performed as the 
result of an increased afterload from the same end-diastolic 
length, eince the rate of development of tension is not increased 
30. 
under such circumstancee. 
In a further seri~s of experiments investigating the role 
of the central nervoue system on ventricular performance, 
Sarnoff et al, demonstrated that the position of the heart on 
a particular Starling curve was determined by the level of end-
diastolic filling of the left ventricle, whereas the particular 
Starling curve the heart was operating on, was determined by 
the degree of sympathetic or para-sympathetic sti-:n.ulation.< 5o) 
These authors demonstrated that the symp~thetic system affected 
ventricular contractility directly, but that the effect of vagal 
stimulation on the ventricle was secondary to its effect on 
atrial activity. Sarnoff and Mitchell integrated their find-
ings(5l) and concluded that the use of the left ventricurar end-
dia.stolic pressure as a determinant of left ventricular stroke 
work or power in th~ construction of left ventricular function 
curves would appear to be quite valid. '.l'hese investigations 
countered to a large extent the objections raised by Rushmer( 52 ) 
who felt that tn the intact animal the basic muscle physiology 
applicable to isolated preparations was so obscured by nervous 
and humoral factors that the basic principles were never called 
into action. In later work the latter author(53) has demonstra-
ted the validity of the assumptions governing the pressure-
circumference relations in the left ventricle in the intact 
unanaesthetized animal. 
(c) The Role of the Afterload: 
In the intact animal the role of the changing afterload 
or arterial pre3sure on length-teneion relationships ariaes as 
an important q1iestion not applicable to the isolated muscle 
preparations where this remains constant. This aspect was 
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investigated by Sonnenblick and Downing.< 54 ) These workers, 
using the cat heart preparation, evaluated stroke work as a 
function of LVEDP at different controlled levels of aortic 
pressure and showed that at any given LVRDP stroke .work was 
very much dependent upon. aortic pressure. Over a wide range 
of aortic pres~ures (75 - 120 mm Hg mean aortic pressure), 
stroke volume was maintained constant. Only when mean arterial 
pressure was raised to more than 150 mm Hg did a decrease in 
stroke volume occur at the same LVEDP. Their conclusion was 
therefore that stroke work (product of stroke volume and mean 
aortic pressure) is determined in the intact heart ~ainly by the 
contractile state and the aortic pressure. An increase in 
contractility induced by norepinephrine was consistently 
accompanied by an increase in stroke volume at any given LVEDP. 
They also suggest that alterations in contractility may be 
better described in terms of the relation between stroke volume 
and LVEDP rather than between stroke work and LV~DP, thus 
excluding the limi tatio.ns imposed by a changing afterloa.d. 
The same lfmitations also apply when using stroke power (stroke 
work/duration of ejection) to define contractility. The relation 
of ventricular ejection rate (stroke volume/duration of ejection) 
to LVEDP was suggested as ·a useful measure of contractility by 
adding the dimension of time without the li~itations of the 
afterload. 
(d) Heterometric and Homeometric Autoregulation: 
Taking into consideration these principles, the stroke 
work of a ventricle de~ends on two separate intrinsic mechanisms 
at any given state of contractility. Firstly, the ventricular 
work may be increased at a constant arterial pressure by augmen-
tation of stroke volume. This involves the Frank-Starling 
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principle and involves an increase in end-diastolic ventricular 
volume. Secondly, if the stroke volume is maintai~ed constant, 
the arterial pressure and consequently the work of the ventricle 
may be increased over a wide range with yery little alteration 
in LVEDP. This is in accordance with the afterload principle 
and allows for large changes in ventricular work without imping-
ing on the reserves provided by the Frank-Starling principle. 
These two phenomena have been termed heterometric and home0-
metric forms of autoregulation respectively by Sarnof~( 29, 49) 
Homeometric autoregulation has important implications: 
(i) it allows the ventricle beating at any given rate 
to eject the same stroke volume agai~st a wide range 
of resistances without requiring an increa~ed end-
diastolic fibre length with its attendant mechanica l 
disadvantage. In a fash i on it a c ts to ensure hetero-
metric autoregulation over ce1·tain ranges of function. 
( ii) the increases in contractilj.ty, especially tha;t aspect 
of it exhibited as a more raridly developed ventricular 
pressure, shortens the froportion of the total cardiac 
cycle that is occupi ed by systole which is, of course, 
of great advantage when heart rate is increased. 
Diastolic interval with its important implications 
for ventricular filling and myocardiaJ· perfusion is 
maintained as long as possible. 
The application of these principles in the function of 
the human heart has recently been outlined by Braunwald.(55) 
(2) FORCE-VELOCITY RELATIONSHIPS IN THE INTACT H~ART. 
The work of Frank in the frog's heart( 23) and Peserico(5 6) 
in the tortoise heart, suggested an inverse relation between 
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the rate of ventricular contraction and the resistance against 
which the ventricle ejected. Fry et a1< 57 ) and Levine and 
Britman(SB) · have investigated the force-velocity relationships 
in the intact heart more !undame~tally, attempting to formulate 
these relationships in terms of the rate -of shortening of the 
contractile elements themselves and the intra.myocardial force 
generated. These investigators have demonstrated conclusive-
ly that the force-velocity relationship existi~g in isolated 
cardiac muscle applies also to the contractile elements of the 
intact ~etabolically-aupported spontaneouely-beating mammalian 
heart. 
However, aortic and ventricular pressures do not remain 
constant throughout the cycle, particularly during ejPction 
and intraventrioular pressurA cannot be directly equated with 
intramyocardial :force since, in accordance with the La Place 
formulation, the relation is greatly dependent on ventricular 
volume, which changes onc·e ejection commences. These investi-
gators have therefore attempted to establish the relationships 
between intramyocardial force, velocity of shortening and fi.bre 
length at any instant in the cycle. A series of instantaneous 
observations are then considered. 
A.V. Hill's model of the components of skeletal muscle i~ 
therefore adapted for cardiac muscle in tte intact heart as shown 
schematically in Fig.lJ. It consists of a circumferential 
arrangement of contractile elements attached to one another by 
a series of relatively stiff springs which represent the series 
elastic components of the heart. The elasticity represented by 
the other spring, running parallel to the contractile elements, 










One would therefore vioualize systolic ejection as the 
result of a grou~ of contractile elemente which are shorten-
ing and applying tangential tension through a series of sprjngs 
to a hollow cavity. The presence of these springs means that 
the shortening v~locity of the contractile elements wilJ not 
be the same as the shortening velocity of the muscle as a 
whole. 
The availability of electromagnetic flowmeters placed 
around the root_ of the aorta, electrical recording calipers 
and high-fidelity pressure transducers has made it possible to 
obtain simultaneous observations of preesure, volume and flow 
at s elected points during the cardiac cycle. 
{i) Obtaining "Force" in the Intact Heart: 
The ventricle is considered to be a sphere. The instan-
taneous systolic volume can be obtained by subtracting from 
the end-diastolic volume the quantity of blood ejected up to 
the point of measurement, this be ing obtained from the flow-
met er t r acings. From this, the instantaneous radius can be ~, 




( where v is the instantaneoui. systolic volume). 
The total tension (T) developed by the myocardium at its 
equator can be obtained from the formula. 
T=P · Tir2 
(where Pie the intra.ventricular pressure in grams/cm~) 
This is then normalized according to the formula. 
T' = f_r' 
2s 
(where T' iB tension per unit length of circumference per 
unit of wall thickness). 
P = intra.ventricular pressure in gm/cm2 
r' = midwall thickness in cm 
s = instantaneous ventricular wall thickness in,cm 
Thia tension, T, represents the force in Hill's force-
velocity relationship. 
(ii) Obtaining Velocity of Shortening in the Intact Heart: 
The instantaneous rate of shortening of the circumferential 
fibres comprising the inner equator of the ventricle (Vcf) can 
be calculated from the flow rate, obtained by differentiation 
of the flowmeter tracing. 
dv/dt = 4 fTr2dr/dt 
(dv/dt = aortic flow rate) 




i.e. aortic flow rate 
2r2 
To calculate the shortening velocity oj the contractile elements 
thems elves it is necessary first to derive t he rate of l engthen-
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ing of the series elastic component. 
The rate of ~ension development (dT/dt) is related to both 
tne stiffness of the beries elastic component (dT/dl) and the 
rate at which the series elastic component lengthens (dl/dt). 
1n.i.t1 rel.ation dT/dt = (dT/dl)(dl/dt) 
may be arranged dl/dt = ai~~i 
The s~iffness of the SEC, dT/dl can be calculated from a value 
of T obtained from a coefficient derived from isolated cardiac 
muscie and involveR the assumption that ite modulus of elasticity 
remains cons~ant during the entire contraction. 
dT/dt can be calculated from the measured dp/dt since 
T=h 
2 
where T = tension per unit length of circumference 
P = intraventricular pressure in gm/cm2 
. . dT/dt = ir. dp/dt + p(dv/dt) 
Sin1. e V cf= - 211 dv/dt, by substitution 
d T/dt = ..L•d p/d t - p•Vcf 
2 4TT 
This supplies one· with dl/dt (per cm of circumference) i.e. 
the rate of lengthening of the SBC, which occurs as the rate 
of shortening of the contractile element. This value dl/dt 
multiplied by the circumference o:f the ventricle can be 
considered equal to the Vee, the "velocity" of the force-
velocity relationship. During ventricular ejection dl/dt is 
added to Vcf to obtain Vee to compensate for the change in 
volume that occurs. 
When Vcf and Vee were plotted against myocardial wall 
tension=at isovolumic points in beats subjected to a range 
of afterloads, an inverse relation between tension and velocity 
37. 
could be demonstrated by both groups of author9. In addition, 
it was shown that this relation between force and velocity, 
and its extrapolations to Vmax and Po wei;-e markedly altered by 
norepinephrine and in t}ie o11po.si te a irection by acute heart 
failure or the administration of barbiturates. 
The relationships in the intact heart may thus be summarized: 
(1) there is a reciprocal relationship between the 
tension in the muscle a.nd the velocity with which 
it is shortening at any instantaneous volu~e •. · 
(2) for any instantaneous tension the velocity of 
shortening increases with heart volu~e. 
Fry et al made the obsei·vat · on that the tension-velocity 
relationship in the intact heart is greatly dependent on 
fibre length and suggested that with reference to the cardiac 
muscle, it is more appropriate to refer to its·length-tensicn-
velocity relationships. 
These methods, although considerably more sophisticated 
than any others previously used, still involve several 
assumptions, mainly concerning the effects of alterations in 
vol~~e of the ventricle during ejection. In order to obviate 
these, Ross et al resorted to the ·def:cition of the force-
velocity relation in single isovolumic beats, obtained by 
rapidly occluding t.h~ aortic root by means of a pressure-driven 
balloon.< 59 ) They showed that such determinations of force-
velocity curves could provide insight not only into the level 
of contractility, but also provided a means whereby the 
influence of changes in resti ng fibre-length on the force-
velocity relation could be analysed. Similar observations have 
recently been reported in the conscious dog by Taylor et a1.< 60) 
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Using radio-opaque markers sewn on to the ventricle and high 
speed radiophotography, Sonnenblick et al have also estab:fshed 
the application of the force-velocity relation to the human 
heart.( 27 , 61 ) 
(3) Act i ve State in Muscle and Force-Velocity Relation: 
Ross et al(59) observed that when Vee was plotted against 
time during single contractions, a measurable delay in the 
achievement of maximum Vee always occurred. These findings 
agreed with those of Levine et a1( 6i) who found that the 
ventricle is mechanically fully activated wfth its active state 
close to maximal within 30-50 msecs after the onset of pressure 
rise in the intact heart. Ross et al(sg) also demonstrated 
by comparison of isovolumic and isotonic beats, a secondary 
rise in Vee at the onset of ejection in the isotonic beats. 
Vee and ~rticularly its maximum rate of shortening varies 
therefore even within the isometric phase of ventricular con-
traction. Angelakos et al( 63) made the same observation using 
a sensitive intraventricular micromanometer. 
These changes in active state were not observed by Levir.e 
and Britman(SB) using the measurement of blood flow at the root 
of the aorta assn index of the rate of contraction. The 
velocity of blood flow at the root of the aorta may therefore 
not ac.curately reflect events in the myocardium.. The suggest-
ion becomes evident that the measurement of·intraventricular 
pressure remains the most faithful measure of myocardial 
mechanics available. The reason for these alterations in 
active state are not clear. It has been suggested that these 
may be entirely the result of alterations in compliance occurr-
ing with realignment of fibres during contraction(57) and may 
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not be true alterations in contractile element action. 
Sonnenblick, however, suggested as a result of observations 
in cat papillary·muscles, that in cardiac muscle, for a given 
contractile state, once shortening has commenced, the i~stan-
taneous velocity of shortening becomes a function of instan-
taneous muscle length, essential)y independent of the point 
at which shortening began.(b
4 ) Inotropic interventions 
accelerate the onset of the maximal active state, in9rease its 
intensity, shorten its duration and hasten its decline.(
6S) 
Similar conclusions are drawn by Brady(bb) who points out that 
the force of the contractile elP.ment must precede externally 
manifested tension, at least by a small segment of time, but 
at present the isome~r1c contraction itself appears to be the 
best available index of the time course of the active state in 
heart muscle. These concepts have recently been synthesized 
into a three-dimensional model describing the interrelationship 
of these various factors. ( 
67' 68) 
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C. DETERMINATION OF CONTRACTILR STATE IN THE H~ART OF THB 
fflACT ANIMAL. 
Highly sophisticated apparatus and techniques were 
required to. establish the pr i nciples previously outlined and 
to demonstrate that the same fundamenta.l relationships between 
force, velocity of shortening and fibr-e length which obtain 
in isolated cardiac muscle are also applicable to the functional 
contractile elements of the intact spontaneously beating heart. 
Extensive surgical manipulation, anaesthesia and open-chested 
pr~parations were oft~n necessary. Such measures are obviously 
not practical or even possible in the study of the fully intact 
conscious animal or subject. It there ore remains to select 
aspects of these techniques that could be applicable to the 
study of the intact animal. 
{a) Pressure Measurement in the Isometric Phase of Ventri ular 
on traction. 
It has already been indicated that the measurement of 
intraventricular prPssure( 59 • 65) remains the most faithful 
measure of myocardial mechanics available. Likewise it has 
also been stressed by Brady that analysis of the isometric 
cardiac contractions gives the best insight into the time 
course of the active state in heart muscle.< 66) It remains 
therefore to investigate.the feasibility of utilizing the 
measurement of pressure during the isometri.c phase _ of ventricu-
lar contraction as an index of the contractile state of the 
ventricular muscle, since measurement of intraventricular 
pressure, although presenting certain problems pertaining to 
catheter systems, remains a simple and readily adaptable 
procedure. One is obliged to assess, however, to what degree 
accuracy has to be sacrificed for simplicity and applicability. 
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The value of the rate of development of ventricular 
pressure as an index of ~erformance capacity was first 
commented on by Frank who noted in his exreriments on the iso-
me~ric curve of contraction of the frog's heart that the 
gradient of the slope of the ascending portion of ventricular 
pressure is determined by the degree of ventricular filling.( 23) 
He also defined the segment of the maximal velocity of short-
ening by stating that the maximal velocity is prior to the peak 
pressure being reache~. Wiggers observed in the dog's heart 
that as LVEDF is increased, the height of pressure and the 
slope of the isometric curve .both become greater.< 69 ) He also 
demonstrated that when adrenaline was administered to his 
preparation an increase in the height of pressure and the 
gradient of tne slope during the isometric phase of ventricular 
pressure occurred without any _concomitant rise in LV~DP:(45) 
WiggerEf not only defined the fact that the isometric period 
showed a steeper rise, but also that it occupied a shorter 
period of time; i.e. max dp/dt was increased. 
(b) DetPrmiriants of LVmax dp/dt. 
The haemodynamic determinants of the maxi~al rate of rise 
· of pres.sure (max dp/dt) have been investigated in detail by 
several groups of workers.(70,7l) The findings of Wallace and 
his co-workers( 7l) can be summarized as follows:-
(1) if the heart rate is increased, (their range was 
80 to 220 beats/minute), LVmax dp/dt increases 
in linear fashion. Aortic pressure and stroke 
volume were kept constant. 
(2) LVmax dp/dt increases linearly with left ventricular 
end-diastolic pressure (LVEDP), achieved by increas-
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ing stroke volume at constant aortic pressure. 
(3) if aortic pressure is increased while maintaining 
rate and LV'EDP constant, LVmax dp/dt increases 
linearly in the range between 60 and 140 mm Hg 
mean pressure. 
(4) if ventricular activation i's altered by pacing 
with ventricular electrodes instead of atrial 
' electrodes, LVmax dp/dt decreases immediately, 
even in the presence of a concomitant rise in 
LVEDP. 
(5) the inotropic agents norepinephrine and acetyl-
strophanthidin cause an increase in LVmax dp/dt 
in the prPsence of a fall in LV~DP. 
LVmax dp/dt can therefore be utilized to serve as an 
index of extrinsically induced changes in myocardial contrac-
tility. Interpretation of changes in LVmax dp/dt can be done 
only after taking into consideration alterat~ons in heart rate, 
aortic pressure and LVE.DP. Reeves and Hefner also showed, 
using direct measurements of myocardial tension by a Walton-
Brodie strain gauge, that in response to inotropic interven-
tions max dT/dt, total tension and the Tension Time Index, 
obtained by multiplying tension by rate, were. increased. ( 72 ) 
In their experiments max dT/dt consistently revealed greater 
changes than the other measurements. 
~: 
The influence of heart rate on LVmax dp/dt has been critically 
evaluated by Mitchell, Wallace and Skinner(?3) who came to the 
same conclusions as the previously mentioned authors. Their 
work was however performed in the right heart by-pass prepara-
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tion. This same aspect has since been investigated in the 
conscious dog by Nob{e et al( 74-) and the same generalizations 
were found to be applicable in that LVmax dp/dt increases 
linearly with heart rate in the presence of controlled after-
load and initial fibre length. 
Afterload: 
The influence of the afterload, i.e. aortic pressure, on the 
rate of development of left ventricular pressure was first 
realized-by Wiggers.( 6) He indicated the need for control 
of this variable in the assessment of contractile responses. 
Wallace et al{?l) investigated the role of the afterload during 
conditions of constant stroke volume and heart rate. Eleva-
tion of mean aortic pressure resulted in a linear increase in 
LVmax dp/dt whether or not LVEDP rose. When aortic resistance 
was abruptly increased between two consecutive contractions, 
such that the first contraction after elevation was initiated 
from the same LV~DP, a linear relationshi~ was once again 
demonstrated between LVmax dp/dt and mean pre~sures, between 
50 and 130 mm Hg. These authors found an equally good correla-
tion of LVmax dp/dt with aortic diastolic and aortic mean 
pressure. 
LVEDP: 
This was shown to influence LVmax dp/dt in virtually predictable· 
fashion according to the Frank-Starling principle. The 
definitive studies are commented on by all the aforementioned 
groups of authors.(?O,?l,?2 ,73) 
Reeves et al(?O) demonstrated that the infusion of methox-
amine, a sympathomimetic agent with virtually pure alpha-
adrenergic activity and the effects of which on the heart are 
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produced through alterations in the peripheral vasculature 
only, resulted in an increase in LVmax dp/dt as well a~ an 
increase in systolic pressure. From their published data 
it is evident though that a relatively large increase in 
LV"EDP is required to effect an increase in LVmax dp/dt. 
(c) LVmax dp/dt as an Index of Myocardial Contractility: 
The behaviour of LVmax dp/dt with haemodynamic alterations 
and inotropic interventions have been discussed and the similar-
ity between its changes and those of the force-velocity relation 
and in particular Vmax, is evident. The fidelity with which 
LVmax dp/dt reflects alterations in the force-velocity relation 
and hence the basic contractile state of the myocardium,has 
been the subjec~ of several recent investigations. 
The assumptions involved in extrapolating force generation to 
tension development and pressure measurement have been outlined 
by Badee~.< 75 ) 
The peak rate of tension generation in the myocardial 
fibres, as reflected by pressure generation, occurs during the 
midportion of the isometric phase of the ventricular pressure 
curve. This is indicated in Fig.14 obtained from· a high 
s~nsitivity photographic recording in a dog during an inotropic 
stimulus, an infusion of isoproterenol. The oscilloscopic 
beam here had a light source with 3600 oscillations per second. 
During the peak phase of isometric tension development, the 
recorded line is separated into its component dots on this 
100 mm/sec recording. It is apparent that the greatest distance 
between the dots appears just prior to aortic valve opening. 
The highest output of a differentiator circuit, appearing as 









( time lines 100 msec) 
curve. The electrocardiogram is also shown. 
The relation of peak LV dp/dt to contractile element 
events was investigated by Ross et al in their study of iso-
volumic beats in the dog heart.( 59 ) These authors succeeded 
in relating LVmax dp/dt to the time course of the velocity of 
contractile element action as shown in the composite Fig.15 
(taken from RoAs et al(59)). 
This shows the time course of events occurring during three 
single contractions, one being isovolumic (open squares), one 
against a relatively high afterload (control, open triangles), 
and one against a lower afterload (unloaded, closed circles). 
The relation of peak dp/dt to aortic ejection and left 
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ventricular pressure generation is clearly demonstrated. 
FIG. 15 
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Deserving of comment is the fact that in the isovolumic beat 
in which ejection was prevented, the peak dp/dt coincided 
. 
exactly with that in the beats in which eJectioh occurred. 
In a recently reported comparative study, Covell et al(? 6) 
critically evaluated the value of the force-velocity curve · 
obtained in single isovolumic beats, the peak rate of rise of 
left ventricular pressure (LVmax dp/dt) and the ventricular 
function curves relating LVEDP and stroke work and power, as 
indices of contractility in the canine right heart by-pass . 
preparation. Stimuli of alterations in heart rate, norepine-
phrine infusions and hypothermia were employed to change the 
contractile state. These authors demonstrated that the 
force-velocity curve measured in isovolumic beats; is the most 
sensitive index of myocardial contractility, but significantly 
demonstrated that LVmax dp/dt was not greatly inferior. 
This measurement revealed smaller, but distinctly comparable 
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changes during all their alterations in inotropic state and 
was greatly supe~ior to the work or power v.s. LVEDP curves. 
During several subtle alterations in contractile state, the 
former measurements revealed changes whereas the latter ones 
remained unchanged. 
Tolman and Young(??) using the heart-lung preparation also 
measured simultaneous changes in the slope of left ventricular 
pressure tracings and alterations in stroke work v.s. LVEDP 
and came to the same conclusions. A similar study was also 
recently reported in the conscious sedated dog by Taylor et 
a1( 60) who measured l eft ventricular pressure and its first 
derivative through a short polyethylene cannuli3, inserted direct-
ly through the chest wall. Isovolumic beats were obtained by 
a power-driven balloon situated just above the aortic valve on 
a catheter. Their conclusions correlated well with those of 
Covell(? 6) and Tolman and Young.(??) 
These various groups of investigators all demonstrated 
that although not as accurate as actual force-velocity curves, 
LVmax dp/dt closely approximat es the more sophisticated 
measurements as an index of myocardial contr~ctile state and 
is more sensitive than the curves relating stroke outp~t, work 
or power to LVEDP. These conclusions serve to confirm the 
views previously expressed by Rushmer.(7B) 
The use of LVmax dp/dt as a measure of myocardial con-
tractility has been reviewed by Siegel et al.(79) These 
authors have proceeded to show how, , by the use of time-tension 
relationships during the isometric phase of left ventricular 
contraction, LVmax dp/dt,as a measure of contractility,can be 
amplified. (BO) Out of their observations emerged the fa·ct 
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that a fundamental difference can be identified between the 
way in which myocardial isometric force is developed by the 
Frank-Starling mechanism and by a primary change of contrac-
tility in the contractile element. Using the right- heart 
by-pass preparation and isolated papillary.muscles, these 
authors demonstrated that at a constant rate of stimulation, 
increments in initial length produced no alteration in the 
durat;ion of · the ris·ing phase of isometric tension ( taken from 
onset of tension rise to peak tension). Both the maximum 
integrated systolic isometric tension (IIT), obtaine~ by 
planimetrically integrating the area beneath the rising phase 
of the isometri.c contraction, as well as the maximum rate of 
development of the tension, (or pressure) dp/dt increased with 
increases in end-diastolic volume and fibre length. 
The ratio~ remained constant therefore over the entire 
range of fibre lengths studied. In the presence of an increase 
in myocardial contractility, the r9.ti.o-~ increased to a new 
constant which was independent of fibre length. Unlike 
increases in initial length, in which both dp/dt and IIT 
increased in parallel, keeping a constant ratio, with an ino-
tropic intervention, dp/dt increased much more th~n IIT so that 
the ratio~ increased. An increase in rate alone also 
resulted in an increase in the ratio dp/dt. These authors 
~
suggest that these observations are consonant with force-
velocity data in that increments in fibre length, which increase 
Po without increasing Vmax, also do not alter the ratio~· 
They further propose that the net effect of examining the ratio 
~ is to eliminate the effect of changes in Po produced by 
fibre length alone so that the index is altered only by changes 
in Vmax relative to Po i.e. by true primary alterations in 
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contractility. 
Clinical application of the measurement of dp/dt has been 
-reported by Gleason and Braunwald.(Bl) These authors examined 
the f~rst derivative of the ventricular pressure pulse in human 
subjects by monitoring pressure with a needle introduced direct-
ly through the chest wall. A limited number of observ~tions 
were also obtained by ~n intracardiac micromanometer si~1ated 
at the tip of a cardiac catheter. These authors demonstrated 
an incrPase in LVm~x dp/dt -i ~ the human heart with infusion of 
isoproterenol, exercise and after ventricular premature contrac-
tions. Unlike the effects of acute elevations of ventricular 
end-diastolic volume, haemodynamic abnormalities that result 
in a chronic augmentation of ventricular stroke volume, did 
not result in abnormal values for LVmax dp/dt. It was found, 
however, to correlate well with the peak systolic pressure 
chronically d~veloped by the ventricle. It was postulated that 
the high LVmax dp/dt observed in ventricles that developed 
elevated pressures reflect the increased muscle mass that is 
present. This is consonant with the views of Sandler et a1( 82 ) 
who presented P.Vidence that the thickness of the ventricular 
wall increases in proportion to the systolic pressure chronically 
developed by the ventricle. Patients who had experienced 
congestive heart failure or who had roentgenographic evidence 
of left ventricular enlargement and- elevation of the ventricular 
end-diastolic pressure tended to have lower values for LVmax 
dp/dt than might have been expected according to their systolic 
pressure and heart rates. This may be explained accord ing to 
the Law of La Place as outlined by Rushmer(B3) and Gorlin.( 84) 
It is apparent that any given rate of development of tension by 
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the myocardium in a dilated heart, would result in a slower 
rate of pressure rise and, hence, in a low LVmax dp/dt. 
Buckley and Zeig(B5) have also ·demonstr~ted in the isolated 
heart that acute left v~ntricular failure is accompanied by a 
decrease in the rate of ventricular pressure rise. 
(d) TECHNICAL ASP'ECTS OF TH'E MEASUREMENT OF dp/dt IN THE 
IRTAaT HIA~T. 
Differentiation: 
The maximum rate of rise of pressure in the left ventricle 
can be obtained either by manual estimation of the steepest 
slope of the left ventricular preasure curve on high-sens i tivity, 
high-speed tracings or by electronic differentiation of the 
output of an electronic pressure transducer. This can be 
accurately and .automatical-ly ~chieved in continuous fashion by 
the R-C circuit. The output of such a circuit is proport.ional 
to the first time derivative of the s i ne wave of ·the left 
ventricular pressure course. 
are indicated in Fig~16.< 86 ) 
The components of the R-C circuit 
o----.l 
INPUT - CAPACITOR 
.-- RESISTOR OUTPUT 
FIG. 16 
If a current is passed through such a circuit, the total 
voltage drop will occur across the resistor. A certain phase 
lag will be imparted by such a circuit (with reference to the 
original current). Negative charges will accumulate on one 
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side of the capacitor. As the charge accumulates, the voltage 
ac~oss the capacitor increases and the current in the.circuit 
decreases. Since the sum of the voltage across the resistor 
and the capacitor must equal the original applied voltage, when 
the voltage across the capacitor increases, the voltage across 
the resistor must decrease •. This decay will occur at a rate 
proportional to the time-constant of such a circuit. A graph·ic 
description of the series of events, usine square-wave changes 
in voltage are shown in Fig.17. ThP. effect of a reduction in 
the time constant is also indicated. 
FIG. 17 
INPUT VOLTAGE 
t = R C 
3 
By means of such a circuit, the first derivative with respect 
to time of the pressure pulse ·can be determined at any inst'i.Ilt 
in the cardiac cycle. The time-constant of such circuits are 
usually of the order of 0.1 to 0.5 msec, providing differentia-
tion with output frequency linear to i~put frequency in the 
range 0-75 cycles per sec. 
Recording systems: 
The limitations of recording systems used in the measure-
ment of cardiovascular phenomena have been outlined by Wood.(B7) 
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In a detailed analysis of the requirements -Of recording systemf 
Fry has set the following criteria for such a system:(BB) 
(i) it must have static accuracy i.e. it must have 
stability and be free of drift from a constant 
baseline. 
(ii) it must have dynamic accuracy i.e. it must si~ulate 
the ~ynamic events with fidelity: This implies 
that it must be free from noise artifacts, endogenous 
or exogenous. 
(iii) it must have low physiological reactance i.e. it must 
produce minimal interference with the events due to 
its physical presence. 
Since such systems are comprised of (a) a transducer 
(b) an amplifier and (c) a ~ecorder, the fidelity of such a 
system, and particularly its amplitude response (amplitude rat: 
at any given frequency) will be equal to the product of the 
amplitude response of each of the components. 
Modern equipment consist of transducers with sufficient 
dynamic accuracy to have a linear response at frequencies well 
beyond the limits of any cardiovascular phenomena. The ampli-
fier and recorder systems, particularly if oscilloscopic syste! 
with photographic recording is used, can for all practical 
purposes be considered as not contributing to any distortion o: 
the signal, apart from the possible introduction of noise 
signals. These are of particular importance if high amplifi-
cation ratios are used but may be partially attenuated by the 
- introduction of electronic filters into the circuit. 
The limiting factor of importance in all these systems 
therefore is confined to the method of connection of the trans-
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ducer to the system being monitored e.g. a catheter system. 
Micromanometer systems have recently been devised whereby the 
transducer, built into the tip of a catheter, can be introduced 
into the required situation where pressure is to be sensed. 
These micromanometer~, apart from being expensive, have certain 
limitations which preclude their use under most circumstances, 
notably the inability to be calibrated according to a ze~o 
standard while in situ. 
Limitations of Catheter-manometer Systems: 
Catheters have great limit~tions that contribute to the 
inaccurate recording of physiological events. These have been 
discussed by Fry(BB) and by Franke.(B9) The use of such a 
probe as a transmission system almost always degrades the 
~ 
dynamic response of the transducer system since i n general the 
physiological information will be distorted in transit through 
the probe and noise, generated from extraneous sources along 
the probe, will appear at the transducer element indistingu1sh-
ably from the physiological information. Characteristically 
the pressure-monitoring system has~ fluid-filled column between 
the blood vessel or ventricular cavity and the transducer mem-
brane. The catheter tube usually has stiff walls and is filled 
with physiological saline solutionp For faithful recording of 
pressure as a function of tlme, the deflection of the membrane 
should be directly proportional to the pressure at the catheter 
tip. The membrane needs to be defl·ected by the pressure and 
hence the fluid column in the catheter must be physically dis-
placed by the pressure pulse. The inertia and viscosity of 
the fluid mass in the catheter will therefore enter importantly 
into the dynamic response of the system. The presence of air, 
even in microscopic bubbles, can alter the physical charac-
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teristics of such a column to a profound extent. Outward 
displacement of the walls of the catheter will serve to 
attenuate the pressure wave. 
Pressure recording errors in such a system arise from both 
the intrinsic transmission properties of the system as well as 
from "noise" related to extrinsic motions imparted to the system 
by direc.t contact of its walls with mov lng systems. 
The intrinsic transmission properties may impose four 
groups of errors oq the.physiological event:-
(1) Multiple reflections of the frequency cornponents:-
frequency components approaching the various "resonant 
frequencies" of the system may be greatly amplified 
because of summations of reflected waves with incoming 
waves if they are in phase. 
(2) Unequal attentuation of the different frequency 
components during transmission. 
(J) Different transmission times for each frequency 
component. 
(4) Wave generation from extrinsic motions. 
The need for assessment of the fidelity of such a system 
is therefore evident. The dynamic accuracy of such a system 
may be determined from its frequency response curve. This will 
be outlined in detail in the Methods section. 
Since the first derivative of ventricular pressure is a 
function of frequency, rather than amplitude, the degree of 
damping in the catheter system is of utmost importance. Any 
significant damping will retard the upstroke of the pressure 
curve. The importance of using systems with low damping ratios 
is thus desirable, but such systems are often non-linear for 
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amplitude even at low frequencies. The contribution of non-
linearity for amplitude to the recording of the derivatives 
of pressure is not known. Knopp et al(90) comparing a sh~rt 
tube directly inserted into the left ventricle with a conven-
tional catheter system, found that the catheter-manometer 
system tended to underestimate rather than overestimate LVmax 
dp/dt. Their catheter-manometer system, however. was operated 
with the output passing through a 15 ·cps filter and the contri-
bution of this enters another variable. 
The frequency range of dynamic events in the cardiovascular 
system has been variously estimated to lie between 0-20 cps by 
Wiggers(9l), 0-33 cps by Klip< 92 ) and even 0-100 cps by 
McDonald.(93) The latter two estimations are, however, based 
on theoretical considerations. McDonald in an extensive 
series of Fourier analyses of cardiovascular wave forms, 
suggests that for practjcal purposes, a range of 0-20 cps is 
adequate.( 93) Knopp et ~l(go) used a system linear to 90 cps 
and conducted Fourier analyses on their recording~. They found 
that 95% of the energy components of significance occurred at 
15 cps or less, even at high heart rates. 
included direct measurements of LVmax dp/dt. 
Their estimation~ 
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). THE AIMS OF THES'E IN'V'ESTIGATIONS. 
The !actors known to influence myocardial contractility 
have been discussed and a method suitable for the assessment 
of the contractile state of the myocardium in the int~ct 
animal has been outlined. 
It has been known for a long time that thyroid diseases 
are associated with profound cardiac mani!estatione. · The 
}1.yperthyroid state is a.ssocia.ted with a hyperkinetic circ,:i.la-
tory derangement whereas the opposite situation holds in hypo-
thyroid conditions. The incidence of cardiac disease in both 
!!ituations is much greater than is commonly appreciated.<? 4) 
Two mechanisms for the haemodynamic manifestations of 
thyro-cardiac di3eases have been invoked. Firstly the hormone 
may have a direct effect on the myocardium and secondly it may 
act by sensitization 0£ the heart muscle to the effects of the 
sympathetic nervous system and the catecholamines. An extensive 
literature, recently reviewed by Harrison< 95 ) has arisen attempt-
ing to prove either or both of these mechanisms. 
The purpose of this thesis and the experiments described is 
to assess the role of thyroid hormone as a possible determinant 
of myocardial contractility in the intact ani~al. The animal 
model used was the intact conscious dog in an effort to eliminate 
the variable effects of anaesthesia. Myocardial contractility 
was assessed primarily by the estimation of LVmax dp/dt, in an 
attempt to gain insight into the force-velocity relations of 
the myocardium under the influence of thyroid hormone. In 
addition the more conventional expression of contractility in 
terms of output, rate of output, work and power in relation to 
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LVEDP was obtained simultaneously. Contractility is assessed 
accordi ng to the conditions outlined by Blinke(9 6) and by 
Blinke and Koch-Weser.(97) 
In this fashion it is hoped to establish whether effects 
of the hormone are in a primary fashion affecting the funda-
mental properties or the contrac~ile machine or whether the 
changes in performance ari~e solely secondary to effects removed 
from the heart. 
Using the dog with experimentally induced hypo- and hyper-
thyrodism,the alterations in myocardial contractility attribu-
t~ble to changes in thyroid statue are defined. An attempt i ·e 
then made to characterize the increased contractility encountered 
in the hyperthyroid state in terms of fractions associated with 
the increase in heart rate and that med i ated directly by the 
hormone. By means . of the beta-adrenergic blocking agent, 
propranolol, the incre~se in contract ility in the hyperthyroid 
· state is further analysed into a fraction due to increased 
stimulation of beta-receptors by endogenous catecholamines and 
. 
the fraction induced by a direct action o! the hormone. 
The 1~fluence of alterations of thyroid state on the 
contractile responses to beta-adrenergic stimulation was investi-
gated by infusions of isoproterenol in normal, hypothyroid and 
hyperthyroid dogs. Thyroxine (T4) was used to induce the hyper-
thyro id state; experiments were also performed with triiodo-
thyronine (TJ) to demonstrate the rapidity with which thyroid 
effects on myocardial contractility could occur. 
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4,. PROTOCOLS, MAT'ERIALS AND M'ETHODS. 
The level of myocardial contractility was mea~ured in normal 
adult dogs, in dogs rendered hypothyroid by the administration 
of r1 31 and in dogs treated with thyroij hormone until hyper-
thyroid. All animals were kept under the same conditions at the 
.facilities of the New England Primate Research Centre, Southboro, 
Massachueette. 
Normal dogs: 
These were both males and females randomly selected from a pool 
of animals reared under the same conditions. The animals had 
to appear normal in all respects and had to be free from infected 
wounds. Autopsy confirmation of normality at the end of experi-
ments was obtained in all animals. All dogs with heartworm at 
autopsy were excluded from the series. 
Hypothyroid dogs: 
These dogs were from the same pool, but had been treated with 
11 31 from six weeks to twelve months prior to study. These 
animals had commenced to gain weight and had elevated serum 
cholesterol levels, but did not show the external manifestations 
of gross myxoedema. 
Myxoedematous dogs: 
These animals had been given rl3l two years prior to study. 
Myxoedema as evidenced by marked weight gain, a dry scaly skin 
with lard-like subcutaneous tissues and failure of hair growth 
after shaving was present in all animals. Serum cholesterol 
levels were grossly elevated. 
Hyperthyroid dogs: 
These animals were randomly selected from the pool of dogs and 
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were studied in the normal state. Following the baseline study, 
they were given 1-thyr~xine by subcutaneous injection daily for 
periods ranging from one t6 four weeks. 
(a) Induction of Hypothyrodism: 
Animals were given 1131 by intravenous injection. A single 
dose of 25 millicuries was given after obtaining baseline weight 
and blood samples for estimation of total serum cholesterol. 
A repeat dose was given three weeks later. This procedure had 
previously been found to render dogs hypothyroid without rap1:lly 
causing death.(gB) Haemodynamic studies in these animals were 
performed as early a:, six weeks after' 1131 and as late a.s 2! 
years after administration. The progress of the hypothyroid 
state was monitored by estimations of body weight and total 
serum cholesterol. Protein-bound-iodine estimat ions were 
initially obtai~ed, but were discarded since all animals had 
. 
radiographic procedures involving iodine-containing contrast 
media which rendered future estimations invalid. 
Untreated dogs maintained under the same conditions retai~ed 
normal levels of serum cholesterol without any weight gain in 
a period of observation of one year. 
In order to exclude possible effects of secondary complica-
tions of hypothyroidism e.g. pericardial effusions or coronary 
atherosclerosis on the haemodynamic profile of these animals, 
coronary arteriography was performed in all animals at the 
conclusion of each study. After completion of the series of 
experiments, each animal was examined at autopsy. The heart was 
removed, weighed and the coronary arteries were injected with a 
radio-opaque injection mass of lead acetate in agar, according 
to the technique of Schlesinger.(99) 
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Roentgenograms were obtained a~d examined for any lesions of 
the coronary arteries. Pericardial effusions were not found in 
any of the animals. Heartworm was ,found in two of the dogs and 
· these were excluded from the series. 
(b) Induction of Hyperthyroid State: 
Eight dogs were studied in the normal state. Treatment was 
then com~enced with 1-thyroxine sodium (1-T~). The powder was 
dissolved in O •. 1 N Sodium hydroxide solution and diluted to the 
appropriate concentration. 
by subcutaneous injection. 
Each dog was given 0.1 mg/kg daily 
Each animal was studied after 7 
days of treatment and again at three or four weeks. Since no 
differences were found between the studies at three and four 
weeks they are treated as a single group. In this fashion each 
dog served as its own control. A further control was obta · ned 
in one dog stujied in the baseline state, after one week of 
thyroxine administration, after a further two weeks of the 
solvent for thyroxine alone and finally after a further one week 
of thyroxine again. 
Conditions of Studz: 
All studies were conducted after overnight fasting. 
Morphine sulphate 1.5 mg/kg was given subcutaneously one hour 
before the commencement of the experiment. The resulting 
sedation was light enough to permit the animals to walk from 
their cages to the catheterization laboratory, but sufficient 
to enable catheterization to be rerformed without any need for 
restraints or muzzling. 
Percutaneous catheterization of both ventricles and the 
aorta was performed by the Seldinger technique.(lOO) Two 
percent procaine was used as local anaesthetic. 
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Faemodynamic observations were obtained on two occasions 
fifteen minutes apart to define the baseline before any further 
procedures were initiated. 
2. Relative Contributions of Heart Rate and Associated Auto-
regula Lory Component ancl the Direct 'Effect of the Hormone. 
In the dogs submitted to thyroxjne treatment the influence 
of an increase in heart rate on LVmax df/dt was assessed during 
the control study and after induction of the hyperthyroid stat.e. 
The rate increase was achieved by electrical stirr.ulat-ior- of the 
right a trit;im. The importance of maintaining the normal path-
ways of conduction in the assessment of myocardial contract1lity 
. (22) ha8 been emphasised. Rate - LVmax dp/dt curves were 
obtaine~ in all dogs during the control and hyperthyroid statee 
and the curvee analysed for significant differences in eleva-
tion and slope. Information was also obtained on whether the 
autoregulatory mechaniRm .Ltself was altered by thyroid treat-
ment. In all studies. the pacing was performed immediatel;r 
subsequent to obtaining the baseline haemodynamic observaticns 
i.e. before any drugs were adffiinistered. Complete carture of 
the sinus mechanism had to be obtained w· th a normal PH interval 
on the electrocardiogram before the tracings were accepted for 
&.nalysis. 
3. 
Sutsequent to obtaining baseline haemodynarnic observations 
in all animals, infusions of tl:e beta-adrenergic stimulant, 
jsoproterenol were administered to all animals. This agent was 
chosen because of its relatively pure beta effect in comparison 
to both norepinephrine and epinephrine, both of which were 
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found to have significant alpha effects with resulting brady-
cardia in their.tact animal. Better dose-resfonse curves co~ld 
therefore · be obtained both for contractility and heart rate 
with isoproterenol compared to norepir:ephrine and epinephrir. e. 
The dose levels used ranged from O .01 to C. 20 pg/kg/min in all 
animals. This rather narrow range was adhered to becaus~ of its 
relative freedom from both ventricular extrasystoles and rest-
lessness in these conscious animals. Since disflacement of the 
curve as a wholP rather tha extension of its extremities was 
involved it was found to be s.3:tisfactory • .All infusions were 
standardized by being of twelve minutesduration with observations 
obtained at that time in all instances. A constant rate of 
ir.fusj on was ma"lr:.tained by means of a Braun pump. 
4. Relative Contributions of ~ensitization to Endogenous 
at.echolam1nes and DirAct li!ffect of the Hormone on the 
Myocardium. 
This was investigated in the group of dogs rendered hyper-
thyroid by complete pharmacological blockade of the beta-
receptors with propranolol. This was done during the control 
euthyroi d study and again after hyperthyroidism had been 
~nduced. The degree of beta-b1ockade obtained with 0.4 mg/kg 
proprano)ol was assessed by challenge with the highest dose 
of jsoproterenol used in the stimulation experiments, 0.2 )lg/kg. 
5. 'Effect of 1-triiodothyronine on Resting HaemodynamJcs 
and Responses to Isoprotere_!!ol. 
16 normal and 6 hypothyroid animals were used to examine 
the influence of 1-triiodothyronine (l-T3) by infusion and in 
another 4 dogs by single injections. Baseline observations 
were obtained in all animals. After this, infusions of iso-
proterenol were administered as usual and observations obtained. 
6). 
Follow:i.ng a rest period of one hour during wh ich the baseline 
state was again obtained, an infusion of ·1-triidothyronine was 
commenced and observations repeated after 15 minutes. The 
infusions of isoproterenol were then repeated in the same doses 
for the same periods. The experiments were controlled by 
infusions of the 0.1 N Sbdium hydroxide U3ed as solvent for the 
l-T3, diluted to the same concentrations with normal sali~e as 
when the l-T3 was added. 
The experiments were repeated, in o~der to establish 
specificity for l-T3, with d-Triidothyronine in exactly the same 




- The catheters used were the same in all animals. Where 
possible the same catheter was used repeatedly in the same dog 
undergoing serial studies. The catheters were inserted over a 
P .E.160 ''Kifa" guide wire (United States Catheter and lnetrurrient 
Co., Glens Falls N. Y.) inserted through a 1.6 gauge Seldir..ger 
needle after· withdrawal of the stilette. Size 6F, "Rotrene II" 
polyvinyl catheters ,Electro-catheter Corporation, Rahway, N.J.), 
8Q cm long with fo~r side apertures within 1 cm from the tip 
were used for all experiments. The catheters were moulded into 
a "pig-tail" curve for left ventricu lar cannulat1on and with a 
gentle "C 11 curve for rigbt ventricular cannula ti on. 
shapes are indicated in Fig.18. 
FIG. 18 L. V. R.V. 
The two 
The catheter used for cannulation of the aorta was left straight. 
The femoral arterie!I were punctured after making a puncture in 
the skin with a pointed knife-blade. large enough to insert the 
needle. The catheters were inserted and pos·tioned in 
the ventr.1cles and aorta by retrograde advance under direct 
fluoroscopic monitoring with display on a closed-circui t tele-
vision module. The aortic cathet r was placed with its tip . : 
in the arch of the aorta. The catheters were connected 
directly through a ·three-way sto cock to the transducers 
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rep~atedly flushed with heparinized rhY?iologicaJ Ral~ne 
solution. Ea.ch dog was given 20 mg ne pa.r i a at the completion 
of c~thetecization and thereafter 10 mg every hour by intra-
venous injection. 
Pacing Instruments: 
Used was a bipolar pacing catheter (United States Catheter 
and I nstrument Co., Glens Falls, N.Y.) inserted by cutdown under 
local anaesthesia on either a brachial or an exte rna.l j ug,i lar 
vein. The catheter was advanced under d.rect vision on the 
fluoroscopic screen into the right atrium and the paci ng unit 
~ttached. The impulse generator used was a specially ~edified 
Electrodyne TR-6 exter~al pacemaker, capable of delivering 
impulses at a rate of 0-200 per minutes (courtesy of ElPctrodyne 
Company, Westwood, Massachusetts). rhe minimal rate sufficient 
to cause repetitive stimulation was oqtained and obser-.rations 
recorded after 5 minutes. The r ..... te was t'.len increased step-
wise by 10 beats per minute s.nd A.teach new rate haemodynamic 
observations obtained after 5 minutes. Tracings were discarded 
when A-V block developed. 
Recorders and Transducers: 
The electrocardiogram, left ventricular prP.ssure at 11 · gh 
and low sensitivity, aortic pressure, t~e first derivative of 
left ventricular pressure and a zero baseline were displayed 
continuously on the oscilloscopic screen of a~ Electronics for 
Medicine D.R.8 recorder, {Electronics for Medicine, White Plains, 
N. y •) 
Recordings were obtained at high speed (100 mm/sec) for 
analysis of events within the cardiac cycle ~nd at slow speed 
(10 mm/sec) for accurate estimation of heart rate. The time 
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markings were set at 0.1 sec intervals for tne hign speed 
tracings and at 1 sec intervals for the slow speed. At least 
ten cycles were included in each high speed trace and the sloN 
trace was obtained over a 30 second period, during the perfor~~ 
ance of a cardiac output . estimation, in order to obtain an 
accurate estimation of stroke volume. 
All recordings were obtained ph~togr~phically and fixed 
for high resolution i n order to obtain accurate records for 
estimqtion of ejection times. 
Pressure measurements were obta i ned with P23dB pressure 
transducers, (Statham Instruments, Hato Rey, Puerto Rico), 
placed level with the midchest po i ~t. These transducers were 
calibrated against a mercury column at the start of each day . 
Amplification was through SGM-2 channels of the EFM DR8 
recorder. The low sensitivity pressure trace was recorded 
directly thr?ugh the channel whereas the output Nas amplified 
by a ratio of approx1mately 10 through a slave channel to 
obtain a high sensitivity tracing for analysis of changes in 
left ventricular end-diastolic pressure. The low sensitiv i ty 
trace gave a deflection · of 35-40 mm deflection/ 100 mm Hg. 
Pressure in the aorta was measured simultaneously with a 
second channel calibrated to equal the displacement of the 
channel used for left ventricular pressure measurement. 
Right ventricular pressureo, when recorded, were obtained 
through a channel with its sensitivity augmented by a factor of 
4 in comparison with the left ventricular measurements. 
LVmax dp/dt was obtained continuously by differentiation 
of the left ventricular pressure signal by the built-in R-C 
68. 
saline. Blood was withdrawn from the aortic catheter at the 
rate of 50 ml/mir.. by means ·of a constant-rate Gilford withdrawal 
system (Gilford Instrument Laboratories Inc ., Oberlin, Ohio). 
The blood was paesed through a Gilford cuvette densitometer and 
the output of this recorded with a Texas Instruments"Rect1-
Riter
11
d:irect-writing ink recorder. (Texas Instruments Inc •• 
Houston, Texas). The speed of recording was 1 cm per sec 
enabling manual integration of the dye-dilution curves to be 
performed at O .5 sec intervals. A concentration curve for tte 
dye was obtained at the conoJusion of each experiment with the 
same dye used in the experiments and the blood of the particular 
animal. 
curves. 
Four points were obtained in all these concentration 
Curves were replotted on a semi-logarithmic scale 
with the initial portion of the down-slope extrapolated to meet 
~ 
the X axis in order to exclude the effect s of recirculation and 
arrive at an accurate estimate of the transit time. 
output was obtained from the formula: 
I Q 








output in ml/min. 
amount of indicator injected in mg. 
area under dye curve (mg/ml.sec)(l02 ) 
Micromanometer: 
The cardiac 
Thie was used in six experimente to test the .adequacy of 
the frequency-responses of the catheter-manometer system. 
The model SF 1 catheter-tip transducer (Statham Instruments, 
Hato Rey, Puerto Rico) was inserted into the left ventricle by 
retrograde advance after insertion through a cut-down on a 
brachial artery under local anaesthesia. The pressure record-
ings were obtaine·d simultaneously with those obtained through· 
the catheter-manometer system. Tne outputs of both systems 
were differentiated and recorded simultaneously. 
Calibration of the micromanometer was performed in situ 
against the c~theter-manometer system and ·its derivative out-
put was caljbrated manually on 200 mm/sec recordings done at 
high sensitivity. 
CALCULATIONS: 
(1) Heart rate: 
This was vbtained from 30 sec slow traces at 10 mm/sec 
by manual count1nr. When artificial Jiacing was employed, the 
interval between stimuli was measured on 100 mm/sec tracing~ 
and the rate calculated as 
1 
Rate-= 60 x StimuI"us interval 
(per min) (Sec) 
(2) Prfrnsures: 
These were read off directly against calibration scalP.s 
applied electronically at the beginning and end of each experi-
ment. LVEDP was read against its own calibration scale wit~ the 
junction of the "a" wave and the commencement of the rapid up-
stroke of LV pressure, taken as the reading. The first 
derivative of pressure was obtained by manual measurement of 
the displacement of the beam and the reading obtained in mm Hg/ 
sec as outlined above. 
ted as follows: 
Mean aortic pressure (MAP) was calcula-
MAP= Systolic pressure - Diastolic pressure + Diastolic pressure 
3 (in mm Hg) 
10. 
(J) Ejection Time: 
This was obtained by direct measurement from the 100 mm/sec 
tracings of aortic pressure. The inte.rval between the commence-
ment of pressure increase in the aorta and the nadir of the 
diastolic notch was measured and calibrated according to the 0.1 
sec time markings on the recording. The first few cycles o! 
-each period ~ere excluded to avoid errors due to the initial 
acceleration of the paper moving at such great.speed. 
( 4) ·Stroke Volume and Stroke Volume Index: 
This was obtained by dividing the cardjac output (in ml/min) 
by the heart · rate per minute. 
S.V. = U:~: in ml. 
The stroke volume index was calculated in those instances where 
comparisons were made between various dogs. 
S VI _ Cardiac index 1. n ml/m2 • • • - Heart rate 
The cardiac index wa~ obtai ed from the cardiac output according 
to the formula: 
Cardiac index = Cardiac outi:,µt ml/m2/ 1· Surface area m n 
Where surface area= 0.112 x Wt~ in kg2/3 (lOJ) 
(5) Stroke Work and Stroke Work Index: 
The work performed by the ventricle during each beat was 
calculated as the product of stroke volume and mean aortic 
pressure. 
Since work (W) = Force (F) x Distance (D) 
and pressure (P) = Force ~ F) Area {A) 
while volume (V) = Distance (D) x Area (A) 
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the equation for Work can be wrjtten 
F w =AX D.A. 
= P x V 
The work of the ventricle consists of the sum of two components 
i.e. the work perfo~med in overcoming the pressure against 
which the blood is ejected and the work done in imparting 
velocity to the blood ejected as represented by the formula 
originally proposea o~ Frank.( 2 3) 
w = 
where To -
p is the 
V is the 
M is the 
V is the 
g is the 




Tl je; the beginning and end of aortic ejection 
integratea mean pressure operating during _this 
volume of blood ejected i.e. stroke volume 
weight of the blood ejected 
mean velocity attained by the blood and 
gravitational constant. 
period 
The second component i.e. the kine.tic component is for 
practical purposes about 2% of the total work(l04 ,l05) and since 
the use of the arithmetic mean pressure rather than the sy~tolic 
pressure integrated with respect to time, reduces the accuracy 
of the calculation by about 10%, it was elected to disregard 
the kinetic component and calculate only the "pressure energy" 
component. 
The formula was therefore -
SW= (MAP - LVEDP6 X SV X lJ.6 1 00 
12. 
where SW = stroke work in Gm meters 
MAP = mean aortic pressure in mm Hg 
LV'EDP = left ventricular end-diastolic pressure in mm Hg 
sv = stroke volume in ml 
13.6 = factor to convert mm Hg to cm H20 
The resulting answer is divided by 1000 to obtain the more 
useful dimensions of gm.meters. 
Stroke work index (SWI) was obtained by substituting the 
stroke volume index (SVI) for stroke volume in the above equation. 
It is expressed in Gm/m 
Stroke Power and Stroke Power Ind~: 
The rate of performance of work during the period of 
eject ion was calculated: 
Stroke Power (S.P.) = Stroke work ject1on time 
in gm.meters/sec. 
The stroke power index was obtained by substituting the stroke 
work ind ex for stroke work in the above equation. 
expressed in @l'l/m/systolic sec. 
It is 
The power of the left ventricle indicates the rate at 
which the left ventricle performs work as the continuous product 
of aortic flow and 12ressure. This effective power is not a 
measure of the total rate of energy liberation because the 
viscous losses within the myocardium, which are probably not 
negljgible, are not measured. Instead the power measurement 
may be interpreted as a measure of the rate at which energy is 
transferred from the left ventricle to the peripheral vascula-
ture. (l0 6) 
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.§1etolic ~je~tion Rate: 
This was calculated according to the formula: 
Stroke Volume Systolic ejection rate (s.~.R.) = Ejection ~ime 
with the 1ndex, expressed as the mean systolic ejection rate 
(MSEN), calcul~ted using the stroke volume index.(lO?) 
Total Perirheral Resistance and Index: 
The relat i onship between pressure and flow for the circula-
tion as a whole was expressed by· the ratio 
T 1 · h 1 · t = MPP.n presgure in sy:,tem ota perip era resis ance Flow rate 
Mean aortic pressure was used as the pressure value and 
converted from mm Hg to dynes/cm2 by multiplication with 1312. 
The flow rate was calculated as the ca.rd Jac output ex.pressed as 
ml/sec, e;iYing the formula 
TPR =MAP~ 133,~. 
where TPR -= Total peripheral resi!3tance in '.iyn .. sec/c'.'11' 
MAP = Mean arter1<£.1. :;;reasur1> in mm Hg 
Q = Card·ac outp~t ln ml/sec 
The perilJ:'leral re~;j.stance index 'T.P.R.I.) was obta .... ned by 
using the cardi~c index expressed in ml/sec/m2 
Serum Total Cholesterol: 
These were performei by the ~ethod of 3~ckett using t~e 
Lteberman-Eurchardt reaction. Colorimetric determinat·()ns were 
performed on a Klett-Summerson photoelectric colorimeter.(lOB) 
All determinations were done by one technician (J.M.B.) who 
received the specimens in coded fashion without the ·informa. tion 




The statistical approach utilized throughout w~s an 
analysis of variance. This permitted longitudinal and hori-
zontal analysis with in-group and between-groups comparisons 
e.g. isoproterenol responseG in normal dogs Gould be compared 
to responses in hypothyroid dogs. 
This method was chosen not only for the reason stated above, 
but also for its particular applicability to large groupq of 
readings. The method was used as outli~ed by Snedecor and 
Cochran. ( 109 ) The individual manipulations adapted to the 
requ1re~ent~ of t~e varioQs categories are indicated in fu11 in 
the Results section. The conventional abbreviations used during 
statistical manipu:ations are indicated i~ Table I of the 
Appendix. 
All analyses were performed manually by t~e author Nith the 
use of a standard Monroe Electronic Calculator without the aid 
of proeramm1.ng f11nctions. 
FREQU'ENCY-R"BSPONS'S CHARACTBRTSTICS OF THE CATHETER-MANOMETER SYST~:M 
The need for establishing with bertainty that the frequency-
response characteristics of the pressure monitoring system is 
adequate has already been emphasized. However, since the 
influence of non-linearity for a~plitude on the frequency-
dependent phenomenon is essentially unknown, the approach to 
this problem was to obtain not only the frequency-response limits 
of the system, but also to compare the system as a whole with a 
system with known linearity well beyond the requirements for 
cardiovascular recording. 
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The method used was to test the dynamic response charac-
teristics of a typical catheter used in t~ese experi~ents 
according to t~e method outlined by Wood.(B?) This consists 
of the application of a square-wave change of pressure to the 
system by ruptnring a highly-inflated bf.l.lloon with a rJharply 
concentrated source of in-tense heat. The more compl ica.ted 
met:'lod and a.ppara tus described by Linden ( llO) was thought not 
to be necessary since the important assessment was the direct 
compa~1son with the micromanometer sy3tem. 
A r1bber balloon was placed ov~r the dome of a transducer. 
The side aperttire was connected to an air pump and the ti:p of 
the catheter tested was introduced so th::it al l the side apert:Jres 
~ere exposed within the balloon The rest of the system was 
set up as for standard experimental recordings. The rubber 
ba..:..loon was infla..ted to a pressure of 60 to 70 mm Hg and was 
ruptured using a white-hot cautery needle. The drop in pressure, 
which appeared i:1.st9.nta.neous, was recorded at 200 mm/sec. 
A typical response is shown i'l Fi5 .19 (d19.grammatically). 
I I I I I 




Time lineo 20 msec. 
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From such a record the required data for calculation of the 
frequency-response performance were obtained. 
In linear systems, the response to a rectangular wave 
bears a relatively simple and unique relationship to the 
freql1ency-response curve of the system. If the system is 
sufficiently underdamped it will change ra.p1dly to the new value 
about which it will oscillate at 'i ta nat>.1ral frequency. The 
oscil)ations will die away at a rate determined by the amount 
.-of dampeni~g present in the system. The frequency at ~hich 
the system oscillates and the rate at which the oscillations 
die away are the data required for computation of t~e theoretical 
frequency-resI,onse curve of the system. Th~ un.ifor:n port ion of 
the curve definE>s the frequencies that will be accurately repro-
duced by the system. 
One therefore obtains 
(1) the dampening ratio (h) of t:'le system. This is a measure 
of the amount of damping actually present compared to the 
critic~l dampine (when no aftervibrations will occur). 
(2) the undamped natural frequency (Wu) of the system. This 
would be the frequency of the free vibrations if no damping 
occurred e.g. if the system was frictionless. 
The undamped natural frequency can be obtained in indirect 
fashion from the damped natural frequency. The absolute 
frequency ( W) is related to the undamped na t".lral frequency by 
a constant ratio c;). 
P=X 
P and h enter into a relationship to determine the ampli-
tude ratio (Ra)of the system. 
11. 
The amplitude ratio muut approach 1 for a system that tr.1:!.y 
measures the driving force without being affected by the frequency-
response of the system 
The frequ ncy ratio/ampl·tude ·ratiosare related accord·ng to 
constant relationsh i ps determiY'led by the damping ratio as .:s 
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FREQUENCY RATI0,,8 
In practice it ic quite sufficient to determjne only the 
frequency-amplitude ratlo and not frequency-phase lag ratios 
of such a system. 
The calculations are performe d as follows: 
78. 
h= 
2 2( ) TI + 1ne.. if 
The value for h may also be obtained from standard curves avail-
able relating the percentage overshoot to the damping ratio 
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Once h is known the undamped natural frequency may be computed 
cycles/sec 
.vti.ere Wd is the damped natural frequency, obt9. i ned by counting 
the frequency of the aftervibr~tions in cps. Once hand Wu are 
known, the frequency-amplitude r~tio curves ( Fig .20) for the 
specific value of hare consulted. 
The frequency ratio,~. obtained from the curve may then be used 
to calculate the absolute frequency of the system 
~ . w r =-ru 
W = ~.Wu 
This will indicate the frequency to which the amplitude response 
of the sys-tem may be considered uniform ( ueual ly !. 5%) • 
. The procedure was followed for 12 separate estimations of 
the frequency-re~~onse characteristics. From the analysis it 
" ,, emerged that the h values were extremely low since no damping 
was applied.to the systems in order not to interfere with the 
.frequency-dependent est imations of LVmax dp/dt. As a result 
the mean value to which this system could be regarded as uniform 
was 12 cps. This val11e is not out of line with the requirements 
for measurements o! cardiovascular phenomena indicated by Knopp 
et al. ( 9o 
However, since the influence of non-linearity of such a 
system fop amplitude on LVmax dp/dt could not be assessed in 
this fashion, it_ was thought to be more important t~ do direct 
comparison of the system used in these experiments with a system 
known to provide uniform responses to an extent well beyond 
ordinary requirements. 
Such a system is provided by' a micromanometer which can be 
introduced directly into the ventricle since it is built into a 
catheter-tip • The Statham model SF-1 transducer was therefore 
.. 
used •. The measured linearity of thi.s instrument has been 
assessed to be uniform to levels of~ 800 cps.(B9) 
In 6 separate experimen·ts left ventricles were catheterized 
as described previously with the st~ndard catheters used in all 
experiments. The amplifying and differentiating circuits 
remained unaltered from the usual experiments. A catheter- tip 
manometer was then introduced into a brachial artery by cutdown 
under local anaesthesia and advanced into the left ventricle in 
retrograde fashion and was connected to a second SGM-2 amplifying-
80. 
differentiating system. The pressures recorded by the two 
systems and their respective derivatives were recorded on the 
same record at 100 mm/sec. 
In order to cover a range of pressures and rates, the dogs 
were subj~cted to isoproterenol stimulation, atropinization, 
pentobarbital anaesthesia and methoxamine infusions. The 
tracings were analysed for pressure and LVmax dp/dt in each 
system. Pressure readings were not analysed after seeing that 
the tracings coincided at peak pressures under all circumstances, 
confirming the adequacy of the system for amplitude recording. 
Representative tracings are shown Fig.22. 
l" I I 
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This figure shows simultaneously obtained tracings during a 
control state, during pentobarbital intoxication (40 mg/kg) and 
during an isop~oterenol infusion 0.50 pg/kg/min. The close 
approximation of the peak left ventricular pressures is evident. 
It is obvious that the changes in. LVmax dp/dt recorded by the 
two systems were proportional to each other in stoichiometric 
fashion. 
The composite data for one of these experiments is given 
in Table I ('Expt. No.6/81, 22/10/68, Dog W.146). Each reading 
supplied represents the mean of 12 observations during each 
period recorded. 
indicated. 












~x = 318.1 
N = 9 
Y = 35.34 
~x2 = 11739.3 
~x)2 = 101187.6 
~2 = 1124 3 .06 
-
The statistical regression analysis is 
TABL'E I. 












:z y = 262 .8 
N = 9 
Y= 29.20 
~y2 = 8339 .1 
(3Y) 2 = 69063. 8 












~ XY = 9856.48 
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b = ~ = 576 -9 6 = 1.144 ~x2 496.28 
Y = Y + b {X-X) = 29.20 + 1.144 X - (35.34 X 1.144) = 1.144X - 11. 0 
Id 2 =ly2 - <~xy) 2 = 665.34 - 649.993 = 15.341 xy z'x2 
S 2 id ? 
xy = N _x~ = 2 • 1 g 2 ; S = l • 48 
b 1.144 
t = ~: o.666 = 17.33 (p( 0.001) 
Source Degrees I Mean 
of variation of freedom Sum o! squares Square 
The mean 1 ( ~Y)2 = 7673.76 I I 
Regression· l ~ ~ x~).2 649.99 = 
L X 
I Deviat ions from Id 2 3 = 15.35 5.116 regression xy 
Total 5 ~ ~ = 8339.10 __, 
The outputs of the two systems have a related linear regression 
to a highly significant degree (p<0.001) over the range o! 5,000 
to 11,000 mm Hg/sec, attained in this experiment. The values 
obtained in this experiment are plotted in Fig.23 on Page 8J. 
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Si~ilar highly significant regressions were obtained in the 
other experiments (p(0.001 in each instanc e). 
These findings demonstrate that the catheter-manometer 
syst em used in the se experiments gave the same degree of f idelity 
o! measurement as the micromanometer system) particularly of the 





rates concerned was 50 to 200 beats per minute and th f> range 
LVmax dp/dt was 600 to 12,000 mm Hg/sec. These findings 
consonant with the views and findi"1gs of Knopp et al(90) 
Murphy et al. (111) 
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5. RESULT .• 
1. !f.YOCARDT Al CONTRACTILITY RELATF.D TO THYHOID STATUS: 
25 norma.l and 17 dogs treated with IJ3l between 6 and 50 
weeks previously (mean 17.5 weeks), were studied. Six olserva-
tiona were also obtained in 4 animala treated with 11 31 more 
than 2 years previously (referred to as the myxoedematous group). 
These latter animals had sl.1..1ggish movements, a coars~ skin, 
sparse hair growth and lard-like subcutaneous tissues - all the 
characteristic features of myxo~dema in the dog. 
(a) Senim Total Cholc~terol: 
The oerum cholesterol levels jn 18 normal animals, for 19 
observcit~ons in the hypothyroj.d gro1.tp and for 6 ctservationo in 
tr.e myxoedematous group are indic:.ited in Table II. Since the 
animal8 were not paired, an analysis- of vari'i:1.nce rather than a 
"t-test" is performed, courpar·ne the var·ous grours as units. 
111 The I J - treated groupn could have.been treated as a pair~d 
group with each dog serving a~ its own control, but since a few 
samples were 1ost, the analy8is of var a nce is conducted instea . 
TAPLE I1. 
TOTAL SBRUM CHOLESTEROL (ng/100 ml). 
Norr:iaJ Hypo thyroid M_y:xoedernatou9 
7-J 277 543 
141 398 320 
95 131 327 
137 143 423 
117 190 474 
















L x 2261 6566 2673 
N 18 }Q 6 
! 125. 61 34 5. 57 445.5 
Zx2 2<) 6. 9 .31 2,5(4,442 1,251,179 
c Ix) 2 5,112,121 4.3,112. 1 56 7,144,929 
(2i/)2 284 ;006. 7 2,269,071.4 1,190,821 
Z:x2 12,925 2S5, 371 60,357 
. 
44.85 s. -e. 6.50 2<).44 
Comparison of Norma.l veruus Hypothyroid groups 
Normal H.Yro t h:t:T O id 
X 1 ?5. 61 34 5. 57 
d.f. 17 18 
2· ~x "12,925 295,371 ...... 
Pooled variance - 12~~5 ! 29~~71 = 8808.45 ( 5 d.f.) 
s x~ - x 2 =J a aoa • 45 < 1;1 a + l/1 q l 
=J 952.193 
t 
~ 30 .85 
:: 345.57 - 125.61 30 .q5 
for 35 d.f., t=?.1 3 . P(0.001 
= 7.1 
SjrnjJa.rly a com1 u.ri.son between the hypothyroic. and m;yxo edema.tous 
groups yielded at value of 1.72. For 23 d.f. this yields a P 
value of (0.10 and this is not regarded as significant. 
The dogs treated with rl3l therefore had serum cholesterol levels 
elevated above normal to a h1ehly significant degree. No 
difference in serum choleoterol level a was aprarent. between 
the dogs treated with rl3l between 6 an 50 weeks and those 
more than 2 years previously. 
Serum cholesterol levels were not consistently measured ic 
the dogs treated with thyroxine; several l~vels had to be 
discarded oecause of interference with the colour reaction by 
indocyanine green which had been administered for the performance 
of cardiac output determinations and the data were therefore not 
analysed. 
(b) Body Weight: 
The.values for the 17 animals before and after treatment 
with rl3l are given in Table III. The mean time of observation 
after r131 treatment was 17.5 weeks. The data for the myxoedema-
87. 
separately since each dog acted as its own control. The 
statistical method used 1.s Student's "t-test'' for raired samples. 
TABLT<".: III. 
BODY WEIGHTS (Ke.) 
Hypothyroid Group 
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Sum of squares o! 
differences = 211.11 
""d 2 LJ -
~)2 
s2 
d = N-1 






= 6 .. 538 
for 16 degrees of 
frP.edom p < 0.001 
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Sum of squares of 
differences = 245.89 
s2 
t 
~2 ~ 2 ) 
_.d -
d = N-1 
(_30. 7) 2 
= 245.89 - 4 






for 3 degrees of 
freedom p < 0.005 
'i 
Both the hypothyroid and· the myxoedematous dogs had gained 
weight to a highly significan~ degree since receiving r1 31 • 
All dogs ~ad food avaiJable at all times and could eat if they 
so wished. In contrast 12 of the normal dogs were kept under 
the same circumstances for more than six months. There was no 
weight gain in these dogs. 
The weight data for the group of animals receiving daily 
injections of thyroxine are supplied in Table IV. Since each 
dog acted as its own control the statistical method used was as 
indicated, a Student's "t-test" for paired valueR. Data are 
















s2 5.42 -= 7 d 
= 0. 214 







for 7 degrees of 
freedom p ( 0 .005 
TABL'E IV. 
BODY W1UGH~S 





11 .9 -0.5 -
11.3 -0.l 
10.4 -0.3 

























= ...-o -. 0.....,4"""5-g 
= 13.53 
for 4 degrees of 











Three of the dogs studied at one week died before the study at 
3 weeks and the ~ppropriate statistical changes were made. 
It is evident that treatment with thyroxine O.] mg/kg daily, 
caused a significant loss of weight after one week and a further 
significant loss after two further weeks of t ·reatme t. 
(c) LVmax dE/~: 
Recordings were obtained in all ~he animals. The pata are 
arranged as for serum cholesterol and body we i ght with separate 
analysis of the group recei ving thyroxine since these aniffials 
served as their own controls. The values are i ndicated in 
Table V(a ) , !or t~e 1131 treatment experiments and Table V(b) 
!or the thyroxine treatment . experiments. c . f . page 91. 
91. 
TAB:f,E v~ al. 
1._VT18.X d£Ldt ~mm HSZ:sec). 
Normal Hypothxroid My xo edema tpu!!_ 
4640 3200 2040 
4640 3300 2210 
4370 3300 1970 
4420 3340 2100 
4120 343'> 2480 




















2X 133,690 55,0JO l 1, 0h'1 N 25 17 6 X' 5,347 3,237 ? t 176 zx2 7,333,069 * 1,810,357 iE 285,946 ~ (:.EX) 2 178,730,161 30,283,009 * 1,705,636 * (ix) 2 7,149,206 * 1,781,353 * 284,273 * 
2,X2 18),862 * 29 ,oo 1 * 1. 67 J * S.E. 175.0 103 •. 3 74.7 
(M given X 10-2) 
92. 
Com1arison of Normal a"'.'ld Hyr-othyr,'.)id Grou12_s ( Analyais of va r.!_6.nce) • 
Pooled variance 
- x..., ~. 
t 
Normal H.tkOthyroic 
X' 5 34 7. 6 ')? Jn 0 .J '-· I • 
I r2 X - .( Xl0- 2 ) RJ,862 ?.9 ,00J 
(.1. f. 24 · l6 
lA 386? + 2100 2 ~ ---"'-2-4~ --=1~r---- = 5321.6 (for 40 d.f.) + 0 
::: 
= 
SJ,>.l • & ( 25 + i 7) 
5?5.774 
2 .... ')? 
yl - x2 
s- - -)tl x:2 
9.208 
for 40 d.f., 
5 34 • 7 6 - 32 3. 7 
22 .9 . 




(ii) Comparison of H,,YE~thyrojj..and Myxoedematous Groups (Analys1~ of Variance.) 
!JJ:rot~roid Myxoed~~!:!~ 
X 3231.0 2176.0 
~x2 ( xl0-2 ) 29003 1673 
d.f. 16 5 
Pooled variance = 2900J lb 
+ 167 3 = 
+ 5 1460.78 (for 21 d.f.) 




j 1460. 78 1 ( 17 + ~) 
J 329.259 
18.14 
J23.7 - 217.6 = 18.14 
106.1 
-ia-.-i-4 = 
for 21 d.f. P z 0.001 
5.84 
94. 
!.b]LE V( bl .. 
LVmax dp/dt (mm Hg/se£l.. 
Control. 1 week 1 week 3 weeks 
Th1ro2[in~. Thy_,roxine. Thiroxine. 




6,400 9,400 9,400 13 100 
6,400 8,830 8,830 1?, 670 
5,660 11,430 11,430 10,000 
7,200 10,970 10.970 10,700 
S:x 48,210 82,070 52.050 58,220 
N 8 8 5 5 
X 6,026 10,258 10,410 l] , 644 
A ~x2 2,943,381 8,547,075 . 5,477,311 6,846,g14 
A(Y.x) 2 23,242,041 67,354,849 27,092,025 33,895,684 
* ( ;x)2 2,905,255 8,419,356 5,418,405 6,779,137 
* ~x2 38,126 127,719 58,906 67,777 
S.E. 260.9 477.6 W6. 7 650.8 
c~ values given X 10-2 ) 
95. 
(i) Com arisen o! Control and 1 week trPatment eriods aired t-test. 
(ii) 
Mean difference= 423.25 











differences = 1. 648,520 
!:a2 - ( i:Nd} 2 
N-1 
1,648.520 - 1,433,124.5 
7 
30,770.7 
1025.8 - 602. 6 
.;30:no.1 
8 
~ = 6,824 
= for 7 d. f. P <0.001 
and three week treatment eriods 
Mean difference= 123.4 










= 1) 64 .4 - 1041 
/ 5'/,62.LJ 
5 
= l?).~ r-4_-.2-6 
= = 1.49 
for 5 d. f. P) 0.5 
The data !or the norma, hypothyroid and myxoedematous groups 
are shown in Fig . 24. The results obtaine d in the dogs treated 
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These, results indicate that both r131 and thyroxine induced 
highly significant deviations in LVmax dp/dt away from normal. 
1 1 31 treatment resulted in a highly significant reduction in 
LVmax dp/dt in the hypothyroid group studied at a mean of 17.5 
weeks after treatm.ent, wi.th the myxoedematous group studied 
between ~wo an~ two-and-a~half years undergoing a further highly 
significant reduction. 
Thyroxipe treatment, in the dosage used in these experiments 
(0.1 mg/kg/day) caused a highly significant elevation of LVmax 
dp/dt in each dop,. The significance of this is heightened by the 
fact ,tha t each dog acted as its own control. Further treatment 
for an additional two we~ks did not increase the levels to a 
significant degree. Inspecti.on of the data reveals, however,· 
that the animals that responded maximally in one week did not 
undergo any further increase whereas the animals that showed a 
more modest increase at one week had larger increases during the 
subsequent two weeks of treatment. 
( d) Other H'1emorl.vnamic Measurements: 
The analyses qf the values obtained for heart rate, cardiac 
index, stroke volume index, mean aortic pressure, LV~DP, ejection 
time, mean . systolic ejection rate, left ventricular stroke work 
index, left ventricular stroke power index, peripheral resistance 
index and right ventricular max dp/dt are indicated in summary 
form in Table VI; the values of LVmax dp/dt are included for the 
sake of completeness. The actual values are indicated in Table 
2 in the Appendix. In this table the mean values and the stand-
ard errors of the means are indicated with the levels of signifi-
cance of the deviations. The table is again divided into sections 
98. 
fa and (b) with section (a) containing t~e data for the 
experi1lents involving treatment with 11 31 and sectiori (b) the 
data for the experiments with thyroxine. 
TABLE VI(9.). 
6. a A from Normal :iypothyroi d from Myx- :'rom hypo-
nor'Tial thy ro i a. normal oedematous 
23 17 6 
LVma.x dJ.,/dt 
(mm Hg/Gee) 5347_175 . 3237.t.103 P<O·OO/ P<O·OOI P<O·OOI 
T-Ieart t'a te 
(per ~i~) 78!2.5 
Car1iac i~dex 3614 +ll J ( ml/:ni:i/m ) 
S.V.T2 6 5 7 r l/ - ) 4 • +1 . • m !ll 
L.V.s.r. 156 2 ( mm Hg) - !. · 9 
M.A. r- . 













P.R.I. 5 2 2 30 (dyn. sec. cm- m- ) 4 +77 
RVmax dp/dt 











193+14 .9 f<.O·OOI 
4160:t,276 f<.O·OOI 
1025;t88 P<o·o2s 
47.::.3-4 P<O·Oo/ P<o·of 
1058:,35 P<O·OOI P<O·OOI 
22 • .'3+1 . 2 P<O·OOI f<0 ·025' 
115!8. 3 P(O ·OOI f<O·OS 
87+6.6 f<o ·oo, P<o·01S 
10.18+0 .78 N.3. N.S. 
228.:_5. 4 p<o·oot f<o ·o5' 
99.:_4. 5 P<O·OOI P< 0·005' 
22. 2+1. 6 P<o·OOT P<o·005' 
97:t,6.J P(O·OOI f<o ·OO? 
6555 +48 P<O·OO t P~o.oal 
515;t95 P<O -025 N. S. 
gg . 




Cont r ol + . :r ~ No . ·~ ... ... ~ perio·d 1 week T4 3 weeks T4 0 i!C: 8 "'18 ""8 
I I 
,--I ,--I 0 
Body weightn 8 ll.B4+0 . 34 11.14+0. 29 P(. .oo5 -. (kg) 5 11 . 7 4 .t.O . 5 6 l l • 18 +O • 4 ·1 10 . ~ 6+0·. 4 7 p< ·00/ f<-001 
L'fma.< dp/dt 8 6026-i'-261 10258+477 f"< •00[ 
(.mm Hg/sec) 5 5132+ 37 3 10410 +-607 ll 644;t651 - N.s.- p<-005 
Heart rate 8 00+4. 8 112+3.CJ ~ · 00 t;° 
( per m ., ) 5 79+7.? 110+4.6 14 3:_lg - -- -----w:-s P<·o5i 
Cardiac i~d ex 8 3139+188 5080+412 p<· 00( 
(ml/min/m) 5 J957;t212 5 4 66+608 5502+5 60 - N . :!". --,r. s--: 
S.V.1
2 8 47.1+3.2 45 . 5+J.8 N.S. ( ml/m ) 5 ;l.'2+3.q 4q.6+5 . l 40.1:,4.5 -- -T "l • s ....... 
M.LP. 8 110+ 3. 5 11~+3.9 P<· o, 
(mm Hg) 5 11 o~~. 5 116+5. 7 109 _5.4 - 'N' • ('"'I 111' P< ·oS-
LV'E 1) a 8.52+1 . 28 C:-. 02 +-0 . 57 N • :5. 
( 'DID Hg) 5 8 . Q4+2 .07 4,.80+0.70 4. 44+0.72 - - 1. ,... N. S . 
~ 
r..Je~tion time Q 204 ,! • 6 176+ 3. 7 f<.. Oo/ J 
(msec) 5 207 -J.7 176+5.l 154±.9 . l ~.s. P<·oJ. 51 -
M.S .B R. 8 230+ ;.4 25.9+21 . 4 N.S. 
(ml/m /sec) 5 248_:/0. 4 284+28.l 257!_43.l --- 1L .;--:- '--~. s. 
LVSWI 8 65+c..J.2 68 , 6•4. 5 N.S. 
( ~/m) 5 70!.7-l 7 3. 6+5. 5 58 . 3.:t.8,9 -w~s: -._NI 
LVSPI 8 31'1+25 . 8 393+25 . 7 P<-02s-
(gm/m/sec) 5 342+36.7 42 3+ 30 .1 373:_46.5 c----- - NI--,~s-: 
P.R.I. 
5 2 
8 2385+126 1980+234 N. S. 
(dyn. sec/cm m ) 5 2242 +-136 l.S56;t378 1644+135 N.S. P<·o5' 
RVmax dp/dt 8 14 71+139 2559+263 P<· ot (m~ Hg/sec) 5 1 490+225 2662+37.5 2634.:t256 N • -g-,- f<.·6051 .. 
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In the dogs treated with 11 31 a signifjcant change occurred not 
only in LVmax dp/dt as indicated previously, but heart rate was 
al Ao reduced to a highly sj gnif icant iegree with a f',1rt1er 
significant reduction apparent in the myxoe<lematous group in 
comparison with the hypothyroid group AR30ciated with t~e e 
changes were parallel alterations in cardiac inde~, stroke 
volume index and eje~tion time. Peak left ventr·cular systo1·~ 
presnure waG reduced to a hi~hly sign'ficant iegree in comparing 
normal v.3. hypothyro:d and hypothyroii v.s. myxoedematous groups. 
Aorti~ mean pressure was, however, not different betNeen t~e 
normal and hypothyroid groups, but t'l-ie myxoedematous groups had 
pressures highly significantly less than nor~al and significantly 
less than the hypothyroid group. 1iV'EDP -was not sienificantly 
different i~ the hypothyroid and myxoede111atous groups in com-
parison with the nor~aJ eroup. The mean syatolic ejection rate 
was highly significantly reduced from normal to hypothyroi:i and 
further from '-lypotnyroid to myxoedematous gr:,ups, as were both 
left ventrjcular stroke work an'i power indices. A reduction :."l 
myocardial contractility of the left ventricle is therefore 
reflected also by these i~dices of. contractility in confirmation 
of the alterations encountered in LV~ax dp/Jt. 
Right ventricular max dp/dt was al3o measured i~ all 
animals. Both the hypothyroid and myxoedematous groups had 
significantly reduced values, but t~ese two groups were not 
significantly different from each other. 
Treatment with thyroxine had the opposite effect. In 
Table VI(b) the summary analyses are given. Analyses for each 
measure were conducted for the 8 animals st~died during'the 
control and 1 week periods; three animals died subsequently and 
101. 
the values obtained for the remaining five animals were extracted 
from these periods for comparison with the three-week treatment 
period. 
control .. 
In this fashion each dog acted rigidly as its own 
In additjon to the increases in LVmax dp/dt already outlined, 
heart rate, cardiac index and eject .ion times were altered signifi-
_cantly between cop.trol period and one-week treatment period. 
Further significant chanees between one-week and three-weeks 
could not be demonstrated; this may be attributed to the fact 
that fewer anima]s entered into this analysis with consequently 
much larger variances. The stroke volume index remained unaltered; 
although cardiac index t:icreased to a hithly sjgnificant degree. 
this was accomplished mainly by an increase in heart r-a.te. 
The findings with reference to mean systolic eJection rate and 
stroke work index reflected this as well. Left ventricular 
stroke power index was, however, increased significantly, 
reflecting the highly significant reduction in ejection time 
observed. Caution has to be exP.rcised i-i regarding this as a 
true 1~crease of contractility, since such alterations in ventri-
cular ejection are compatible with a mere increase in heart r9.te 
(which has with it an autoregulatory increase in contrac-
tility(l07,112). 
In t:iis group of dogs a highly signi.f icant i"l.crease i.'.l 
RVmax dp/dt could be shown between the control and one-week 
and control and three-week treat~ent periods. 
Peri~heral resistance index was not significantly altered 
after one week of treatment; this was due to a significant 
increase in mean aortic pressure that accompanied the lar~e 
increase in flow. With continued treatment for the second two 
102. 
weeks a highly signifjcant alteration in flow/pressure relations 
occurred. The cardiac i,dex continued to rise, although a P 
vaJ ue < 0 .10 only could be demonstrated ( because of a reduced 
number of an i.mals and consequently higher variance), while _the 
mean arterial pressure underwent 9. r; i gn i ficant reduction yield-
ing a significant reduction in peripheral resistance. 
(e) Conclusi0nz: 
It is possible to show that rl3l treat~ent ~nd thyroxine 
treatment induce changes in myocard i ~l contr9.ctility in opposite 
directions in nor~al animals. The evidence for hypothyrodism 
was an i ncrease in body weight and total ser~m cholesterol, while 
the animals on thyroxine, in addition to development of si~nifi-
cant tachycardia, all lost weight to a s i gnific~nt extent. 
The changes in myocardial contract .i.li ty can he demonstrated 
independently in both ventr i cles by measurement of the peak rate 
of pressure development, reflecting the force-velocity relations 
operating in the ventricles; and were shown for the left ventricle 
additionally by mechani sms utilizing the Frank-Starlin~ principle 
and man i fested as changes in output, work and power. In these 
groups of animals myocardial contractility can be correlated 
directly with t~yroin status. 
2. RELATIVE CONTRIBUTIONS OF HEART RATE AND DIR"BCT EFFECT OF HORMONE TO CONTRACTILITY CHANG~s. 
Accompanyi~g the changes i~ myocardial contractility with 
the alterations in thyroid status were, however, si~nificant 
changes in heart rate. The next phase in these investi~ations 
was directed towards assessment of the relative contributions 
of the autoregulatory alterations in contractility related to 
the changes in heart rate and the direct e~fect of the hor:none. 
103~ 
This was studied in the ani11als that had under~one an 
increase in myocardial contractility. An attempt was made at 
increasi~g the heart rate of the hypothyroid animals by atrial 
pacing to the range of normal, but this was not possible because 
of the unexpected high degree of A-V block encountered duri!'l~ 
artifici~l atrial pacing at increasin~ heart rates. 
Althou~h these experiments were performed in a)l 8 animals 
receivin~ thyroxine, records suitable for analysis were obtained 
from 6 dogs only; the other records were rejected because of the 
occurrence of A-V block to a si~ificant degree at relatively 
slow rates in one dog and in the other animal the rate at which 
pacine- was initiated was so hi,!P;h that a curve wit!l a satisfactory 
number of points on it could not be obtained. In each animal a 
rate-LVmax dp/dt curve was obtained wh"le in the contrQl state 
and a~ain after treatment with thyroxi~e. The detailed analysis 
of the findings in one animal, typical of the ~roup as a whole 
will be shown, and the data for the rest o! the ani~als will be 
shown in summary form. All the animals behaved similarly. 
except one ani:nal that had a hi~h ini-t ial rate on one occasion -
this was a particularly excitable do~ and a hi~h sympathetic 
tone may have contributed to his atypical findin~s~ 
104. 
TABLE VII. 
Dog G.495: Experiment No. 8/82, 16/8/68, 23/8/68, 6/9/68. 
( i) Control state: 
Rate: LVmax dp/dt -
( X) ( y) ( XY) 
113 6720 759,360 
122 7030 857', 660 
137 76 0 1,043,940 
151 7560 1,14·1,560 
171 7570 1,294,470 
193 8.200 1,582,600 
N = 6 
887 °2Y 44700 6,679,590 
X 147.8 1 7450 
135,713 ~ y2 33,342,200 
~2 i¥12 333,015,000 
....... 4585 l, 321,200. 71,440 
.... 
Y = 1 + bC'-Y) = 7450 + 15.58X -2303 ·- 15.58X + 5147 
~ d 2 ~ 2 ~ :Sx~) 2 = ~ xy · = ·L.. y l, 327,200 - l; 113,100 = 214,100 i:x 
sxy 
2 Id 2 
214!100 = 53,525 = ·N:~ = 
sx sxy = 2)1.3; S0 = .2Z = 2il.J = ).416 YW 1.1 
t b 15.58 (P <.O .025) = s;- = ).4lb = 4.516 
105. 
Source of variation I 
Degrees of Sum of Squares Mean freedom Square 
The mean 1 ( ZY)2 = 333,015,000 
N 
Regression 1 1!4)2 = 1,113,100 
_, X 
Deviations from 
~ 2 regression ·4 d = 214,100 53,5~5 i ---' xy 
TOTAL 6 ....., 2 334,342,200 ~y = 
For the following periods, after one week and after three weeks of 
thyroxine treatment, the procedure followed to calculate tn·e 
regressions and their significance, was i:lentical to that above. 
(ii) After ) week Th· roxine (iii) After l weeks Th:Lroxine 
Rate LVmax dp/dt Rate LVmax dp/dt 
113 7,780 130 11,570 
117 R.040 13g lc!.900 
1.36 8,680 150 13.440 
148 9,300 157 13. 640 
180 10 • 350 166 13,660 
190 10 ,o 30 187 14,180 
193 9,980 
b = 28.98 b = 3g.74 ,. ,. 
Y = 2~.98X + 4708 Y = 39.74x +· 7079 
t = 7. 98 ( P < 0 ~001) t = 3. 75 ( P < 0. 0 25) 
The procedures followed in the other animalswere identical to 
those outlined for the animal above. The collected data are 
presented in Table VIII. For all ani~als the LVmax dp/dt at 
rate 140 was obtained for analysis of statistical significance 
in both slope and elevation. These are indicated as well. 
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TABLE VITI. -
Coe!:'f i rJ cnt y I LVn:ax d T Ir!. 
Dog 
nterce ,t t'I .J " of re ·resrJj on 
1;. -1 - at r'3. te l4G No. w 3 wlrs. -
wk" 1 




G. 4 05 I 15.58 28.98 3q.74 5147 4708 7079 I 7300 8700 126 I 
I 
28. J 6 ]0 .] ( 48.00 408B 8000 8600 
G. 500 I 
4 37? ', 2fJ7 ?1 
I 10500 
G.41.6 ']o .1 3 44. 6:1 4580 4225 7400 r.773. 1() .14 :i1 .27 4187 53go 5600 I 8800 
I .c.493 
G. 4 28 
t Mea"l 
4 7. 68 37 t 34 170 3031 I I 6800 8200 17.11 22.2r-i )440 8091 5800 11~00 
2,3.lJ 31. 27 4 J.R7 3602 4<371 f2 7 3 fPl f g·n1 1?"15 
A "t tes II for paired values W' s then rer-"'or1TJed on the val ms 
occurring at rate 140 during the con rol and cne-Neek trea ment 
Jiericd. Data for 3 weeks were not i r:clud.ed because 9ati~factor.r 
curves coulcl be o bto 1.ned in t ,o u.r lrnaln only. T};.e "t teot 11 
rever.Jeii e.• !?'igni ficant e levation in tl-ie LVmax dp/dt occurr!ng 
at the same rate (1~0) after one week of thyroxi~e treatment 
(P(0.025,. A f:rar,hic illustration is Jrovic!ed in Fig.?5. ~ 
Thi.s revea.lo the in:!.tial restir:.g value for-a1J the dogs trea ed 
with thyrox:..re plotted against a curve or,tained from the mean· 
values for coefficient of regression and int ercert on the Y 
axis for .i-tll the animals in wh ich artificia.l pacing wa.fJ performed. 
The 95~ confidence limits of this curve are indicated. It is 
seen ttat in every inRtance the point, the co-ord ir,a. tes repre sent-
ir:g the LVmax dp/dt at that particular rate, fallR well'above the 
area in which this could have been contributed to by r~te ~lone . 
It io furthermore noted that all animals, exce pt one, shov.ed 
progressive increments in the coefficients of regression. Be cauqe 
the numbers were so small, statisticaJ analysis was not att empted. 
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• 1 week thyroxine 
0 
o 3 weeks 0 
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Conclusion: 
The adrriniatrat·cn of thyroxine to these dogs resulted in 
an increa0e lr LVmax dp/dt a.o well as heart rate. When the 
heart rate ~as elev~ted over a wide range of rates by artificial 
atrial pacing, the levels for LVmax dr/dt were significantly 
higher at all levels of heart rate after thyroxine. This is 
interpreted as indicating that the treatn:ent with thyroid hormone 
induced an elevation of myocardial contractility greater t~an 
could be attributed to the increase associated merely with the 
increase in rate. A change also occurred ir. the coefficjents 
of ljr.ear regression which probably indicates an alteration in 
the rate - contractility autoregulating mechanism, but the 
108. 
contribution of this to the increased cortractility appeared 
relatively 'ir.s.ignificant. 
3. INFLUENCE OF THYROID C:TATPS ON RESPONSES TO BETA-ADRBN'EHGIC STIMULATION. 
Followine the demonstration that the resting haemodynamic 
profile of their.tact conscious dog could be correlated with 
its thyroid status, with pa.rticulur reference to i~dices of 
myocardial contractility, it was thought relevant to investigate 
the behaviour of the myocardium under the influence of beta-
adrenergic stress. The agent isoproterenol, ad~i~istered by 
12 minute irfusions at various doses was used. Dope-response 
curves were obtained 1 r. normal, hypothyroid, myxoedematous 
groups and in the thyroxine-treated animals during the co'1trol 
state, after one week and agair after thee weeks of treatment. 
Since each dog acted as its own control in the thyroxine-treatment 
experiment s, theae dat~ are analysed separately. 
The stati~tical approach was a two-way analysis of variance 
of the response profile for each group of dogs. The responses 
wen, part1 tioned further into the various co'Tlponents of treatment 
effects and regression, linear, quadratic and cubic. An inter·-
group comparison became more feasible with such a detailed within-
group vert·cal and horizontal analysis8 
The data for LVmax dp/dt in these groups is presented in 
Table IX; the statistical method followed is outlined. The data 
for the other haemodynamic observations are presented in Ta.ble X 
while the details omitted here are contained in the Appendix 
Table 3. 
Since LVmax dp/dt is calculated to t~e nearest 10 mm Hg/sec 
. 
109. 
-1 tr.e statistical manipulations are all performed coded at 10 ; 
hence values are ind i cated x 10-l. 
TABLE I X. 
(a) LVmax d~/dt duri ng i Roproterenol i nfun 1ons in Normal Dogn. 
T5'.rnproterPnol dose (pi:r/kg/min) 
I 
Baseline 0.05 0 .10 0.20 
464 516 532 663 
464 654 748 916 
437 540 654 680 
480 57q 729 818 
416 535 552 600 
510 574 661 775 
500 505 547 b50 
591 608 680 7Q4 
493 5S6 572 592 
4g4 5 30 547 565 
610 775 -880 9 36 
4 36 4g3 543 612 
510 74 5 823 888 
635 6t.J 668 731 
649 731 7AO 884 
tJ40 880 837 888 
500 505 547 650 
610 775 880 936 
510 745 823 888 
640 731 780 884 
640 880 837 
. 
888 
566 590 625 644 
720 796 824 1005 
2x 12515 14906 16069 17887 
N 23 23 23 23 
x 544.13 648.09 698. 65 777.70 
~x2 6,967 961 9,999,420 11,562,591 14,318,845 
~x2 158 168 339,036 335,949 408,203 
The co~ponents of regress i on for the treatment sum of s1uares were 
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The final analysis of variance t~erefore wa,s: 
Source of variation Degrees of ! Sum of I Mean F. I P . fr eedom Squares I Square , l 
Total 91 1,901.685 I .. I 
l ! Error 66 191 400 j 2.,900 
Dogs 22 1,04g,957 I 47,725 I 16 . 4 (.001 
Treatments 3 660,328 2.20,109 I 7').8 (.001 I - - . (a) Linear components i 621 ,330 , 214.25 (.001 
( b) Quadratic component s , 35,011 12.07 (.005 ... 
( C) Cubic components 1 I 3 t g87 I l 1. 37 N.~. 
( b) LVmax dp/dt during iso£.Toterenol j nfusions in Hypotr •• yr0 ..:. c Dogs. --
. 
Basel ne Isoprotereno1 ( p p /k e:/,nin) 
0.05 0.10 o. 20 
330 380 431 486 
334 382 547 604 
34 3 430 510 536 
293 382 386 470 
378 502 555- 763 
.260 386 452 572 
371 489 556 672 
280 334 361 546 
374 397 414 469 
223 . 334 423 465 
242 4 21 507 629 
: X 3428 4437 5142 6212 
N 11 11 11 11 
X 311. 64 40).36 467.46 5 64. 73 
~x2 1,098,648 1,819,231 2, 45 ~226 3,600,088 >x 2 JO, 358 29,506 49,575 92,002 .... 
111. 
The components of regression for the treatment sum of squares 
were calculated using the following system of weighted coefficients 
I Linear Quadratic ' Cubic Totals ' 
I 
Regression Regression Regression 




I c:142 I +l -8 +6
l 6212 +9 I +5 I -1
Divisor 1540 1694 1210 
Contrast 23743 -3828 -572
Sum Sq. 366058 8651 270
! F




<0.001 (0.05 N.S. 
I 
The f nal analy�i� of var1ance for the hyJothyroid group 
therefore was: 
Source of Degrees of Sum of Mean 
F. variation freedom Square Square 
Total 43 576,421 
�rror 30 61,472 2,049 
Dogs 10 13q,970 13,9971 6.8) 
Treatments 3 374,979 124,q93 61.0 
[al Linear comp. 1 366,05 i 178. 65
b) Quadratic comp. 1 8,651 4.22







( c) LVmax d dt durin 
~ : 
112 . 
roterenol infusions in m xo edematoun 
Baseline 
Isoproterenol (p g/ke/m~n) 
0.05 0 .10 o. 20 
204 287 320 314 
221 248 297 3 q 
197 327 406 598 
210 278 359 429 
i x 832 1140 1382 1E60 
N A 4 4 4 
x 208.0 285.0 345.5 415.0 
x2 173 , 366 328,086 484,326 7'12 , 002 
LX 2 310 3186 6845 5 3, 10'.? 
The components of r egression for the treatment swn of squares 
were calculate~ us1ng the following system of weight~d co-
efficients: 
To~aJ. e Linear I Quad r1. tic Cub:c regress i on rep;resoion regression ! 
R)2 -7 I +7 +3 1140 -3 -4 -8 I 
1382 1 -8 +6 
1660 -;-g +5 -1 
Divisor 
! 
560 616 440 
Contrast 7078 -1492 8 
Sum ofFsquaresl 8g461 3614 0 
24.21 0 , 97 0 
j 
p < 0 . 001 N.S . N.S. 
113. 
The final analysis of variance was: 
Source of variation Degrees of Sum of Mean square, F. freedom. Squares 
Total 15 156,518 
'Error 9 33,253 3694. 7 
Dogs 3 30 .190 10,063 2. 72 
Treatments 3 93,075 31 025 8.39 I (a) Linear 
I j ( b) regression l 8 , 461 24.21 Quadratic l Io .91 regression l 3614 
(c) Cubic regression ! 1 0 0 
From these ana:yses, the linear dose-resronse curves were 
calculated: 
(a) No r'nal a.n imal s : 
...... 
Ti u y (calculated below) 









0 = ContraRt = 44 1 729 = lJ.8g Divisor 3220 
y = y + bu. 
y, = ~~ = 61~~77 = 667.14 







667.14 - 97.23 
667.14 - 41.67 
667. 14 + 13. 89 
667 .14 + 125 .01 
5 69. 91 































0.05 b' 8 80 = o:r = 
0.10 
0. ?O u '= b'(X-X) 
0.35 - 0.0875 X = 
= y + b(80X-7) = y - 7b + 80 bX 
(7 X 13.89) + (80 X l).89X) 
= 569.91 + 1111.2ox 
= 80x - 7 
The equation for the linear slope describing the .response o! 
LVmax dp/dt in the normal animals is therefore 
Y = llll.2X + 569.91 
in terms of units of isoproterenol ad~inistered. 
The same procedure was followed for the hypothyroij and myx-
oedema~ous groups. 
For hypothyroid group Y ~ 12J2.8X + 328.92 
For myxo edematous group y = 1011. 2X + 224. 89 
The dose-response curves were then examined for differences 
in slo?e and elevation above the X axis. The error sum of 
squares for each group was used to calculated a pooled variance. 
(a) Comparison of slopes, normal v.s. hypothyroid groups: 
Pooled variance 
( s2) 
= 19lt400 + 61,47~ = 
6 + 30 
b (normal) = 13.89 
252,872 = 2634 
96-
with variance S2 
= ~
6M = o.s1s fi·visor 
115. 
b (hypothyroid) = 15.41 
with variance s2 _ ~Jd _ Divisor - 1 4 - l.?lO) 
t = ;::=.;=========== 
s 
= 12-41 - 1J8q _ 1.52. 
~ 
f 2.526 
~ 2634 1 1 ) <mo+~ 
= 1.52 = 0.956 for_ 96 d.f. p is not 1.589 
( b) The slopes of the hypothyroid and rnyxoed.ema tous groups 




(c) Comparison of elevation above X axis, normal v.s. hypo-
thyroid groups was obtained by comparing the overall means of 
each curve, using the pool ed variances to obtain an est ·mat e 
of error. 
Y (normal)= 667.14 
Y (hypothyroid) = 436.79 
poolPd variance (s2 ) = 2634 
Yn - fh 
= 667.14 - 436.79 
~ (1 1 J 2634 ( 23 + IT) 
= f~~a15 ·= 12.25 
for 32 degrees of freedom P < 0 .001 
116. 
When similarly compared, the elevatjon of the hypothyroii and 
myxoedematous groups were highly significantly different ( P < 0 .001 
( d) A cornparison was also_ done t. in sirni lar fashion to that for 
the linear regression component, of the quadratic regre3sion 
H If components between normal and hypothyroid_ gro~ps, but with at 
value of 0.587, the difference was not significant. 
The analyses for heart rate and cardi~c index, conducted in 
si~ilar fashion, are presented in Table X. The data for the 
variance analyses are presented in summ~ry fashion; an asterisk 
indicates where a component reached significance. The values 
for LVmax dp/dt and cardiac index were analysed., coded X 10-1 • 
117. 
TABLE x. 
Degrees Sums of Squares of freedom 






Total 91 43 15 1,901,685 576,421 156,518 
'Error 66 30 9 191,400 61,472 33,253 
Dogs 22 10 3 l,049,Q57 * 139, g70* 30,190 
Treatments 3 3 3 660, 328* 374,979* 93,075* -- 621,330* 366,058* 8g,461* Linear component 1 1 1 
Quadratic component 1 1 1 35,011* 8,650* 3,614 
Cubic component 1 ) 1 3,987 270 0 
Heart rate 
Total 91 43 15 24,229 7,789 95g 
'Error 66 30 9 3,321 1,256 341 
Dogs 22 10 3 9,361* 3,411* 209 
Treatments 3 3 3 11,547* J,122* 409 
Lir.P~r component 1 1 1 1i-:-450* 2,988* 405* 
Quadratic component 1 1 1 51 65 0 
Cubic componeni. 1 1 1 46 69 4 
Cardiac index 
Total 91 43 11 1,486,585 415,818 8,280 
'Error 66 30 6 252 ,101 7 J, 35 J 2,094 
Dogs 22 10 2 670,195* 254,297* 416 
Treatments 3 3 3 564,289* 88 ,168* 5,770* 
558 ,811* 
--
2 ,-615* Linear compon?-nt 1 1 1 78,886 
Quadratic component 1 1 1 965 3,355 1,597 
Cubic .component 1 1 1 4,513 5,927 1,558 
= Normal H = Hypothyroid M = Myxoedematous 
In table XI are indicated the results of the analyses for 
significant differences between the various groups for LVmax dp/dt, 
heart rate and cardiac index. The values for the various ani~als 
are indicated in Table 3 of the Appendix. 
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TABLE XI. 
Coefficients of D1fferences 
linear regression (P value) 
N H M N-H I N-M H-M 
LVmax dp/dt 13.89 15.41 12.63 N.S. 
I 
N.S. N.S. 
Heart rate 1.885 1. 392 0.85 <.025 <.005 N.S. 
Cardiac index 13.17 7.16 2.495 (.005 (.001 N.S. 
~ 
Grc1.nd means Differences 
(Y) (P value) 
N I H M N-H N-M H-M 
LVmax dp/dt 6671 4368 3134 I < .001 (.001 < .001 
Heart rate 90.4 77. 5 50 • .3 < .001 !<·001 I · .001 
Cardiac index 4.294 2738 1420 (.0011<-00l < .001 
I I 
The grand means (Y) are supplied as measures of vertical dis-
placement. 
N·= Normal H = Hypothyroid M = Myxoedematous 
Thyroxine treatment and responses to isoproterenol. 
The data are shown in detail for LVmax dp/dt to demonstrat e · 
the mark~d e ffe ct that thyroxine treatment had on these responses. 
Only the data at one week of treatment are analysed, the responses 
at 3 weeks were so variable that statistical analysis was not 
possible. These will therefore be shown in graphical form. 
Table XII contains the responses of LVmax dp/dt during 
isoproterenol infusions in the doses O (baseline) , 0.05, 0.10 
and 0.20 pg/kg/min, first during the control study and again 
after 1 week of thyroxine treatment (0.1 mg/kg/daily). The 
data are again handled coded X 10-1 • 
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TABLE XII. 
Control study 1 week thyroxine 
Dog (Dosages of isoproterenol (pg/kg/min) No. 
0 0.05 0 .10 , 0.20 0 0.05 ·0.10 0.20 
1 
' 
500 505 547 650 1142 1310 1169 1160 
2 
I
610 775 880 936 792 1061 1160 1029 
3 I 510 745 823 880 1120 .1475 1534 1~75 
4 I 640 731 780 884 940 1274 1023 1116 
5 640 880 837 888 883 1093 1284 1392 
6 566 590 625 644 1143 1316 1385 1334 . 
7 I 
720 796 824 1005 I 1097 1236 1269 1304 
~x 5887 
I 
8765 8824 8910 4186 5022 5316 I 7117 
X 1 5g8.0 717.4 759.4 841.0 I 1016.7 1252-1 1260.6 1272.91 I 
Source of Variation Degrees of Sum of squares Mean F p freedom Square 
Total 55 4,434,581 
. 
Error 42 526,519 12,536 
Dogs 6 261,905 43,650 3.48 <".01 
Treatments 7 3,646,157 520,879 41.55 < .oo 
After the analysis of variance, t~e values were analysed for regression 
before and after thyroxine treatment. The weighted coefficients shown 
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The coefficients of regression of the linear components were calculated 
as shown prE"viously, for the group before and after thyroxine treatment. 
Before thyroxine 
A 
y =. 1131.2x + 6294.5 
A 
After thyroxine y = 1053X + 11,084.J 
Thyroxine therefore had a hjghly significant effect (F = 248,34) by 
producing an elevation of the curve as a whole. In addition to the 
curve having highly significant linear components, both before and 
after treat~ent, an effect producing a highly significant quadratic 
component became evident on analysis after treatment. Before thyroxir,e 
the quadratic component was insignificant. In addition to being 
elevated, the dose-response curve now had a significant curvature with 
the convexity upwards. This i~ shown in Fig.26. The calculated 
linear regression lines are inserted as a thin solid line, whereas 
the actual values obtained are inserted in bold line. 
FIG.26 
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The data for the other haemodynamic measurements are indicated in 
, 
summary form in Table XIII. The grand means for the curves (a measure 
of vertical displacement) are indicated and the F values for the 
thyroxine effect. Since all curves had linear regression components 
with no differences in coefficients, these are not indicated. 
Those jnstances wherp, a significant quadratic co~ponent appeared after 
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In normal dogs, an infusion of isoproterenol in the doses 0.05, 
0.10 and 0.20 µg/kg/min caused an increase in LVmax dp/dt, 
heart rate and cardiac output with dose-response curves having 
highly significant linear regression. The effect of treatment 
with rl3l was to cause a significant lowering of the entire 
curve with no alteration in its slope. With the development 
of frank myxoedema, the curve was lowered to a further significant 
degree, but th~ slope was still not significantly different from 
123. 
that occurring in the normal animals. The effect of thyroxine 
administration on the othPr hand, was to cause a significant 
elevation in the curve, without alteration again in the linear 
slope, but with a highly significant convexity developing; 
the initial portion of the curve had a stepper gradiPnt than 
in the nor~al state, but as is evident in F1g.25, failure to 
maintain the linear slope occurs at the higher doses employed. 
Thyroxine ~rPatment siwilarly caused elevation of the dose-
response curves for heart rate, cardi~c output, stroke volume, 
systolic and dia.stolj c pressures, ejection time, stroke power 
and sy?tolic ejection rate. This occurred at an end-diastolic 
pressure that was significantly lower (P< .005), hence a true 
further increase in contractility is reflected during isoprotere-
nol stimulation, attributable to the prior administration of 
t"lyroxine. Of ~articular significance is the fact that such 
'an effect could not be shown for the curve of left ventricular 
. stroke work but was present to a highly significant degree for 
strokP. power and systolic ejection rate; the factor of rate of 
action enters into both the latter but not the former measure-
ments. 
The interpretation of t~ese findings is complicated by 
unavoidable factors. Although a reduction in height of 
dose-response curves could be shown after rl3l treatment, the 
slope remained unaltered. This may be attributable to the 
fact that all the dogs gained significant amounts of weight 
following rl3l ireatment and since the isoproterenol doses were 
calculated on a weight basis, these animals all rP-ceived grPater 
1:.tbsoJute amounts of isoproterenol during the studies in the hyyo-
thyroid state compared to their study in the euthyroid state. 
The relative contribution of thia could not be assessed. 
124. 
'Bvidence for thin was, however, obtained from four serial 
stu'dias in ·one severely :nyxoedematous animal. T11e animal a,,3.s 
studied twice dnring his severely 'llyxoedematous state and on 
two occasions after · thyroid replacement. 
depicted graphically in Fig.27. 
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In this figure is also included t:1.e dose-response curve obtained 
in six normal animals for comparison (the broken line). It is 
evident that during the two studies performed while in frank 
myxoedema (PBI=0.4 µg/ml) the curves were not only depressed 
but also had a flatter slope than those obtained after ~dministr~-
tion of thyroid powder (U.S.P.), 60 mg daily, for one month. 
... 
125. 
The dog weighed 2.4 kg less after thyroid replacement (studies 
2 weeks a.pa.rt) and therefore received a smaller !3.bsolute amount 
of isoproterenol; yet the slope of the curves appeared t9 have 
bee, increased. Statlstic~l tests were not performed since 
only the one study was possibl e. 
In the experiments involving treatment ~ith thyroxine it 
becam~ P.vident that extreme hype ensitivity to 1soproterenol 
may have '.lrisen and tli.at the curvea obtai:ied r.iay slready be 
situated in the plateau . Six ·_further experiment3 were t:ierefore 
performed 1h8erting dose levels of 0.01 and O.OJpg/kg/min before 
t"le usual lowent dosE> of 0.05 Jlf!/kg/rnin. Simil!'l.r ph~nornena we re 
obta1~ed; three of the typical ~xperi ments are shown in Fig.28. 
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In the left hand panel it is evident that the dog respondP-d with 
an elevation of 800 mm Hg to the lowest 1osP used (0.01 pg/kg/min) 
after one week of treatment with thyroxine, whereas no response 
was obtained during the control study for this 1ose. The curve 
then continued with the characteristic curvature and actually 
fal t erP-d at the highest dose level wi t'1 a smaller rei:rponse than 
at the 0.10 pg/kg/min level. 
In the centre panel, the characteristic elevation of the 
curve with the mar~erl hyperresponsiveness at the lower dose 
levels is demonstrated. In the right hand panel there was no 
hy:perresponsiveness to the low levels at one week of treatment, 
but this phenomenon was markedly present associ:::i.ted with massive 
elevation of the curve after three weeks of treatment with 
t:iyroxine. 
CONCLUSIONS: 
The responses of the myocardiu-rn. to beta-adrenergic stimul-::i.-
tion are influenced tn opposing directions by induction of hypo-
thyroid and hyperthyroid states. Large changes i:1 the elevation 
of the dose-response curves to isoproterenol could be demonstra-
ted, but the 1 in ear slopes remained unaffected. In the ~ypo-
thyro id state, the changes in slope may have been prevented by 
the administration of larger amounts of isoproterenol calculated 
on the basis of the body weight of the animals, all of which had 
gained weight. Tn the hyperthyroi1 state the linear dose-
resp6nse relationships are completely different; the heart has 
increased responsiveness at very low dose levels, but cannot 
maintain the same dose-response relationship9'with the develop-
ment of a marked convexity in the dose-response curve; these 
J 
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changes occur at a greatly elevated level of contractility 
compared to the control state. 
ADDENDUM: 
Since the development of the curv9.ture in the dose-response 
curve occurred at very high levels of function, the question 
arose whether thi3 may be a failure of the frequency-response 
characteristics of the recording system, rather than of the 
myocardium or its control mechanisms. i 
This was evaluated by repeating the experiment in one 
animal; the curve with its usual convexity was found to r~ach 
a plat eau at 14,000 mm Hg/sec. Atropi~e was t~en injected 
(0.1 ~g/kg i~travenously) and the isoproterPnol i~fusion repPated. 
The initial portion of the ct1rve remai:ied unaltered, but at the 
0.10 and 0.20 µg/kg/mi n dose levels of isoproterenol, lPvels of 
17,800 and 19,000 mm Hg/sec were obtained. 
in this dog are supplied in Appendix Table 




It becamP clear therpfore that the appar~tus was quite 
capable of performing at levels well beyond the apices of these 
curves; the response to atropi"le suggested that the vagus nerve 
must have a powerful inhibitory i~fluence at such levels and may 
be the factor, rather than a myocardial one, responsible for the 
convexity i~ the dose-response occurring at s·uch high levels of 
pe;rfo r'llance. 
4. RELATIVB CONTRIBUTIONS OF SENSITIZATION TO ENDOGENOUS CATECHOLAMINES AND DIR'f.:CT EFFECT OF TH~ HORMONEs·oN THE MYOCARDiuM. 
Since it was shown that an alteration in responsiveness 
to beta-adrenergic stimulation could be induced by the induction 
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of an alteration in thyroid state, it was thought relevant 
to assess the relative influences of altered sensitivity to 
catecholamines and the direct effect of the hormone on the musclP 
in the production of the altered resting levels of ~yocardial 
contractili ty. 
The beta-adrenergic blocking agent, propranolol, was 
utilized in the group of animals treated with 1-thyroxine. The 
response to propra.nolol and final level of LVmax dp/dt obta.ined 
after complete blockade, (judged by fqilure to resrond with an 
incrPase of ratP or LVmax dp/dt to an isoproterenol infusiqn of 
0 .50 pg/kg/min), were obtained during the st,1dy i~ the euthyroid 
state and agal3 in the hyperthyroij st~te accomplished by daily 
injPctions of 1-thyroxine, 0.1 mg/kg, for one week. It has 
already been demonstrated that the haemodynarnic changes of 
hyperthyroidism can be :1:1duced iri this period of thyroxine treat-
ment. Reaaings were obtained 20 minutes after the administration 
of propranolol i!'ltravenously, 0.4 mg/kg. T~he results are 
summarized in Fig.2g. This shows the resting levels o.f LVmax 
d~/dt in both the euthyroid and hyperthyroid state before and after 
blockade with propranolol. 
Table 5. 
Details are supplied in Appendix 
Statistical evaluation of the changes induced by propranolol, 
utilizing the "t-test" for paired values, revealed a significant 
increase in the response to propranolol in the hyperthyroid 
state. The me~n response obtained in the euthyroij state was 
1922 mm Hg/sec reduction in LVmax dp/dt; in the hyperthyroij 
state the mean response was 3640 mm Hg/sec. This value is 







I ' 8000 
E 





















The mean resting va-lue for LVmax dp/dt was 6122 m:n Hg/sec before 
propranolol in the euthy!oid state anj 10,884 m~ Hg/sec i~ the 
hyperthyroid st~te. These val1es were highly signi ficantly 
different ( P <.O. 001). The ·mean res tine value after propranolol 
was 4200 mm Hg/sec in the euthyroid state and 7244 mm Hg/sec in 
the hyperthyroid state. These values were also highly signifi-
cantly different ( P < 0 .005). In none of the dogs dii the 
value of LVmax dp/dt after propranolol blockade in the hyper-
thyroid state approach the levels of LVmax dp/dt even before 
propranolol in the euthyroid state. It is therefore clear that 
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after complete blockade of the beta-adrenergic receptors, a 
highly significant effect remains following trPatment with 
thyroxine. 
The effects on heart rate were not as easy to evaluate. 
The mean effect of propranolol on the five animals in the 
euthyroid state was 14 beats/min reduction; in the hyperthy~oid 
f 
st9.te the mean effect was 18 "beais/min reduction.. These values 
approached, but did not achieve statistical significance 
( P( 0. 20). The statistical evaluation would have been more 
valid if larger numbers could have been studied. The mean 
rate before propranolol in the euthyroid state was 78 beats/min 
and 110 beats/min irr the hyperthyroid state; after propranolol 
the rates were 64 in the euthyroid state and 92 in the hyper-
thyro i:i state. 
Data on cardiac output were not analysed becausr of the 
poor quality dye-dilution curves obtained after propranolol 
in the euthyroid state; this was as a consequence of both the 
slow rate and the reduction in contractility after propranolol. 
CONCLUSIONS: 
B;y- means of blockade of the beta-adrenergic receptors with 
propranolol it has been possible to demonstrate that the 
increased myocardial contractility encountered in the hyperthyroid 
animal was composed of a greater than normal fraction due to 
stimulation by endogenous beta.-adrenergic factors and also a 
component independent of the beta-adrenergic receptors and 
attributable to a direct effect of the hormone. 
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ADDBNDUM: 
As well as evaluating the role played by the adrenergic 
system in the m~nifestation of the hyperthyroid state in the 
dogs, it was thought relevant to attempt an assessment of the 
possible role of the parasympat.hetic system in the maintenance 
of the low heart rate and low contractility of the myxoedematous 
animal. Only one experiment was possible (the o~her three 
animals died~ one from an acute myocard~al infarction in the 
presence of patent coronary ar:teries, sustained during the 
infusion of isoproterenol. 
This myxoed~matous dog had a resting heart rate of 38 beats 
per minute and a resting level of LVmax dp/dt of 2210 mm Hg/sec. 
The dog was then given atropine 0.1 mg/kg; the heart rate 
increased to 150 beats per minute, representjng a 300% incrPase 
whereas LVmax dp/dt increased to a steady-state peak level of 
3690 mm Hg/se~, · representing a 66% increase. Although one could 
not extrapolate about the role of the parasympathetic system in 
the manifestation of the cardiac state of myxoedema, one could 
draw the conclusion that the heart rate is controlled to a larger 
extent than myocardial contractility by the parasympathetic 
system. 
5. ~FFECT OF L-TRIIODOTHYRONINB ON RESTING HAEMODYNAMICS AND RESPONSES TO tsoPROT~RBNOL. 
It was shown that the treatment wi°th- daily injections of 
1-thyroxine induced an elevation in the resting levels of 
LVmax dp/dt and an upward displacement of the dose-response 
curve to isoproterenol. Since triiodothyronine (T3) has been 
shown to be a rapidly acting form of thyroid her.none (ll3) 
assessment of its effects on the responses of the dog heart to 
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beta-adrenergic stimulation was thought to be pertinent. 
16 normal and 6 hypothyroid dogs were used in these 
experiments. Infusions of isoproterenol in the doses 0.05, 
0.10 and 0.20 pg/kg/min _"were used, each dose being infused for 
12 minutes. Following the completion of infusion of the 
highest dose used, the dog was allowed 90 minutes to recover 
and repeat baseline observations were obtained of pressures, 
f 
hP-art rate and cardiac output. An infusion of 1-trijodo-
thyronine in the dose 0.1 pg/kg/min was then givep _for 15 minutes 
. 
and repeat observations obtained. The isoproterenol infusions 
were then repeated in the same doses for the same periods. 
In an additional 6 contr~ experiments the procedure was the 
same, except that the triiodothyronine was not added to the 
0.1 N sodium hydroxide solution and the infusion of solvent 
diluted in physiological saline was given by itself. In an 
additional four experiments, the dextro-isomer of triiodothyro-
nine was used in order to. establish whether the effects observed 
were specific for 1-triiodothyronine. The solvent and d-TJ 
control experiments were performed in normal dogs only. 
The detailed values are in the Appendix Table 6 The 
statistical method used was a two-way analysis of variance with 
partitioning of the treatment sum of squares into displacement 
and regression (linear, quadratic and cubic) components. 
The analyses of variance for LVmax dp/dt and heart rate in the 
euthyroid experimental and control groups are given in Table XIV 
while the alterations ln grand means of the response curves are 
shown for the other haemodynamic measurements, in all the 
groups, in Table XV. 
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TABL~ XIV. 
EXPERIMENTAL GROUP (EUTHYROID). 
LVma x dp/dt (coded X 10-1 ). 
Source of variation 
T t l 0 a. 
Error f 
Dogs 
Treatments -- -( a) T3 effect on rest-
ing values. 
( b ) T3 effect on iso-
proterenol response~ 
( C) Pooled linear 
regression 
I 
( d) Pooled g_uadratic 
regression 







(a) T3 effect on rest-
ing values 
(.b) TJ effect on iso-
proterenol responses 
.( C) Pooled linear 
regression 
( d) ~ooled quadratic 
regression 


































' . ... 










2.92 I< .025 
I 
7.14 < .005 
0.11 N. S. 
7.56 (.01 
40 .48 <.001 
1.24 N.S. 
0.02 N.S • 
3.9 (.01 







CONTROL GROUP {SOLVENT INFUSION). 
LVmax dp/dt (coded X 10-1) • 
.. 
Degrees 




f Dogs 5 
Treatments 8 ..... - - ·- '-• 
( a) Solvent effect on 1 
resting values -
( b) Solvent effect on iso- 1 
proterenol responses 
(c) Pooled linear 1 
regression 
(d) Pooled quadratic 1 
regression 








( a) Solvent effect on 1 
resting values 
1 
(b) Solvent ef·fect on iso- 1 
proterenol responses 
(c)"Pooled linear 1 
regression 
(d) Pooled quadratic 1 
regression 
( e) Pooled cubic 1 
regression 
I . 
Sum of F p Squares 
1,119,034 I 147,443 I 
669,112 36. 30 ( .001 
302, 47~ 10.25 < .001 -
2,916 0.79 N.S. 
I 
' 37 o.oo N.S. 
248,979 67 • 54 I< .001 
9,190 2.49 N.S. 





2,435 5. 20 < .005 
6,547 8.73 ( .005 
85 0.91 N.S. 
(-)462 4.93 N.S. 
I 
5,490 ~8.62 1 < .001 
27 0.28 ( .001 
14 0.15 , N.S. 
The regression components are presented by pooling the values 
before and with TJ since no differences in the coefficients of 




l-T3 administration • 
.. 
The alterations in grand means (a·measurement. of vertfr11l 
displacement) are presented for all the haemodynamic measurements 
in Table XV. 
TABL"E XV. 
1. Euthyroid Experimental Group: 
Y before TJ 
LVmax dp/dt 5g54 
(mm Hg/nee) 





Stroke .... volume 




LV stroke worlr . 37. 6 
(gm meters) 
LV strok e power 190 
(gm rneter87sec) 
Syst. eject. rate 139 
( 11!1/sec 
Eject.ton time 197 
(msec) 
LVBDP 9.4 
( mm Hg) 
Periph. res5otance 4334 (dyn.sec/cm) 
y after TJ F • .. P. I 
6667 7. 5 6 (.01 
88 0 N.S. 
2472 0.02 N.S. 
, 
26.8 0.19 N.S. 
} 14 3.54 N.S. 
37.5 0 N.S. 
218 10 .11 (.005 
155 7.24 <.02 
173 56.06 <.001 
'8 . 5 l. J 2 N.S. 
4874 2 .g4 N.S. 
I 
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2. Solvent Control Grou12.: 





N.S. , LVmax dr,/dt 6271 0 
(mm Hg/sec) 




2654 2148 f,.63 ·< .025 
Stroke volume 31.8 27.5 9. 21 < . 01 
(ml) 
MAP 112 120 1?. 76 < .005 
(mm Hg ) 
LV strokP work 44.2 
( gm meters) 
40.9 3.02 N.S. 
LV stroke power 231 2 21 0.08 N.S. 
( gm meters/sec) 
Sysj; ejp,ct. rate 165 154 1. 69 N.S. 
(ml/sec) 
I Ejection time 194 
(msec) 
179 43. 8 <.001 
I LVEDP 1.8 
(mm Hg) 
9.0 6.89 < .025 
j Periph. resistance 
( dyn. sec/cm5) 
3706 552b 24.02 < .001 
r I 
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J. Hy1,othyroid Group: 
• Y before TJ Y after TJ I F. I P. I 
LVmax /s/dt 4575 5437 J6.92 < .001 (mm Hg sec) 
< .05 I Heart rate 79 76 4.18 ( per min) 
Cardiac output 2140 2215 0.95 N.S. ( ml/min) 
Stroke volume ~6 .9 28.8 4. 39 < .05 (ml) 
Mean arterial pressure 101.8 110.3 13. 65 ( .005 ( mm Hg) 
LV stroke work 33.2 40.3 26.21 .-- .001 
(gm metPrs) 
LV stroke power 159.6 199.6 37.04 .' .001 
( gm metPrs/ s~c) 
Systolic ejection rate 129. 3 143.0 9.71 .,,. .005 
(ml/sec) 
Ejection time 207 
( msec) 
201 4.18 < .05 
LVEDP 8.98 8 .62 ' 0 . 52 N.S. (mm Hg) 
Peripheral resistance 
( dyn. sec/ cm5) 
4307 4643 1. 65 N.S. 
. d-TJ Control Group: 
LVmax dp/dt 7531 7467 0.11 N.S. (mm Hg/sec) 
Heart rate 92 100 I 4. 35 <.05 ( per min) 
Cardiac output 2751 2428 J .61 N.S. (ml/min) 
Mean arterial pressure 104 114 23.08 (.001 (mm Hg) 
Stroke power 211 209 0.04 N.S. 
( gm meters/sec) . 
Systolic 
I (ml/sec) 
ejection rate 156 14 2 4.37 {.05 
LVEDP 6.06 6.88 1.53 N.S. ( mm Hg) 
l I 
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When the isoproterenol infusions werP. administPred in the 
presence of an 1-triiodothyronine infusion, the dose-response 
curves were significantly higher for LVmax df/dt, left ventricu-
lar stroke power and systolic ejection rate. This was accom-
lished without any alteration in the baseline levels, or in the 
heart rate responses. These ventricles wel'e therefore respond-
ing with more rapid generation of pressure and with more rapid 
shortening in the absence of an increase in heart rate or in 
cardiac output. The velocity-dependence of the effect is 
emphasized by the absence of any effect on responses of either 
stroke volume or stroke work, but the prP.sence of high1y signi-
fic~nt incrPases in stroke power and systolic ejection rate. 
The effect was specific for tte presence of 1-triiodothyronine 
(0.1 ,µg/kg/m1.n) in the infusate and cou.1.d not be shown either 
during infusions of the solvent alone or with infusions of 
d-tri iodothyronir,.e in the same dose. The curv-es for LVmax dp/dt 
are shown in Fig.JO. 
The responses obtained in the euthyroid group are also apparent 
in the hypothyroid group, except that they were obtained with 
higher degrees of significance. The hypothyroij animals, too, 
in contradistinction to the euthy~oid group, had a significant 
reduction in the responses of heart rate. This is particularly 
notable in view of the higher levels of significance of the 
velocity-dependent measurements. The hypothyroid animals in 
contradistinction to ~he normal group also had increased 
responses of mean arterial pressure (P<0.005). This caused 
the emergence of significantly increased responses of left 
ventricular stroke work in this group. 
u 
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In the control group a similar result w~s obtai~ed in that 
the mean arterial pressure was higher during the infusions of 
isoproterenol and solvent. LVEDP was also, however, increased 
significantly ( P < . 025). These factors may account for the 
significant reduction in ejectio n ti~e observed iri this group 
and is reflected by the highly' significant increase i!1, c~lcul3.ted 
peripheral resistance. The change in mean arter ial pressure 
responses was also present in the group of animals receiving d-T3 
instead of 1-TJ. 
These effects were obtained aft~r infusions of l-T3 lasting 
15 minutes. In order to define t~e time required for the effect 
to develop experiments were performed in four anima]s in which 
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1-TJ waa administered duri~g an infusion of jsorroterA~ol, 
Nhile a conti~uous slow-3peed recordin6 of LVmax d~/dt was 
obtained. In two dogs the l-T3 was given by continuous 
ir1fu3ion at the rate of O .J. p.g/kg/rnin. In the other two 
animaln the total dose for 15 minutes was given as a single 
injection. 
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Such an experiment is ilJustrated in Fig.31. 
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This reveals an incrP.ase in LVmax d p/d t commencing 15 rr..inu te8 
after the start of the l-T3 infusion. No increase in heart 
rate was shown to occur at the sa~e time. The t~mes obtained 
for the onset of action of 1-TJ in the other 3 dogs were 8 
mjnutes, 11 minutes and 12 minutes. It would appear -+;o be 
mediated therefore in a matter of approximately 10 minutes. 
Four control experiment s were performed in which only the 
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solvent of t~e l-T3 was injected (2 dogs) or ~nfused (2 dogs) 
dur:.ng th.e iscproterenol infusion. No change in LVmax dp/dt 
waR seen in any of. these ·animals. ThiR proved that the effect 
waR caused by the presence of 1-triiodothyronine. 
C~)NCLUSIONS.: 
1-Triiodothyror.ine can be shown to have an effect on the 
responses of the myocardium to a 1eta-adrenergic stress within 
15 minutes of its administration. The effect is il'lotrop1c 
without any chronotroric manifestation~ in the periods studied 
and yet becomes apparent on the velocity-dependent aspects of 
ventr:.cular function. The effect was not apparent on the 
rest.~g ventricle in the time of observation in these exreri-
rnents. An additional increase in myoc~rdial contractility over 
-~ ~ and above that caused by the ·soproterenol became apparent and 
is aRcrJbable to the presence of 1-triiodothyronine. 
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DISCUSSION". 
1. LV~ax d2/dt as~ ~easure of Myocardial Contractility: 
In these experiments LVmax dr/dt was found to be a useful 
index of the contractile state of tte myocardium. 
found not only to be a sensitive measure, but was alterBd under 
all circumstances in parallel fashion with other measurerrents 
of myocardial contractility: ventricular stroke work, power and 
.rate of ejection. In these respects our results correlate well 
(90) '111) with the findings of Knopp et al, ri~urphy et al and 
Covell et ai.< 76 ) Our findings support particularly the vJews 
of the latter group of authors w~o also found this measurement 
to be a more nensitive index of myocardial contractiljty than 
those based on the Frank-Starli~g principle. In their co~para-
tive stu~y LVmax dp/dt waH second only to airect measurement of 
the force-velocity relutions in isolated isovolumjc be,:1ts 
obtained with much more sophiRticated apparatus and previous 
surgical intervention. LVm~x dp/dt can be obtained continuously, 
involves relatively simple ele,ctronic apparatus and its measure-. 
ment through a catheter-manometer system appears suffic.1ently 
accurate if precautions against dampi~g of the synterr are taken. 
A valiiable insight into directional changes in at lPast ottained 
with such a system. In our experiments excellent correlation 
was obtained with an intracardiac micromanometer. 
The importance of measuring tr.e rate of pressure, and 
indirectly rate of tension development rather than total tension 
developed becomes obvious, even though the latter measurement 
may be used with benefit under certain circumstances, in the 
isolated myocardial preparation usine; the Walton-Brodie strain 
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. (8 114) gauge and allowing the afterload to change. ' For ouch 
changes to be interpreted as alterations it ittrinsic contrac-
tile state, end-diastolic fibre length must not have increased 
in length. 
Substantial alterations in myocardial contractiJ.1.ty may 
be overlooked if height of peripheral arterial pressure rather 
than the rate of ventricular pressure development is measured. 
In these experiments, mean aortic pres~ure was found not to be 
different from normal in animals recently treated with 11 31 
despite significant changes in body weight, serum cholesterol, 
heart rate and LVmax dp/dt. It was only with the development 
of frank myxoedema that the mean arterial pressure became 
sien i ficantly reduced. In the animals treated with thyroxine 
the mean arterial pressure was initially increased but after 
two further weeks of treatment ttis measurement was no difterent 
from the normal level, ln contradistinction to LVreax dr/dt which 
was grossly elevated. LVmax dp/dt is therefore a more direct 
measure of events at a myocardial level than is peripheral 
J;ressure which is profoundly influenced by the state of 
peripheral arterial tone. 
In their in-vitro preparation, Buccino et al(ll5) succeeded 
in demonstrating, in cat papiJ}ary muscles, profound effects of 
thyroid hormone on the rate of tension <levelopment without 
alteration in the total tension developed. The admitistration 
of 1-triiodothyronine for 15 minutes in our experiments augmented 
exclusively the velocity-dependent aspects of myocardial action 
at a time when no alteration in pressure or volume-dependent 
measurements could be demonstrated. The incre~ses in LVmax 
14). 
dp/dt ( Table XV) occurred ir parallel with observed , hortenir.g 
of left ventricular ejection period and with incrPases of the 
calculated indices, left ventricular stroke power and systolic 
ejection rEi.te. These effects were observed in the absence of 
any jr.crease in heart rate. It becomes apparent that, particu-
larly with reference to the action of thyroid hormone, it is 
important to assess those aspects of myocardial function that 
incorporate the velocity of contraction. 
When the inotropic effects of ttyroid hormone were 
acconpanied by chronotropic effects, the percentage changes 
were much greater tor LVmax dp/dt than for heart rate or cardiac 
output. Tr. is is illustrated 1n Table XVI which represents 
an analysis of these poo)ed measure~ents in the animals treated 
witt 1-thyroxine. 
TABLE XVI. 
HEART RATE CARDIAC OUTPUT LV max dp/dt , 
. 
, I,: 
(per min) (ml/min} mm Hg/sec 
CONTROL STA TE 79 2286 6110 
AFTER THYROXINE 
( 0.1 mg/kg/day} 110 3028 10,410 ·-
7 days ( f38.3%) (f32.4%} (f70.3%} 
21 days 143 2996 11,644 
(f81.2%} ( f 31.0%) ( f 90.6%) 
Mean values for the same 5 dogs in all periods. 
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The percentage increase in LVmax dp/dt was greater at an 
earlier stag~ and exceeded the increases in nPart rate and 
cardiac output even with prolongation of treatment. 
These considerations may account for the failure of 
Benforado and _Wip;gins( ll.6_) to demonstrate 9 differences in the 
performance of ventricular muscle strips from normal and hyro-
thyroid rats. These authors measured iotal tension develop~d 
in animals six weeks after treatment with 1131 when sienificant 
alterations in body weight, heart rate and basal metabolic rate 
could be demoristrated. Of particular interest is their faiJure 
to show differences in tte tensions developed during incrPases 
in rate of stimulation to 320 contractions per mi~ute. Their 
findings are in striking contrast to those of Buccino et al.(ll5) 
2. Myocardial Contra.ctility and Thyroid Status in the Intact Dog. 
Treatment with 1131 in these dogs caused a reduction in 
heart rate, cardiac index, peak systolic pressure and LVmax dp/dt, 
evident as early as six weeks after treatment. These ..changes 
were progressive until, in the frankly myxoe~ematous dogs, 
studied more than two years after rl3l administration, the 
complete syndrome of myxoedematous heart disease (ll7,lJB) had 
developed. These animals had a lower pulse rate and cardiac 
index when compared to the normal dogs and dogs treated less than 
one year previously with r1 31 • All the criteria of myocardial 
contractility were reduced to a highly significant degree in the 
left ventricle and in the right ventricle a highly significant 
reduction of the maximal rate of pressure development was shown. 
1he possibility that these haemodynamic manifestations were 
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mediated through complications of the hypothyroid precess 
e.g . 
.. atherosc':l.erotic narrowing of the coronary arteries ( ll9) 
or 
pericardial effusions(
120.' was ruled out by the demonstration of 
the absence of both these changes at post-mortem examinati
on, 
including coronary arteriography. To complete the 
picture, the 
animals had gained weight, werP. slow in their·movements an
d 
faiJed to grow hair in areas where it had been shaved. 
They 
had lard-like s~bcutaneous tissues and highly elAvated lev
els of 
serum cholesterol. One of these ani~als died four days
 after 
an isoproterenol infusion. Autopsy and h i stological 
examination 
revealed an acute myocardial infarct involving the left ve
ntricle, 
in the presence of patent coronary arteries. 
On the other hand, the administration of 0.1 pg/kg 1-thyro
xin 
daily by subcutaneous injection, resulted i n striking haemo
-
dynamic changes, comparable to those of hyperthyroid heart
 
d . . (118,121) 
l k f th 
isease, as ear y as one .wee a ter e commencement 
of treatment. These change~, summarized in Table VI(b) sh
owed an 
increase in LVmax dp/dt, heart rate, cardiac index (withou
t a 
change in stroke volume index) and a significant reduction
 in 
systolic ejection period. LVmax dp/dt and stroke power were 
significantly increased .. fo.r the left ventricle and the max
irr:um 
rate of rise of pressure in thA right ventricle was also s
hown 
to be highly significantly increased. With further treatm
ent 
for two weeks, body weight decrP.ased progressively, but si
gnifi-
cant increases in heart rate and contractility could not be 
demonstrated. The peripheral resistance index had dropped 
significantly by the third week of treatment. Our observations 
of the maintenance of a normal stroke volume and mean syst
olic 
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ejection rate is in support of the finding by Goldstein and 
Killip( 122 ) that both these calcu]ated values remainPd unchanged 
in their patients with thyrotoxicosis on catecholamine depletion 
with guanethidine, in contradistinction to the other haemodynamic 
measurements which became reduced. 
These dogs were general]y excitable, invariably developed 
diarrhoea but were adequately sedated by thP same dose of morphine 
administered during their euthyroid state. Ventricular fibrilla-
tion occurred · n two of these animals d~ring isoproterPnol 
infusions and a ttird died from irreversible acute left ventricu-
lar failure that occurred during an isoproterenol infusion. 
The LVmax dp/dt of this animal had reached the level of 16,000 
mm Hg/sec. The occurrence of cardiac failure in previously 
normal dogs as a result of the administration of exogenous thyroid 
has been documented by Piatnek-Leunissen and Olson.( 123) 
The changes in myocardial contractility causAd by the 
induction of hypothyroidism and hyperthyroidism were.diametric-
ally opposite and progressive. Myocardial contractiljty can 
therefore in the intact ani~al be correlated with the thyroid 
status of the anirral. This is in support of the findings of 
Buccino et al in papillary muscles from such animals.(ll5) 
The findings of these authors have indicated that these changes 
in myocardial contractility arP. of a primary nature and manifest 
a direct effect of 1he hormone on the functional characteristics 
of the contractile mechanism. Views have previously been 
expressed that the haemodynamic manifestations of thyroid heart 
disease in the intact subject are entirely secondary to peripheral 
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actions of the hormone. Resnik and Harrison(ll8 ) and Howitt 
(121) and Rowlands s uggested that the alterations in cardio-
vascular function were secondary compensatory manifestations 
of the changes in r.eripheral metabolic requirements. Theilen 
and Wilson ( 12 4 ) invoked alterations iri peri1,heral vasoconstri c-
t ion, on the basis of e~cessive rP.sponse of atropinized thyro-
toxic individuals to phenylephrine, as being the primary source 
of the haemodynamic alterations, whereas Harri sin ( 125) supJiortP. 
the view that alteration of function in the adrenergic system 
induced by the abnorw.al thyroid state was the -primary p~tho-
p~ysiologic mediator. Aumann ana Youmans( 126 ) attempted to 
invoke differential sensitization of adrenergic neuroeffector 
systems as being primarily involved with the cardiovascular 
manifestations secondary to these. The demonstration by 
Buccino et al(llS) that ~rofound alterations in contractile state 
of myocardial muscle, devoid of any nervous or metabolic 
influences can be induced by thyroxine adm i nistration, have 
resolved most of these arguments and point to a definite ~yo-
cardial effect of the hormone. 
Our experiments have succeeded in demonstrating, by direct 
measurement, the ~lterations induced by a change of thyrold 
status in the intact animal. Several autr_ors have attem:r-ted 
to demonstrate this by indirect assessment of the functional 
state of the heart. De Groot et a1< 127 ) attempted by simul-
taneous recording of the carotid pulse and the phonocardioeram 
to demonstrate a reduction in the isometric contraction period 
and systolic ejection time in hyperthyroidism. These changes 
could, however, be mere manifestations of the tachycardia 
148. 
encountered in this state. Howitt and Rowlands( 128 ) have 
likewise attempted by the measurement of the systolic ejection 
rate to quantitate the altePations in myocardial contractile 
state in tr.yrotoxic patients. Our findings ~nd those of 
Goldstein and Killip( 122 ) demonstrate that these calculated 
derivatives may remain normal in the presence of marked altera-
tions in contractility~ since both numerator (stroke volume) and 
denominator (ejection time) are reduced as a result of the 
accompanying tachycardia. Howitt et al(lJg) have recently used 
the rate of rise of pressure in the aorta ~s an index of myo-
cardial function. This measurPment 1s determined not only by 
the velocity of ejection of blood from the left ventricle, but also 
by the distensibility of the systemic arterial bed and by the 
mass of blood that is accelerated.(lJO) It can therefore at 
best be used_~~ a mere reflection of ventricular function. These 
authors nevertheless came to the conclusion tt~t myocardiaJ con-
tractility is increased in clinical hyperthyroidism, but could 
not establish whether the changes in aortic dp/dt t~ey documented 
were merely mediated through the incre1se in hPart rate. Recently 
(1 -1) Amidi et al J by simultaneous recording of the electrocardio-
gram, carotid arterial pulse and phonocardiogram, me~sured left 
.ventricular ejection time and exterual isovol~mic contraction 
time in normal, hyperthyroid and hypothyroid subjects. Fro~ 
simultaneous determinations of cardiac index and heart rate, 
predicted values for these measurements were obtained. It was 
found that in thP. normal subJects the actual and predicted values 
were identical, but in the hyperthyroid subjects the actual values 
were less than the predicted and in hypothyroid subjects exceeded 
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the pred i cted values at any particular heart.rate. Thes
e 
differences were interpreted as being mediated by primary 
alterations in myocardial contractile state in these· conditio
ns. 
Ueda et al(l32 ), by transseptal left heart catheteriz~tion in
 
6 cases of hyperthyroid heart disease, ~emonstrated increased 
i 
systolic ejection rate and calculated cit~~mferential fibre 
shortening velocity in the left ventricle. Values for LVm
ax 
dp/dt are nowever not supplied. Their opinion was that the 
thyrotoxic heart .vas overloaded by increased venous return and
 
speeded up by thyroid hormone without involvement of a change 
in contract1lity. 
3. The nature of the increased contrf?.cti1!:_ty in hyperthyroid dog
s: 
( a) Char,1.cteri za. tion by rate-,S?on t.r'-3..ct i. l i t,v curves. 
"' 
As indicated, several g rou i)S of investi.gSt.tors have recently 
speculated that an increased state of myocardial contractility
 
exists in thyrotoxtcosis q,nd have atte:npted to delineate it by 
various indirect measurements. Although these groups have 
succeeded in demonstrating that several of these indirect ind
ices 
of myocardial cc;>ntractili"ty are · ncrease1 in thyrotoxi~osis 1:1
.nd 
reduced in hypothyroidism(
1 29 ,l3l,l32 ) they could, h~wever, not 
ascertain whether the changes t~ey obse~ved were not merely 
associated oanifestations of the altered heart rates encounte
red 
in these states. 
Our experiments performed by increas.ing the heart rate 
artificially in nor~al and hyperthyroid . dogs have indicated th
~t 
although a fraction of the increased myocardial contractility
 
was due to the autoregulatory increase associated with the 




LVmax dp/dt in the hyperthyroid state were in excess of t!'le 
expected level attributable to an increase in heart rate. 
Trie rr:i.te-LVmax dp/dt curves furthermore ind.teated t:i.a.t although 
the autoregulatory mechanism is reset to operate at a higher 
level of contractility, reflected by t!'le vertical displacement 
of the curve, there was also an alteration in the rate-coritruu-
tility mechanism, reflected by the increased coefficients of 
regression shown in four of the five animals. This, however, 
appeared to account for a relatively insignificant fraction qf 
the en~ire incre~se in contractillty. A control experiment .. 
perfor:nPd indicat ed the specificity of the displacement of t!'le 
curves for thP presence of l-T4~i~ the daily injPctions. Care was 
also taken in these experiments to utilize the normal conduction 
pathways by conf1ning observ':itionR to atri,:.1...L pacing wit!'lout 
eviuence of heart block. Thia accounts for tbe f~ct that thPse 
experiment3 could not be rerformed in the hy~othyroid animals, 
since these animals manifested vary ing degrees of A-V block, even 
at rates not substantially greater than their resting rates. 
The use of morphine as a sedative may have co:1tributed to 
these prohibitive difficulties encountered in the hypothyroid 
dogs since thi~ agent is known to increase vqg~l effects i~ the 
intact animal(l3J,l 34 ) and it has recently been postulated that 
th~ rarasympathetic system may ~ave increased tbne i~ the hypo-
thy;oi:l stat.e.(l35) On the other hand i t was a particularly 
suitable agent to use since it has been demonstrated not to have 
any direct inhil?itory effect on r1yocar:lial contractility, (l3 6) 
particularly as assessed by rate-LVmax dp/dt curves.(l3?) 
Our observations answer directly the questions put by 
Howitt et al( 129 ) who felt that although t:iey could not ::lemon-
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strate the primary increase i~ myocardial contractility, that 
it had to be there and was probably over and above the rate-
related increment. 
(b) Characterization b• beta-adrener•ic blockade with ·ro~r~nolo l 
The question whether the hyper~ctivity of the cardiov~scu1ar 
system in hyperthyroi~ism is due to sensitization of the system 
to t~e effects of endogenous catecholamines, has been raised by 
(12~) several groups of authors, as reviewed-by Harrison. J The 
suggestion ~as been prompted mainly by tne nirr.ilarity of mani-
festations of thyrotoxicosis and an infusion of epinephrine. 
One approach to the problem has been the use of the beta-adrener-
gic blocking agents, net}1ali:ie and pror,rl:lnolol to try and 
establish to what extent beta-receptor-mediated effects contri-
bnte to the patho1hysiulog1cal sL-tte. 
Howitt et al( 129 ) Jemonstr~ted that the effects of i~tra-
venous propru.nolol are gre :1.ter .,in hyperthyroid subjPcts tfl3.n i :i 
euthyroid controls, implying that there is increased sympathe,tic 
activity i~ hyperthyroi1ism. Their conclu~ions are based on 
observations of hea_rt ra.te, cardiac outp•lt, stroke volume, 
systolic ejection rate, aortic max dp/Jt, left ventricular strokP 
work, stroke power, pressure-ti~e-1er-minute and ejection ti~e. 
These authors had previously shown that after intravenous 
propranolol the ·heart r1:1te of hyrerthyroid patients in' s.inus .. 
rhythm or wjth atrial fibrillation, though redllced, remained 
elevated above the level attained by giving the same dose to 
normal subjects.< 128 ) It was concluded that the residual 
tachycardia was due to the direct effect of thyroxine. The 
same conclusions have been reachPd by ~ilson et al using 
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nethalide in hyperthyroid patients,(l]B) Wilson et al using 
propranolol in·triiodothyroni~e-induced hyperthyroidism(l39) 
by Cairoli ~nd Cront(l 40) using propranolol in the unanaesthe-
tized rat after thyroxi-:i-e-ind11ced hyperthy~oidism and by 
Goodkind with ~eference to heart rate, peak systolic left 
ventricular pressure and LVmax dp/dt in the open-chested ~Ji~ea-
pig .( ll4) Two of these groups of ~uthors(J.Jg,i 4u) E¥3tablished 
that rropranolol exerted effective adrenergic blockade in the 
hyperthyroid st:::i.te by dernonstrati~g effective blockade of the 
action of exogenous isoprot erenol. Our own observati~ns 
confirmed this point with respect to isoproterenol. 
The effpct of propr~nolol on myocardi~l contractility in 
the hyperthyroid st9.te as meas11red in the intact animal, has 
not been reported. 
In the experiments summarized in Fig.29 it is evident 
that the same relationships can be demonstr9.ted for LVmax d~/dt' 
in the hyperthyroid dog. The effect of propranolol was l 
increased significantly after induction of hyperthyroidisM and 
in no instance dij it reduce the rPsting value to the levels 
obtained in normal animals. A substantial fraction of the 
increased level of contractility i:'.l the hyperthyroid dog,is 
therefore not mediated through stimulation of beta-receptors by 
endogenous catecholamines, even though the activity of these 
appear augmented, and is attributable to a direct effect of the 
hormone. 
Thyroid status and responses to catecholamines. 
The synthetic beta-adrenergic stimulant isoproterPnol was 
used to evaluate the responses of the heart in terms of rate and 
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contractili ty in normal, hypothyroi_d and hyperthyroid dogs. 
Although not a naturally~occurring catecholamine, its use has 
definite advantages. It is a relatively pure beta-stimulant and 
its effect on a?rtic pressure i~ the dose range used in these 
experiments is mi~imal. Vagal inhibitory reflexes are there-
fore not significantly elicited by large alterations of pressure 
as is the case with nore,p1nephrine and ep~nephrine. Curves with 
highly sienificant linear regression on dose were obtained for 
heart r=1.te, cardiac output and LVmax dp/dt. IsoproterPnol is 
metabolized by the same pathways as the natur~lly-occurring 
catecholanines.(l 4l) 
The effect of induction of the hypothyroii state was to 
profoundly lower the entire dose-response curve for all haemo-
dynamic measurements without a significant alterci.tion in the 
·- .,. slope of the curve. The maintenance of the same slope may, 
however, be due to the larger absolute amounts of isoproterenol 
administered to the hypothyroid and myxoedematous animals, all 
of which had gained excessive amounts of weight and the doses 
were c_alculate1 on e. weight basis. In one severely myxoedema-
tous animal it was, however, possible to obtai~ four s;~dies 
without significant· change in weight over a six month period. 
The curves obtai~ed during the myxoedematous state clearly had 
a reduced er~dient in comparison to the curves obtained during 
thyroid replacement. 
The hearts of these animals can therefore respond to the 
stress of beta-adrenergic stimulation with loss of normal dose-
response relationships only in the severely myxoedematous state. 
The entire response occurs at a much lower level of contractilit). 
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Since myocardial oxygen consumption correlates linearly with 
LVmax dp/dt(l4~) this finding may explain the beneficial effects 
of induced hypothyroidism in patients with severe angina pec~oris 
. and congestive cardiac failure, first proposed by Bl-~mga.rt et al;} 
( ) (14 '3) recently reviewed by Andrus. 144 The heart of such a p':'.l.tient, 
from the haemodynamic point of view, maintains its ability to 
respond to stress, but operates at a much reducPd level- of 
¥ contractility and oxygen consumption with some attenuation of 
the responses to bet~-adrenergic stress. In man, however, in 
contradistinction to the dog, the hypothyroid state is comvlicated 
by the early development and exacerbation of coronary athP.ro-
sclerosis. 
In the hyperthyroid animals, the opposite effect was seen. 
The dose-response relationships for LVmax dp/dt and heart rate 
were entirely disturbed by the administration_ o-f thyroxi:1.e for 
one week. This occurred in addition to a massive elevation of 
the level of contractility at which the heart functions. The 
dose-response curve now had a convex configuration instead of the 
strictly linear form in the euthyroid state. The plateau occur-
red at higher dose levels. On the other hand a marked incrPase 
. in r~sponsiveness to isoproterenol could be demonstrated at very 
low levels of the drug, levels at which the response during the 
euthyroid state was minimal or absent. This is in direct 
support of .the observation by Riggs et al( 146) in the dog, using 
epinephrine infusions. The use of atropine revealed that the 
plateau of the curve was not the result of failure on the part 
of the contractile mechanism, but of a powerful buffering action 
by the vagus nerve. The same conclusion was reached by Riggs 
• et al and lends support to the suggestion of Hoffmann et al(l47) 
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tnat the vagal inhibitory influences can be increased by cate-
cholarrines in the hyperthyroid state. It 13 also notewort~y 
that Beznak ·found the capacity of the heart to perform work 
greatly increa~ca in thyroxine-treated rats. (l4B) These 
observations stand in sharp contrast to those of Whitehorn 
et al(i49 ) who showed decreased contractile capacity in ventricu-
lar muscle from rats treated with thyroid, but these authors 
u~ed an in vitro system only with isolated strips of muscle. 
Our Pxperimental findines are in direct opposition to t~ose 
of Margolius and G~ffney(lSO) and van der Schoot and Moran(lSl) 
who found no alteration in.responsiveness to catecholamines with 
alteration in thyroid state in dogs. As is evident in our 
experiments invo lvine; triidothyronine, the hearts of our animals 
responded br,iskly and responses in contractility could even be 
demonstrated in th~ absence of changes in heart rate.· It is our 
beli~f that the difference between our work and their experiments 
is the absence and presence of, firstly, pentobarbital anaesthesia 
and, secondly, of extens ive surgical intervention e.g. an open-
chest preparation v.s. an intact coascious ani~al. We further-
more measured LVmax dp/dt directly whereas these authors measured 
peripheral arterial pressure anl heart rate. 
An illustration of the variable ~ffects of pentobarbital on heart 
rate and myocardial contractility is provided in Fig.J2. 
Observations of LVmax dp/dt and heart rate were obtai~ed in a 
dog during euthyroid state and after one and three weeks of 
thyroxine treatment. Percentage changes in LVmax dp/dt are 
conspicuously ereater than in heart rate. The dog was then 
given atropine;· the influence on contractility was minimal, but 
heart rate increased further. Following atropinization to 
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preclude any med1ution of effects through the parasympathetic 
system, pentobarbi tal was given 25 mg/kg by intravenous inJectio 1, 
a dose sufficient to iniuce light surgical anaesthesia. Th~ 
disparity of effects on heart rate and ~yocardial contractil1ty 
are striking. Pentcbarbital haR also been shown to act at 
( 1 c:: 2) various autonomic reflex levels. ~ 
It remains djfficult to interrret these data in terms of 
whether."responses" to catecholamine secretion are increas ed or 
decreased by alteration of thyroid status in these animal~, 
since from this study it appears that the majn effect of the 
hormone is to establish the level of contractiljty at which the 
heart operates, rather ttan alter the responses at a particular 
level. Our findings therefore do not help to resolve the 
contradictory conclusions of Brewster et al,(l53) Schneckloth 
et l,(l~4 ) Murray and Kelley,(l5 5 ) Hoffmann et al(i47 ) who all 
• 
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found incre~sed ~sensitivity'' to injected catecholamines in 
hyperthyroidism, and Hoffmann et al(l4? ) and Scheckloth et al(i 54 ) 
who demonstrated decreased responses in hypothyroidism on the 
one hand with Margoljus and Gaffney,(lSO) van· der Schoot and 
Moran,(lSl) Hess and Sh;nfield(i55 ) and Aoki et al(l5?) who 
found that alterations ir. thyroid state did not alter responses 
i 
to catecholamines. Most of these investigators , however, reli~d 
on measurements of peripheral arterial pressure and heart rate 
to arrive at their conclLi.sions; weight alterations ·were in no 
instance corrPcted for i~ exrer iments involving hypothyroid 
subjects. Our findings a~d conclusions correspond more exactly 
with those of Leak and Lew(i5B) who conclud~d that responses to 
catecholamines remain intact in hypothyroidism until severe 
myxoederna develops, and are altered wit~ disturbed dose-response 
relationships in the hyperthyroid state. 
The finding that trijodothyronine will augment responsP.s 
to isoproterPnol without a demonstrable effect on resting 
haemodynamics and level of contractility, lends further support 
to this contention. The principal effect again was found to be 
an elPvation of the level at which responses occurred. The 
occ~rrence of the effect within 15 minutes corresponds tavourably 
with the demonstration by K:einfeld et al(l59) of an effect of 
triiodothyroni~e on the function 0£ the frog's heart in 30 
minutes . The fact that an effect could be demonstrated on 
contractility without an effect on heart rate strongly suggPsts 
that the action of the hormone is mediated not ty the beta-
rP.ceptor but by a mechanism operating nP.arer the contractile 
. element. 
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5. The action of thyroid hormone on the heart. 
A direct effect of thyroid hormone on the heart rate was 
demonstrated by Lewis and McBachern( 160 ) who in 1931 showed that 
the tachycardia of thyrotoxic rabbits persisted in the isolated 
perfused hearts and in isolated atria. They also made the 
significant observations that the rise in pulse rate of their 
rabbits could be detected as early as 2~ to 48 hours after 
commencement of thyroxine administration. Thyroxine added to 
the perfusing medium had no effect on normal atria. Priestley, 
~arkowitz and Yater( 161 ) demonstrated this same effect in 
isolated hearts of dogs and rabbits indicating that the pffect 
was independent of an intact nervous supply to the heart. The 
possible rol~ of significant amounts of free catecholamines, 
derived from the traumatized atrial tissue, could not be excluded 
though. These authors also performed the study on the trans-
planted heart of the dog, the data of one experiment only, how-
ever, being pres.ented. Administration of thyroxine intravenously 
to the recirient animal resulted in a marked increase in rate of 
contraction of the transplanted puppy-heart which had beaten 
at a regular slow rate prjor to the thyroxine injection. The 
increase in rate of the transplanted heart was noted to be far 
greater than that.of the host animal sug~esting ttat not 
only was the initiation of the tachycardia independent of the 
nervous system but in fact counteracted by intact innervation. 
Again the role of circulatlrg catecholamines could not be 
assessed. 
Markowitz and Yater( 162 ) used cardiac tissue entirely 
devoid of nervous elements in an attempt to further resolve the 
problem. Myocardial celln from 48 hour old chick embryos were 
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cultu~ed artificially for several days, displaying rhythmical 
contractions. These cells wou]d not rpspond to the administr~-
tion of epinephrine or acetylcholine, but administration of 
thyroxine to the culture medium induced a striking increase in 
rate of contraction, which was not reversed by acetylcholine. 
Although these authors indicated the purity of their thyroxine 
preparation and controlled their ex~riments in pairAd fashion, 
i 
they omitted a control experiment with the alkaline sol~ent of 
their thyroxine. Since the volume of their culture ~edium was 
so small, a significant change in pH may have occurred and the 
effect of ttis was not assessed. Wollenberger(lb3) has recently 
reported similar experiments and demonstrated a chronotrop1c 
effect for l-tr1iodothyron~ne. The effect on his chick-emhryo 
ventricular-cell preparations came on minutes after administering 
the hormone and was lost within five minute~ pf washing away 
the horrr.one. 
The possible role of the nervous system in the mediation 
of the effects of thyroid hormone· on heart r~te received its 
main support from the work of Brewster et al(lS 1) who studied 
tr-e effect of total sympathetic blockade by epidural injection 
of procaine in normal and thyrotoxic dogs and found the heart 
rate of the two groups identical after the blockade. From thjs 
observation these authors concluded that the tachycardia of 
thyrotoxicosis was entirely mediated via the sympathetic nervous 
system. Their preparation was complicated; not only were the 
dogs anaesthetized with pentobarbital (their euthyroid animals 
had average heart rates of 170 beats per minute), but the animals 
were then subjected to thoracotomy as well as symr,~thetic block-
ade by injection of a large amount of r,rocaine. The findings 
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of these authors have not been duplicated using a less extensive-
ly ~an1pulated preparation and their data thus far stand unsuprort-
ed. In tte .. spinal c'at, Benfey and Varma ( l~4) recently observed 
that myocardial force and heart rate were greater in triiodo-
thyronine-treated animals than in normal. 
A similar approach to define the role of the sympathetic 
system has been tpe use of selective sympathetic blockade, using 
the beta-adren·ergic blocking agents, netha] ide and propranolol . 
As discussed earlier the majority of all authors ar& in agreement 
on both the points that the fraction blocked by these agents and 
the residual fraction are both increased in hyperthyroidism. 
Our own experi~ents have shown that these gener~lizations are 
also apylicable to myocardial contractility in the intact dog. 
Guanethidine, an agent that interrupts norepine phrine 
relea::at sympathetic neuro-effector junctions( 165 ) in addition 
to depletiori of norepinephrine stores at these nerve endings(lb 6 ) 
was shown to have striking effects on,. and may in fact correct 
the signs of thyrotoxicosis~ 167 ) Gaffney et al( 168 ) found that 
the drug could completely inhibit the rise in resting pulse rate 
aml exercise-induced tachycardia of triiodothyronine-induced 
hyperthyroidism. Barker and Makiuchi (l 5g) cor1pared the effects 
of guanethidin e and bretyliurn on. thyroxine-inlluced tachycardia 
in rats. Bretylium act s like guanethidine, but does not dep1ete 
catecholamine stores. The effects of the two agents were idP.nt1c3.l 
and unlike thP. findings of Gaffney et al, did not succeed in 
blocking completely the chronotropic effect of thyroxine. Further 
support for the conclusions of Barker and Makiuchi is provided by 
the findings of de Groot et a1< 127 ) who used the ganglion-blocking 
agents, trimethaphan camphorsulfonate and guanethid ine and found 
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that these agents djd not restore the isometric contraction 
;eriod and the duration of ventricular ejection in thyrotoxic 
subjects to norn:al. 
Reserpine l'las 1'01· a long time had a place in the · symrtoma-
( J 70' tic treatment of thyrotoxicosL, and thyroiri crisis. Bray J 
attem1,ted to define the role of the autonomic nervouo systerr 
i 
in the maintenance of the tdchycurdia in thyroxine-treated rats 
by the use of this drug. Thyroidectomized and thyroidectomizPd-
adrP,no~edul3~ted rats were used. Triiodothyronine ad~inist~1-
tion six weeks after the surgical proceiures, at whicb ti~e 
adrPnal regeneration was complete but endogenous erinPphrjnp 
productio_n c.bs ent, produced a significant increase in hP8.rt rate 
and B.M.R. in both groups. RNce.rpine j.'.1. do1 es ass!lmE'd to pro\l...1.ce 
maxi~al ncrepinerhrine deflPtion, preventP,d the increHse in he~rt ·- .,. 
rate, hut not the increasP. in B.M.R. induced by triiodothyronjne. 
Reserpine admird st rat ion to the tr:yroidectomi zed-ad renomedu l J a ted 
animals resulted in_th e de~th of many animals; this could be 
prevented by thP daily administr~tion of epinerhrine. Trijodo-
thyronine could raise the depressed heart rates of this group 
(t~yroidectomized-adrenomedullated) to norT.al, but not higher. 
Bray suggests that a system - specific catechola~ine -. thyroid 
interaction occurs, proportional to the degree to which the 
system concerned is normally under autonomic control. This is 
supported by his findings that B.M .. R. and oxygen consumption 
were not affected by catecholamine depletion in the triiodothyro-
nine-treated animal, whereas heart rate was greatly. Atropine 
resulted in complete reversal of the reserpine-induced brady-
cardia in the triiodothyronine-treated animals. The heart rates 
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obtained after vagal blockade in these triiodothyronine-
reserpinized r~ts were not different from those of animals 
treated wlth triiodothyronine b~t ~1ot reserpine. 1o data are 
supplied for .. ani:nals · treated with re~errj ne. ,=i.!'!:l atropine only 
and it is thus not posuibl e to assess ·the influence of the para-
sympat~etic syst em s eparat ely from t1e triiodothyronine effect. 
This s t·tdy ws..~ r erformed in t 'le in tact, et li e r--3.naest'.'let ized r':l. t. 
Thier et al(l7l) conducted a similar st~dy on isolat ed rat 
atria obtained· from euthyroid, hypothyroid and hyrerthyroid rata 
with and wit~out s~peradded reserpine treat~ent. T'heir findings, 
su~ported by later eKperiments(l?2 ) showed that reserpinP treat-
ment jid not abolish the differences in heart r ·1 te betNeen ~~e 
v~rlous groupA . Their findings stand in contr~st to those of 
Mendelsohn ( 1731 who foun<.1 t:13. t pretre.:1 t;nent Nl th res err J ne co11ld 
prevent the tachycerdia i nduced by thyroid feed~~e, excert that 
in Th1er's work the rats were entlered hyrerthyroid. by ir.tr:1-
reritoneal i~jection of thyroxine and.the variabl e of gas tro-
intestinal absor1 tio-n was eliminated. 
The contr::l.diction a 1parent in 1.e :'indir.g ~~ of Br·1.y and 
Tl'J.ier et al -Ln the ability of reserpine to normaL.ze t~e heart 
rate of tbe hypert~yroid animal may be important. The work of 
Bray w~" perfor~ed i~ th~ int~ct dnirral , t~at of Thier h~d heart 
rate assessed in the jsolated atrium. An obvious conclusion is 
thereforP that an intact ~ervo~s aystem may be important; not 
only the sympathetic sy stem, tut _1.;articularly the paras.7mpathetic 
system , since atropinization removeJ any differences in heart 
rates in tli.e study of Bray between animals treated with reser1-ine 
and those not so treated. 
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T'l-1e ros si bl e role of t!1.e '.l.U onomi c nervous sys tern in t"1e 
rPsting t~chycardia of experimental hyperthyroidism has been 
inve~tieated by Cairoli and Crou~.(i 4o) These aut~ors, wor~irrg 
with rats, obtained heart rates in t~e conscious anima1s by 
electrocardiography. Propranolol, chlorisondamine and atropi~e 
were used in control and reser~i:ie-treated euthyroiJ and hyper-
thyroid anirnF!.ls. Blockade of beta-adr~nergic receptors produce5 
less cardiac slowing in thyroxine-treated t~an in normal ratJ. 
Atropine subsequently administered, rroduced ~ sharp rise 13 
r~ie in both hyperthyroid and euthyroi~ groups, suggesting t~ut 
t'le vagal effect on the sine-atrial ::1ode Ls not p,:irtl cularly 
abnormal i:i the hypert:1yroid r ·- ts. In these unan,1e:Jthet i.~eJ 
rat:;, the fall iri heart rate 1 rodt1ced ""'Y chlorisonda'.Iline we1.:1 t:. e 
same in both euthyroid and hyperthyroid animals. The heart ru.tes 
of thyroxine-treated raL-, thus recpondej to a e;::3.nglion-blockine 
drug and to the combination of prorr~nolol and atropi~e in a 
manner simiL1r to that of the euthyroid controls. However, 
a disparity in resting heart rate between thyroxine-treated and 
control ani~als is routinely observed hy all investigators under 
all exi,erimental conditions. These aut:'lors therefore concluded 
that the resting heart rate of the thyroxine-treated ~nimal is 
modul::1ted by autonomic mechanisms in a rel8tively normal fasr1ion, 
but t:!1.e high baseline rate is sustained by a non-neur:11 rrocess. 
Our own conclusions with reference to myocardial contractility 
are identical· with those of this former group of authors. 
These authors proceeded to investigate the interaction 
between the autonomic nervous system and the effects of reserpine 
treat:!lent. Treatment with reserpine in hyperthyroid r~ts 
resulted in progressive lowering of the pulse rate to levels not 
l 6Lt • 
different from the levels attained i~ normal controls. They 
t~µ3 confirMed thP earlier observ~tions of Bray.(l?O) T~ese 
reserpine-t eate ~nimal~ were then tredted first with rroprano~ol 
to block any residual effect of beta- receptor stimulation and 
30 minutes later atropine wa•~ given. I'rorranolol induced a 
furt:-1er fall in rate i-:-i both :;roups; atrorine cau::;ed a marked 
i:icrease i:-i. heart rate such that the original di,::;. ·.1ri ty L'l 
res ti:1g r~ tes, before rPse rpL'le treatment,- was re st,) red. 
T11ese fi "ld1ngs st rongJ.y sugeP8t t·ha t ~ese rri:1e can nornal L~ e t 1~ e 
heart r::,i,te ir1 thyroxine-treated r~tu on:'..y if vagal f·.rnct1or is 
intact. Th1s fact, emet'tring from this ·study, may exrla1:1 the 
apr,a:·C'rit cor tr"idictlon in the rPs,1lts of the findines of Br,:1yfl?O, 
3.n:1 Thier.(l?l) 
An additional observation made by these aut:'lors was the 
fact that the differential effect of resPrpine on he~rt rate i~ 
_eutnyroid and l:yperthyroid ani:nals could only be documented in 
the unanaesthetized animal. When the rats were give~ pen~o-
barbital and then manipul~tted s 1rgically the effect of r-eserr ine 
was no longer visible, resembling the effect of atropine admini-
3tration. This observati0n correlates well with our co1tention 
expressed earlier -~ha t observ~t1ons on heart r~te in anaesthe-
tized animals are i~valid ·r used to d1stingu~sh between thyroiJ 
states in experimental animals. The effPcts of anaesthesi~ 
are so variable that no conclusions car. be drawn with any 
confidence. 
The action of reserp i~e in hyperthyroid animals has there-
fore resultPd in attention being focus s ed o n the rarasympathetic 
system as well as on thP 3ympathetic system in thyroid disorders. 
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Reserpine apre·1rs to effect its rate-lowering E>ffect by a 
~ec~anis~ involving the rar~sympathetic system in addit:on to 
its bettpr hnown effect of catecholarrnne jepletion. This focus 
~n the rar~sympathetic system em1hasizes our findings in tte 
myxoede'Tlutou.1 ·log st·.1died wi th atropi.!1e. 
The studies of T~ier, Bray and Cairoli are definitive, 
wel l-cont.rollPd and thej r resnl ts unifor:nly ·urr ort the hypo-
thesis that the intri~sic rate of the hy1erthyroid state is set 
by an action of thyroij hormone directly on the i:;acemai-<er cells, 
rather than by a totally indirect action via the nPrvo~s syste~. 
Their findings suggest that thP i~trinsic rate of the heart i~ 
determ ... ned by a direct action while oscil1:J.tions about th1s set 
level are modulated by the autono~1c nervous system, includ1n7 
free catecholamines. 
The recent findings of Bncci!10 et al, ( ll5) published since 
the commencement of this ~reject, and o~rs suggest that the same 
generalizations apply to contractility. Thyroid horrr ~ne exerts 
a ;rofound i:1fluence ln detPrminine the level of contractility, 
with its i:nportant b1plications for oxyven consumption, by a 
direct action on the contractile mechanism or its immediately 
associated metabolic processes. Our experiments with triiodo-
thyronine confirm the earlier flndi~gs tha the hor"!lone acts to 
alter res~onsiveness to beta-adrenergic stimul~tio~but since the 
effect on contractility can be divorced from effects on rate, 
suggest that the action is not ..at the level of the beta-adrenergic 
receptor. Our experiments have in addition established the f~ct 
that the increase in contractility in hyrerthyroidism is greater 
than can be accounted for by an autoregulatory increase associated 
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with the increase in heart rate. 
The ·n8.gr11tude of the pffect of th(> horTT1one on m,yocarui.:1J 
contract1 1 ity ma} explain not only the beneficial effec~s of 
tnduced hy 1,othyroi:iism on patien"ts wi. th angina. rectoris but 
may also explain the high incidence of cardi'.:J.C disease and 
failure, apart from rhythm listurbances, recently emphas ~z ed by 
Sandler and Wi1son(9 4 ) in ps.tient8 with clini:al hy;.erthyroidjsm, 
es~ecially in f~ti ents with meagre metabolic signs of hy1er-
secretion of the hor~one. 
Recent investigations have shown that the alterat~ons in 
myocard1~1 contract1lity occ1lr independently of changes in Chrdi~c 
· h d h · h h h t ".,tore·-::. ( l l 5) A -l · t norer1.ne1, r1nP an 1g -enert.!,Y r osp a e ~ ,.i1rec 
effect of thyroirl hormone has been shown to occur at the level 
of mechano-chenicdl coupling with a decreased Pffic1 Pncy in the 
conversion of chemical energy to mPchanical work in the myo-
cardium of hyperthyroid 3ubjects.(i74 ) The possibility has 
recent!y been raised that thyroid hormone may act through the 
adenyl-cyclase-cycl1c 3•5• - adenosine mono~hosrhate syste~.(l 7S) 
If, as has been suggested, adenyl cyclas e is in fact the beta-
receptor,(176) an attracti.ve theory for the local1zati9n of 
thy ro j d hormone-ca techolam i nP interaction in tn is co m1,lex system 
presents itself, but remains as yet unproven. 
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SUMM A RY. 
The purpose or this thesis is to examifte the-influence 
of the- thyroid status of an a~imal on the contractile state of 
its myocardium. This is prQmpted by the question whether 
primary myocardial actions of thyroid hormone contribute to the 
• pathogenesis of the haemodynamic syndromes-·encountered in hypo-
thyroij and hyperthyroid heart disease. Since myocardial 
pPrformance was assessed by direct measurement of ·~yocardial 
contra ctility, the principles of c a rdiac muscle physiology that 
underlie the definition of myocardial contractility are described 
in detail. The factors known to act as determinants of the 
contractile state of the myocardium are reviewed as well as the 
~ 
methods of as s essment of myocardial contractility, with particular 
reference to the intact animal. A method is outlined w~ereby 
insight can be gained into the force-velocity relations of the 
intact heart by the measurement of the maxima1 rate of rise of 
pressure in the isometr~c phase of left ventricular contraction 
(LVmax dp/dt). Simultaneous measurements were, however, also . . 
obtained of the more traditional criteria of ventricular function, 
the relationships between stroke volume, work, power and rate of 
ejection versus the end-diastolic pressure, based on t~e Frank-
Starling principle. Since the measurements were obtainei in 
conscious animals seda ted lightly with morphine, percutaneously-
inserted catheters were necessary. ThP. limitations of catheter-
manometer systems in the faithful recording of cardiovascular 
phenomena are discussed and an outline given of the method 
followed for the assessment of the frequ$ncy-response charac-
teristics of such a system. A direct comparison of the 
catheter-mano~eter system with an intraventricular manometer 
system is described to establish the ~dequacy of perf0rmancA 
o.f the system used for the rPcording of the frequency-dependent 
measurement of LVmax dp/dt. 
-LVmax dp/dt, stroke work, stroke power and systolic e·jection 
rate were measured in normal, hypothyroid and hyperthyroid dogs. 
The hypothyroid state was obtained by treatment with r1 31 ; the 
hyperthyroid state by subcutaneous injections of 1-thyroxine. 
Cor:relation of LVmax• dp/dt with thyroid status could be demon-
strated, with LVmax dp/dt revealing greater quantitative changes 
than the other measures of contractil ,. ty. The contribution of 
the increased heart rate with its associated autoregulator) 
increase in contract~lity in the hyrerthyroid animals was 
assessed by obtaining rate-contractility curves by artificial 
right atrial pacing before and after the administration of 
thyroxine. The influence of alterations in thyroid status on 
the myoc~ruial responses to beta-adrenergic stress was investi-
gated by infusions of isoproterenol. It could be shown that 
the hormone determineo tbe Jevel of contractility at which the 
response occurs. In a grossly myxoedematous dog a loss of 
resptinsiveness could be shown; in hyperthyroid animals an 
' increase in responsiveness could be shown to occur at low doses 
of isoproterenol while at higher doses complete loss of the 
dose~response·r~lationships occurred, in addition to the massive 
elevation of the curve. Propranolol was usP.d to demonstrate 
· an increased state of beta-adrenergic stimulation, in addition 
to a direct effect of the hormone on the muscle, independent 
of the beta-adrenergic receptor. A. similar action of 1-triiodo-
thyronine was demonstrated fifteen minutes fol]owing its admini-
stration intravenously. At this stage an inotropic effect 
independent of a chronotropic component could be demonstrated. 
The results are discussed in the light of findings of 
other workers, both recent and earlier. Emphasis is devoted to 
several authors who have recently provided evidence that 
supplementsthe conclusions reached in these experiments. 
a~pects of thyroid hormone action are reviewed and their 
implications in the physic.logy of the myocardium and patho-
physiology of thyroid heart disease diacussed. 
---oOo---
These 
A P ~ J D I X. 
I: = umm~ t1on s .ign. 
J :. I:. tegra tion s l {:rJ • 
N .::: Nurr:ber of o '::;c3ervc1. t ions in a r,rotl l . 
X = Jr: lependen t vari(..1:le. 
y = DerenJen':; variatle. 
Y.. .::: The '.,e,:.n_ value for tr e FI.'O r of x. 
y ·- Tl e Brand mean of the erendent va.r1acles. 
X -- Dev-~-~ t.icn f,'OID the rue':3.n X - x. 
d.f. = De~ree~ of frPedo~. 















= StuJent's t-distrttu icn; 
e..::tjrr.'..iteJ. rne':Hl frorc t}·.e 
i.e. the dev1ation of the 







.:; p are • etwe1::1 clc.w ,es 
w • t h · n c 18. .1 f-, e .:-, • 




Deviation of y frorr 7-. 
Devic.tion of y from Y. 
Calculated values for Y. 
" Dev1::... ti en from regress.:.on = y - Y. 
= Sum of squares of deviations fro~ regression. 
= Mean square deviation from regres~ion. 
= Sample standard devi~tion of the regrAssion coeffic:e~t. 
= ! x within a si!'gle distribution. 
TJ.BLE 2 - IIAEMO DY /ArlI C MBA ':iT'P.~!tENTS AT R't:'~ T JU._ • 
Sect.:cn A - Bu thJ' ro j d GrO\lf': 
Dog LVmax d:p/dt HeArt Rate C3:rd i.ac J r1~ex. M • .A.P. LVBDP "E.T. 
No. ( mrn Eg/ sec) ( I er :ni n) (ml/min/m) ( ·n:n lrg) (mm F,' (!11 ·~ e C) -CJ 
1. 46 0 1 '2 
?. 4640 G6 
3. 4370 64 2489 84 1~ 1 _,.• . - 220 
4 • 4420 72 3766 107 'L5 230 
. 5. 41?0 76 c.155 103 5.5 :~,C· 
L 4BOC 60 ,, ) ")) 110 A • 6 ?CO ...,.t.-J'-
7. 41 (,0 64 ]lt 6 J 14 p .13 190 
8 . :100 5G 38,8.5 J 14 7.1 ~~ic 
9 . 5000 80 3P,,?9 Li? 1 'l. 2lC 
lC. 5CJ10 () ti t704 125 9.5 ' 10 
11. 4930 75 3250 1C8 1.3 "00 
., ) 
...i..' .. 4940 82 347~ 11 'J c3 • 3 l ,0 
13. c.. .. 00 82 ?g48 110 g.o .?C•O 
:4. 4360 q4 1912 79 lC. Q 20° 
11; . 3100 90 3G71 104 7. 'l 200 
1 (). E350 80 34g1 ]16 6. 6 ?00 
., ~ 
.i. I • 6490 9b 4072 104 6.7 .JOO 
lP. 6400 82 384 (, 100 1.2 ?00 
l ') . 5000 80 3829 127 l 'l .1 2?0 
20 . 6100 82 2970 110 o.o 200 
21 . 5100 90 367 c: JC4 7 .... . ,. 200 
22. 6400 102 4272 104 c,. 2 200 
23. 6400 82 3847 lCO 7.2 20:, 
~4 . 5660 58 3240 100 6.0 210 
25. 7200 1'2. 4 613 119 8 ') " • r' ,JCO · 
2 X 133,690 1 ,953 8},111 2,488 207 . 6 -1 • t 95 
x 5,347 78,1 3,613 108 n.02 204·.1 
S. B. 175.0 2.5 113. l ~.47 C. 67 c.. 12 
Section B - H;n o t hj:' ro i d Group: 
Dog IVmax dp/dt HP.art Rate Cq,rjiac In~ex M.A..l. LVEDP 'E.T. 
No. ( mrr. Hg/~:1ec) ( per min; ( ml/mi n/m - ) (mm Hg) (nL'n Hg) (msec) 
1. 3200 46 2350 l03 14.0 ~>10 
2. 3300 66 2450 1·)0 15. 6 240 
3. 3300 70 17 31 10 3 0.1 ?lC 
4. .3340 48 11,_.36 102 8. 4 130 
5 • 3430 90 2846 g3 lC.5 21C 
6. 2g30 64 1763 108 8.1 200 
7. 37">0 70 Jl54 l ?5 1~. 5 220 
3 . 2600 68 1496 85 &.O 200 
q. 3710 80 2555 116 8.6 220 
lC. 2800 66 1742 102 5.2 1qo 
11. 3740 68 2894 86 g,7 240 
le). 3300 84 1J41 115 15,0 210 
1.). J66C 84 32 3 2 127 g • E. "10 
14. 3770 84 171'30 1C9 lC.O ~10 
1 r: . 2160 45 1757 102 10.7 <~10 
l t. 2460 42 15'.)5 80 4,8 2L'O 
17. 2g50 60 2205 91 11 • 3 230 
Z: X 55,030 1,135 36,287 1,769 lfiC).l J, 620 x 3, 2 .37 Gb.7 .:134 .5 104.1 g ,g4 )l_J.q 
S. E. 103.3 3.6 151,5 3.40 0 .'76 3.5 ... 
Section C - Myxoeri.E>matons ,.., -., rou p: 
1. 2040 44 961 94 10. 4 210 
2. 2210 ',., 1084 87 11 ·.o 230 .)U 
J. 1970 50 ·1105 67 t • 5 230 
4, 2100 44 1109 110 1 ~.:' .0 220 
5. 2480 62 1146 92 11.0 ?. 30 
L 2260 45 942 70 10.2 250 
2.X 13,060 283 6,347 :i20 61.1 1,370 
X 2,176 47,1 1057,8 8 6. 6 10 .18 228.J 
S.E. 74. 7 3.35 34.8 6. 5 6 0.78 5,42 
TABL'E 3 - R'ESPONS~S TC 1 SOPROT'ERE\101 J Nlt'USTONS. 
Section {iL 'Eu tr.;:t, ro id and Hal'.]:oth~-ro 111 p;rou,rs: 
A. Euthiroid GrouE ( for va) ues of LVmax dp/dt s ee Pf• 1og-112) 
(a) He:1rt r~te (rer rr.in). 
Dosa~e ir. µg/ke,imin 
Dog ' 
Baseline 0.05 0 .10 0. ,:'0 No. 
1 . 72 7 e: 72 102 
? . 66 66 84 108 
) 64 80 90 115 J. 
4 • 60 66 84 102 
5 . 64 74 84 90 
b. 56 66 80 g8 
1. 80 78 88 . 102 
8. 96 92 g6 106 
g. 75 94 94 124 
10 . 82 74 86 110 
11. 82 Q6 102 120 
12 . 94 94 98 120 
lj. 90 90 92 94 
14. 80 76 82 84 
15. 96 92 112 124 
1 (J. 82 96 106 126 
17. 80 7?. 88 102 
lQ. 82 g6 102 120 
1r· .,, . 90 90 92 94 
20 . 102 92 112 124 
21. 82 96 106 126 
22 . 58 68 86 94 
?3 . 72 88 84 96 
i X 1805 1914 2120 2481 
X 78.5 83.2 92.2 107.g 
S.E. 2 .7 2.3 2.2 2 . 7 
( b) Cardiac Index (ml/mi.n/m2 ). 
Dosage ir pgt) rl_mi n 
Dog Baseline 0.05 0.10 O. 20 No. 
1 . 18fi0 1790 19b0 25 LO. 
0 1460 1890 2540 3370 L.. . 
3. 2490 3010 4060 4 670 
4. 3230 yno 4650 7430 
5. 3150 3520 4850 4570 
6. 3890 3720 5010 :;17 30 
7. 3830 3560 4870 57]0 
8. 4 710 £1240 6010 L 6'10 
9. 3250 5340 4870 6Y":JO 
10. 3470 2910 3410 5"J50 
1] . 2950 4160 5430 60 30 
12. 3910 3040 3220 31 30 
13. .3670 4ogo 5070 502c 
14. 3490 3740 3240 3960 
15. 4.070 3760 4170 52.70 
lb. 3450 4?00 5 380 7t40 
rr. 3830 3560 4870 5780 
18. 2970 4190 4460 6080 
19. 3670 4090 5070 5020 
20. 4270 3760 4170 5270 
21. 3850 4200 5 380 7640 
22. 3240 3550 4640 6240 
23. 4610 6450 5350 6060 
Ix 79,320 86,740 102 , 680. 126,JJO 
X 3,448 3,771 4,464 5,4g3 
s. 'E. 160. 7 200. 4 208. 5 269.9 
B. Hyrotr.yroid Grou p: 
(a.) LVrr:ax lp/dt- (mr:i. Hg/sec) - see page 110. 
(b) Hf'art R::1.te ( per min) 
Dois 
.Dose of Isoprotereno2.. j n p.g/kg/mi n 
No. Baneline 0.05 0 .10 
0. )0 
1. 66 7'c! 78 '16 
::. . 48 66 67 70 
J. go go go 92 
4 . 64 80 84 10? 
5 . 70 76 88 go 
o. 68 7t.: 80 104 
7. 80 84 qo 100 
8. 66 78 80 ClO 
g . Go 6C 64 80 . 
1 C • 4? 7t, t,6 70 
11 . 6C 7P 82 88 
.... 
8J6 8b9 19? "-' X 7 22. 
X 6r.:, ., 7C 79 3t) 
S.E. 3.g ;- • 4 - 0 3 r, ( . ) . ,




2450 3'120 17 JO 5170 L • 
2 . 1440 2'"'50 2~50 .3?.50 
3. 2850 2.410 2570 36qo 
4. 1760 3150 ?g40 Jt.J/0 
5. JlnO 3750 }'~'70 4ROO 
6. 1500 \ 2060 2160 Jt 20 
7. ·2560 3100 3170 J46C 
8. l'/40 1660 1730 l'J90 
9. 2890 4280 24JO ;g30 
10. 1010 1880 2150 2090 
l l . 1430 1860 2220 2000 
~x 22,790 30,320 30,680 36,b?O 
X 2,072 2,756 2,789 3,333 
s. 'E. 219.8 279.2 264.9 318. 6 
C. V;~· xoedema tous G rou r.,: 
(a) L vm~1.x ct1LU_ ( 'Tlm Hr/ s ec) - See r,age 112. 
( b) He::1.rt Rr-tte ( pP-r min) 
Dose in E:3g/kg/mi. n 
Doe Baseline 0.0:, 0.10 0.20 No. 
1 . 44 44 46 48 
2. 38 38 50 6b 
3. 50 r. -, ' , .,~ 54 55 
4 • 44 60 52 (C 
'?:x 176 194 202 ?. 32 
X 44 48 50 58 
S.E. :>. 4 4.8 1.7 3.7 
") 
( C) C·i rdi :1c Tnrlex (ml/min/m'") 
. 
Do e. i n l· e:ik ei_m in 
Dog Br-rnel ine l .05 0 .10 0.20 ~o. 
] . 960 1()30 15JO 1r.__ o 
2. 10~0 l RO 146 0 _J_r ~o 
J. 1)10 1570 J 40 0 169 0 
~x 315 0 478 0 ti J'l O 4720 
x 1050 15go 14 60 1:70 




T.4BL "Po 3. 
Section ( ii) Thyrox.i::ie treated r:roup~~ 
(~) Before thyroxin e treatme~t: 
(i) LVrnax 11/-it 
Dog 
No. 
Iso:rro terenol dose in pg/ke/min 




. 4 . 
r - . 
7 . 








41 , 860 
5 , 980 








~U , 2?0 
7,174 
4RJ. 












1 J , 4 ?O 
7 , 920 
lJ , 200 
'3 , 400 
<1 , fJJO 
l l. , 4 ...)0 
l ) , g70 
71 , 170 
lL , 167 
541 .4 
1 J , 100 
10 , C::10 
14 , 750 
11,740 
10 , ') 30 
lJ ' J cc 
l? , J60 
87,t-50 









S 3, 1 (.0 
7,:;q4 
4 (,q. l 
11 , !:00 
1, , 600 
1 ~ , 340 
10 , 230 
l >, 840 
13 , A50 
L-- , fi'")O 
88 , ,>40 
L! , 606 










0 , 8?-0 
P , 410 
r ')~/ t t 
11, 600 
JO~ 2' 0 
1 :) , 75 0 
J.l,lEO 
l j ' ') 'l 




L: , 7?<1 
)/l" , 
t:. ,. -- • .L 
Ti Before T4 Line:1r recrecs1on r~adra tic r~res sior c,_(, 1 ; .~efreA LOD 
V . S . After Before T4 After T4 Before T!i A :·1; Pr T4 BPfore T4 \ After· 
41P f. ., -7 0 +7 0 +3 
I 
0 - .1. 
5022 
, 
-3 0 -4 0 -9 C - .... :_; ·n 6 - 1· +l 0 -8 0 +6 0 




+E erno +l 0 +'1 0 +5 0 -1 
i. visor 56 980 980 1078 I 101s 770 770 ntrast 1 J , 205 , J /)31 12,()00 - 3897 -112A 3 - 16Qg -4.., 1~ 
of 3 i. 311J7')6 198033 J 69806 13g57 11180':)4 33 63 2q1 Q F. 24P .3 15.8 13. 5 1.1 g.4 0.3 ') . ~ 





( ii) Heart rate ( per min) 

























v.s. After T4 
Divisor 
Contrast 








tt!yroxine . . 
Iso 2roterenol dose in µ_flL..kgf_mj n. 
Baseline 0.05 0.10 0 .20 
80 78 88, 102 
82 96 102 120 
90 90 92 94 
102 92 112 124 
82 96 106 126 
58 68 86 94 
72 88 84 96 
566 608 670 756 
80.5 86.8 95.7 108.0 
5.2 3.9 4.1 5.6 
thyroxine (0.1 mg/kg/day for 1 week) . 
102 120 140 156 
120 150 162 150 
102 114 136 150 
110 122 120 148 
100 114 132 140 
124 156 164 180' 
114 122 128 142 
722 898 982 1066 
110. 3 128.2 140.3 152.3 
J.6 6.5 6.3 5.0 
Linear regression . Qladra tic regression Cubic regre ssio1 
Before T4 After T4 Before T4 After T4 Before T4 After ' 
980 980 1078 1078 770 770 
1686 2478 -50 -714 98 -42 
290B 6266 2 473 12 2 
17.1 36.8 0.01 2.8 0.1 0.01 - - - -( .. 005 .(.001 N.S. N.S. N.S. N.S. I 
Divisor 
Contrast 
Sum of Sq, 
F 
p 
(iii) Cardiac output (ml/min) 
(a) Before thyroxine 

































































































2P , 5<JO 
4,084 
'?63.7 
- - ..... - _ ... _ ---- -- ---..... -- --··-....,.. ~'- _ ...... c,, " ·---:-:--Be fore· T4 11::1.ear ree;ression Q.lu.dr~ t~ regress ton C'albi c regr-ens i or ~.s. After T4 Before T4 After T4 Before T4 After T4 Before T4 After 1 
56 980 980 1078 1078 770 770 
2.35 6 7973 6737. 
I 
315 -2530 223 -1298 
99120 64866 46313 93 5J3g 64 218~ 
42.7 21.9 19.9 j_ 0.03 2.6 0.02 0.9 - - ----< .001 (.001 <.. 001 I N.S. N.S. N~. S. N.S. 
TABLE IV. 
Dog Nu. G.50Q 
1. HESPONS:CS IN EUTHYROID STATE: 
Isoproterenol dosage fg/kg/min. 
0 0.05 0 .10 0. 20 
LVmax dp/d t 
(mm Hg/sec) 
6,400 8,800 8,370 8,880 
Heart rate 82 96 106 126 
( per min) 
2. RJ;SJ>ONSES AFTER ONE Wl~EK THYHOXINE ( 0. 1 mg/kg/day) 
LVmax dp/dt 
( nun Hg/sec) 
Heart rate 
( per min) 
8,830 10,930 
100 114 
12,840 lJ, 920 
132 14C 
3. RESPONSES AFTh'"R THRJIB WEEKS THYRvXINE (0.1 mg/kg/day) 
(a) Before atropine 
















. 200 208 
TABLE V. 
CON'l'RACTILITY AND HEART RATE BEFORE AND AFTER PROPRANOLOL. 
1. LVma.x dp/d-c Eu thyroid state After one week T4. 
0. l mg/kg/da.y 
Dog No. Before After 0.4mg/kg Before After 
1. 5,000 2,180 11,420 5,140 
2. 6,350 4,440 11,200 8,820 
3. 6,400 5,160 9,400 7,880 
4 . 5,660 4,460 11,430 7,160 
5. 7,200 4,760 10,970 7,220 
Heart rate 
1 • 80 80 102 96 
2. 80 54 102 100 
3. 102 78 102 74 
4. 58 52 124 110 
5. ·72 56 114 82 
TABLE VI. 
1. EUTHYRCIB EXPERIMENTAL GROUP. 
( a) LVmax d£[d_!__ - before 1-triiodothyroni~e. 
Dog No. Iaonroterenol (µg/kg/min). 
Baseline 0.05 0 .10 o. 20 
1 4.640 5,160 5,.320 6,630 
2 4,640 6,540 7,480 9,160 
3 4,370 5,400 6,540 6,800 
4 5,910 6,080 6,800 7,940 
5 4,930 5,560 5,720 5,920 
6 4,940 5 300 5,470 ·5 , 650 
With l-tri1odothyronine 0.1 p.g/kg/min. 
1 4,950 5,350 5,800 7,260 
2 3,410 6550 9,210 lC, 250 
3 5,380 6,520 7,050 7,820 
4 6,670 6,810 7,210 8,300 
5 5,670 6,300 6,030 6,570 
6 6,420 6,600 6,750· 7,140 
(b) Heart rate - before 1-triiodothyronine. ---· 
1 72 72 72 102 
2 66 66 84 108 
3 64 80 94 115 
4 96 92 96 106 
5 75 94 94 124 
6 82 74 86 110 
with 1-triiodo thyronine 0. 1 pg/kg/min. 
1 60 66 84 100 
2 66 102 100 114 
3 72 82 118 136 
4 80 84 92 118 
5 58 62 84 128 
6 72 76 78 98 
2. EUTHYRO ID SOLVENT CON~ROL GROUP. 
(a) LVmax dp/dt before l-T3-solvent infusion. 





















with l-T3-solvent infusion 
l 4,580 5,160 
2 5,860 6,630 
3 3,690 4,000 
4 4,~10 5,740 
5 1,,20 7,580 














(b) .!.!_eart r~te before l-T3-solvent infusion. 
1 78 90 108 
2 60 66 84 
3 64 74 84 
4 55 66 80 
5 82 96 102 
6 80 76 82 















































J. d-TJ CONTROL GROUP. 
(a) LVmax dp/dt before d-T3. -
Dog No •. ·Iso proterenol (,ig/kg/min) . 
Baseline 0.05 0 .10 U. 20 
1 6,400 7,310 7,800 8,840 
2 6,400 8,800 8,370 8,880 
3 5 , 660 5,900 6,250 6,440 
4 7,200 7,960 · 8,240 10,050 
with d-TJ 0.1 fg/kg/min . 
1 6,650 7,800 8,820 9,460 
2 6,910 7,800 8,560 7,850 
3 5,650 6,230 6,300 6,350 
4 7,160 7,680 7,920 8,340 
( b) Heart rate - before d-TJ. 
1 96 9.2 112 124 
2 82 96 106 126 
3 58 68 86 94 
4 72 88 84 96 
with d-TJ ( 0. 1 pg/kg/min ) • 
1 86 94 112 136 
2 78 116 120 140 
3 86 112 84 10-8 
4 66 88 90 86 
1.1 f E.8- 19}Q 
4. HYPOTHYROID GROUP. 
( a) LVmax d;e(d t be_f~E~ k_T .3. 
Dog No. lsoproterenol 0.1.pg/kg/min. 
Baseline o.o, 0.10 0.20 
1 3,300 3,800 4,310 4,860 
2 3,340 3,820 5,470 6,040 
3 2,930 3,820 3,860 4,700 
4 3,780 5,020 5,550 7,630 
5 2,600 3,860 4,520 5,720 
6 3,710 4,890 5,560 6,720 
with 1-TJ O .1 fg/kg/min. 
1 3,290 5,000 5,470 6,260 
2 3,860 4,680 5,220 ~ 7,350 
3 3,300 4,100 4,260 5,430 
4 5,150 6 ,930 7,750 8,920 
5 3,010 3,950 4,920 7,000 
6 4,310 5,580 7,070 7,690 
(b) Heart rate - before l-T3. ---·--
1 66 72 ?8 96 
2 48 66 67 70 
3 64 80 84 102 
4 70 76 88 90 
5 68 76 80 104 
6 80 84 90 100 
with l-T3 0.1 p.g/kg/min. 
1 60 75 76 84 
2 40 50 72 80 
3 64 72 80 92 
4 68 75 90 100 
5 60 68 76 82 
6 76 76 102 106 
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Renin in the Diagnosis of 
Renovascular Hypertension 
Acti,·ity in Renal and Peripheral Vein Plasma 
B ertm111 ,\£. lVi11 c r, MD. Wil/1 elm F. L11bbc, l\lR. CliB, 
,\lonis Si111011 , MD, and ]oli11 A. lVilliams, MD 
Renin activity was assayed in plasma from the right 
and left renal veins and a peripheral vein in 47 hyper-
tensive patients. Activity was equivalent in the two renal 
veins in 25 patients without renal artery stenosis; periph-
eral vein activity averaged 20% less. Ten of 17 patients 
with angiographic evidence of unilateral renal artery 
stenosis had significantly greater renin activity in the 
vein of the involved kidney; peripheral vein renin ac-
tivity was equal to that from the vein of the uninvolved 
kidney. Two of five patients with bilateral stenosis had 
significant differences in renin activity between the two 
sides. The correlation between the results of the assays 
and results of surgery (14 cases) was excellent. Differ-
ential renal vein renin assays have diagnostic value in 
the determination of the functional significance of ap-
parent unilateral renovascular disease. 
S tenotic lesions occur in the renal arteries of normotensive as well as hypertensive pa-
tients.' ·3 A variety of methods has been used to 
detect renovascular disease and determine its phys-
iologic significance in hypertensive patients. These 
methods include intravenous urography with modi-
fications ,' isotope renography,' the angiotensin 
amide infusion test/ renal angiography, split renal 
function studies,7·" determination of pressor activ-
ity of untreated plasma," and renal biopsies. ' 0 De-
spite these procedures, the role of an angiographi-
cally visible stenotic lesion in the genesis of 
hypertension may remain in doubt. 
The present studies, which extend our prelimi-
nary observations, 11 were undertaken to assess the 
value of comparative assays of renin activity in 
renal vein plasma from the two kidneys as a mea-
From the departments of medicine. surgery, and radiology, 
Beth Israel Hospital and Harvard Medical School, and the Ya-
mins Hesearch Laboratory, Beth I srael Hospital, Boston. 
Reprint requests to 330 Brookline Ave, Boston 02114 (Dr. 
Winer) . 
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sure of the functional significance of an apparent 
renal artery stenosis. Renin activities of peripheral 
vein and renal vein plasma were also compared. 
Materials and Methods 
Intravenous urography including films made at 
15 and 60 seconds, renal arteriography, and assays 
of renin activity in plasma from the right and left 
renal veins were carried out in 4 7 hypertensive 
patients. 
Renal vein catheterization was performed by the 
percutaneous transfemoral retrograde Seldinger 
technique without complications." With the aid of 
television fluoroscopic control, a curved soft poly-
ethylene catheter, with a side hole within 1 cm 
of the tip, was placed in each renal vein beyond 
testicular or ovarian branches. The final position 
was determined by visualization after injection of 
3 ml of diatrizoate meglumine (Renografin-60). 
Before blood for assay was withdrawn, the catheter 
was thoroughly flushed with normal saline solution. 
The initial 5 ml of blood was discarded and a 25-ml 
sample was then collected in tubes containing so-
dium heparin and placed in ice. A similar sample 
of blood was collected from the brachia! or femoral 
vein after collection of the second renal vein speci-
men. After centrifugation at 2,000 rpm for 15 min-
utes, the plasma was separated and frozen. 
Renin activity in plasma was assayed by a modi-
flea tion of the method of Helmer and Judson. 13 
After adjustment of pH to 5.5 with hydrochloric 
acid, plasma was dialyzed against cold running tap 
water for 24 hours. Isotonicity was restored by 
addition of sodium chloride and pH was readjusted 
to 5.5. The dialysate was frozen until immediately 
prior to assay when aliquots were incubated for 
one hour at 37 C. Amounts of 0.5 to 2 ml were 
added to a double-chambered muscle bath in which 
a spirally cut strip of rabbit aorta was suspended 
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in the inner chamber filled with Krebs bicarbonate 
solution. The buffer solution, with potassium con-
centration of 9.4 mEq/liter, was maintained at 
pH 7.4 by continuous aeration with 5% carbon 
dioxide and 95% oxygen. Temperature was main-
tained at 37 C by circulation of water through the 
outer chamber. Contractile responses, amplified 
nine times, were recorded by a lightweight, gravity-
type aluminum heart-lever, writing on a carbon 
kymograph. Tension on the aortic strips was ad-
justed to 4 gm by counterweights. Freshly pre-
pared synthetic asparaginyl-1, valyl-5 angiotensin II 
was used as the reference standard. Renin activity 
was calculated as millimicrograms of angiotensin II 
elaborated per milliliter of plasma in the hour of 
incubation. 
The vasoconstrictor effect was identified as that 
due to angiotensin II, elaborated by the action of 
renin during incubation, by the following evidence: 
( 1) recovery of the vasoconstrictor material in in-
cubated dialyzed plasma after butanol-paper and 
filter-column chromatography by the method of 
Boucher et al 14 ; (2) complete loss of vasoconstric-
tor activity by boiling the plasma for ten minutes 
before incubation (vasoconstrictor activity per-
sisted when boiling was carried out after incuba-
tion); (3) complete destruction of vasoconstrictor 
principle by incubation with carboxypeptidase or 
lysed red blood cells; and ( 4) no loss of activity 
on prior exposure of the aortic strips to phentola-
mine hydrochloride, phenoxybenzamine hydrochlo-
ride, diphenhydramine hydrochloride, or atropine. 
The recorded blood pressures in each patient 
represent averages of readings obtained on at least 
three days, when the patients were in the sitting 
position and the auscultatory method was used. 
Results 
The term reno vascular disease is used in reference 
to angiographically visible disease of the main renal 
arteries or their primary branches. 
Patients Without Renovascular Disease With 
Kidneys of Equal Size (Table 1) .-Ten patients 
had essential hypertension, two in the malignant 
phase. One patient had membranous glomerulone-
phritis, one bilateral chronic pyelonephritis with 
azotemia, and one primary aldosteronism. 
Renal angiograms were normal in all patients. 
Renography was done after administration of so-
dium iodohippurate I 131 (Hippuran-I-131 ) to five 
patients with essential hypertension; the curves 
were normal in four and bilaterally flattened in 
one (case 1). 
Renin activity in plasma from one renal vein 
was close or equivalent to that in the opposite 
renal vein in every case. The mean renin activity 
per milliliter of plasma from the right renal veins 
was 14.6 mµ.g angiotensin II, that in the plasma 
from the left renal veins was 14.8 m11.g. This dif-
ference between the two sides was not statistically 
significant. In no instance was there a difference 
of more than 4 mµ.g angiotensin II per milliliter 
of plasma. Peripheral vein renin activity averaged 
10. 7 m1-tg angiotensin II per milliliter of plasma. 
The difference between the activities in the renal 
and peripheral veins was statistically significant 
(paired sample t test, P < 0.01). 
In one patient (case 12) renal vein catheteriza-
tion was performed on two occasions, once during 
a period of high salt intake and again during a 
period of reduced salt intake. On a sodium intake 
of 150 mEq per day, the renal vein renin activity 
was 17 mftg angiotensin II per milliliter in both 
renal veins while the brachia! vein level was 13 mµ.g. 
After decrease of dietary sodium to 10 mEq per 
day for four days, the renal vein renin levels in-
creased to 27 m,.tg angiotensin II per milliliter on 
both sides and brachia! vein plasma renin activity 
rose to 22 mµ.g. The aortic strip responses to the 
different plasmas in the two periods of study are 
shown in Fig 1. 
In three patients brachia! vein plasma renin 
Table 1.-Plasma Ren in Activity in Patients Without Renal Artery Stenosis and With Kidneys of Equal Size 
Plasma Renin Activity (mµg Angiotensin II/ml/hr) 
, -
Blood Low Salt Right Left Difference 
Case Pressure, Diet or Renal Renal Between Peripheral 
No. Age Sex mm Hg Fundi • Diuretic Vein Vein Renal Veins Vein Remarks 
1 31 F 190/110 Ill 2 2 0 1 Essential hypertension 
2 43 F 280/155 II + 15 18 3 12 Essential hypertension 
3 39 M 160/108 II 12 10 2 7 Essential hypertension 
4 57 F 200/100 II 7 6 1 5 Essential hypertension 
5 52 M 200/110 Ill 2 3 l 4 Essential hypertension 
6 31 F 230/130 II + 17 19 2 16 Essential hypertension 
7 19 M 185/105 II 18 16 2 5 Essential hypertension 
8 67 F 290/105 II 6 8 2 5 Essential hypertension 
9 56 M 210/170 IV + 44 47 3 33 Essential hypertension 
10 46 F 260/160 IV + 10 11 1 7 Essential hypertension 
11 31 M 180/115 II + 24 20 4 18 Membranous glomerulonephritis 
12 50 M 200/120 II Chronic bilateral pyelonephritis 
17 17 0 13 150 mEq Na in diet for 
4 days 
+ 27 27 0 22 10 mEq Na in diet for 4 days 
13 28 F 160/100 3 3 0 2 Primary aldosteronism 
Mean 14.6 14.8 1.5 10.7 
• Retinopathy is graded accordi'lg to the scale of Keith and Wagener. 
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tensin II per milliliter, 
the mean left renal vein 
renin activity was 12.8 
m1.1g. The difference be-
tween the two sides was 
not statistically signifi-
cant. Differences between 
the two sides ranged be-
tween O and 5 mvg. Ac-
tivity in peripheral vein 
plasma averaged 9.9 mp.g. 
The difference between 
the activities in the renal 
and peripheral veins was 
statistically significant 
(P < 0.001). 
N ephrectomy was per-
formed in one patient in 
1. Aortic strip responses to 2 ml of incubated dialyzed· plaza (case 12) from brachia! 
vein, right renal vein, and left renal vein after four days of a sodium intake of 150 
mEq/day, at left; responses after four days of 10 mEq sodium daily, at right. Response 
to synthetic asparaginyl-1, valyl-5 angiotensin II (ANG) in a concentration of 2 mpg/ml 
of bath fluid is also shown. Number above each concentration refers to height of re-
sponse in millimeters. Time scale reflects kymographic speed of 90 mm/hr. 
this group, a 26-year-old 
hypertensive woman with 
a large difference in size 
between the two kidneys 
(case 14). Intravenous 
and retrograde urography 
activity was less than 5 mp.g angiotensin II per 
milliliter. One of these patients had hypokalemic 
primary aldosteronism. Aldosterone excretion was 
normal in the other two. 
Patients Without Renovascular Disease With 
Kidneys of Unequal Size or Shape (Table 2).-0f 
the 12 patients in this group, eight had differences 
greater than 2 cm in the bipolar diameters of their 
kidneys in the absence of a mass, two had cysts of 
the right kidney, and two had horseshoe kidneys. 
There was evidence of pyelonephritis in the smaller 
kidney in patient 16 and in both kidneys in patient 
20. All had hypertension without angiographically 
visible renal artery stenosis. Only patient 21 had 
recently been treated with a diuretic or low sodium 
diet. 
Right and left renal vein renin activities were 
approximately equal in all cases. Mean right renal 
vein plasma renin activity was 13.7 m1,g angio-
showed no function on 
the left side. The difference in renal vein plasma 
renin activity between the two sides was 3 m, .. g 
angiotensin II per milliliter. Removal of the small 
hypoplastic left kidney did not reduce the blood 
pressure in a follow-up period of 18 months. 
Patients With Unilateral Renovascular Disease 
(Table 3).-Fourteen of the 17 patients in this 
group had a stenotic lesion of a main renal artery. 
Three patients had lesions of a primary branch. 
Ten patients had substantial differences in renal 
vein plasma renin activity between the two sides, 
differences greater than 10 m:,g angiotensin II per 
milliliter (Table 3a). Only one person of these pa-
tients had a family history of hypertension. Pre-
senting clinical manifestations included headaches, 
visual disturbances, and cerebrovascular, cardiac, 
and peripheral vascular disease. Two patients had 
grade IV retinopatny and three patients had grade 
III (Keith-Wagener scale). Patient 34 had an 
Table 2.-Plasma Renin Activity in Patients Without Renal Artery stenosis, but With o;;terences in Size or Shape of Kidneys 
Case 
No. Age Sex 








Plasma Renin Activity (mµg Angiotensin II/ml/hr) ,.------- --- __ __.. _____ _ 
Right Left Difference 
Renal Renal Between 
Vein Vein Renal Veins 





RK " > LK by 12 cm. No 
BP change after remov-
al of hypoplast,c LK 
15 55 ____ F 200/100 11 16 16 0 8 LK > RK by 4 cm 
16 33 M 160/ 95 II 11 12 1 11 RK > LK by 7.5 c·m--
17 69 F---300/135--111 26- --21 5 19 LK > RK by 5 ·cm
 
- 1-8--48 F 200-/120 · --Ill - -- --· 9-- 11 ·----2 7 --LK > RK by 4 _c
_m _ _ _ 
19--45 M 150/90 I ··- 12 ____ 9 ____ 3 _____ 8 - -- LK > RKby6cm 
20 57 M 230/130 ___ 11 - 10-- 8 -- - 2 ·-----6- - ur :::; RK by 2 ciii--
21 56 F 230/120 II + - 19-- - 22 3 14 RK > LK by 2.5 cm 
22 57 M 190(ll_O__ II 9---i) ___ 2 7 Cyst of right kidney 
~ --68 F 20_0 /100 II · 18 16 2 15 Cyst of right ki
dney 
24 56 M 230/140 Ill 10 8 2 4 Horseshoe kidney 
- 25 37 F 160-/100 _ _ _ 11 14 13 I II Horseshoe kidn
ey 
Mean 13.7 12.8 2.2 9.9 
0 RK signifies right kidney; LK signifies left kidney. 
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ANG FEM .VEIN LT RENAL RT RENAL ANG. administration of sodium iodohippurate 
I 131 were abnormal in six of seven pa-
tients. A patient with a branch lesion, 
case 25, had a negative test. Split renal 
function tests were positive in three of 
four patients with main renal artery 
stenosis and were negative, one by the 
Stamey and one by the Howard tech-
nique, in the two patients with lesions 
in primary branches. 










TIME ( Hours) 
1 58 
The differences between the right and 
left renal vein renin activities in these 
ten patients ranged between 13 and 81 
2. Aortic strip responses to incubated dialyzed plasma (case 30) 
from femoral vein (1.0 ml), left renal vein (1.0), and right renal 
vein (0.5 ml) are shown in comparison with responses to 2 and 
4 mµg/ml bath concentrations of synthetic angiotensin II. 
m µg angiotensin II per milliliter with a 
mean difference of 49.3 mµg. In the pa-
tient with a difference of 13 mµg, the 
left renal vein renin activity was four 
times that of the right side. The mean 
activity in the plasmas from the involved 
average blood pressure of 180/90 mm Hg and grade 
II fundi at the time of the renin study. In the 
previous four months he had been treated with 
methyldopa. Blood pressure before drug therapy 
averaged 210/110 mm Hg, and fundi were grade III 
at that time. Eight patients had differences of 
more than 1.5 cm in the bipolar diameters of their 
kidneys, four had delayed appearance of contrast 
material on the affected side on intravenous urog-
raphy. The intravenous urogram was normal in all 
respects in two patients. Renograms made after 
sides was 98.9 mµg angiotensin II, that in the plas-
mas from the uninvolved sides was 49.6 mµg. This 
difference was statistically significant (P < 0.001). 
The mean activity in the peripheral vein plasma 
in the eight patients in whom peripheral vein plas-
ma was obtained was 42.4 mµg. There was no sig-
nificant difference between the activity in the renal 
veins of the uninvolved side and that in the periph-
eral veins. The aortic strip responses to treated 
plasma from the three sites in a typical patient 
( case 30) of this group are shown in Fig 2. 
Table 3.-Plasma Renin Activity in Patients With Unilateral Renal Artery Stenosis 
Plasma Renin Activity 
(mµg Angiotensin II/ml/hr) 
r--
Renal Renal Difference 
Low Salt Vein Vein Un· Between 
Case Fundi Diet or Involved involved Renal Peripheral Surgical Follow-Up, 
No. Age Sex BP (K-W) Diuretic Lesion Side Side Veins Vein Procedure Mo BP 
(a) Patients With Substantial Differences in Renin Activity Between the Two Renal Veins 
26 57 M 200/110 II + Right 47 29 18 27 By-pass 36 130/80 
main graft 
27 57 F 200/100 Ill + Right 60 20 40 13 Nephrec- 30 128 / 84 
main tomy 
28 32 M 200/120 Ill Left 105 24 81 28 Hemine- 24 140/80 
branch phrectomy 
29 37 M 210/140 Ill + Left 124 65 59 70 Nephrec- 15 160/90 
main tomy 
30 48 F 220/120 II + Right 83 21 62 19 Nephrec- 9 135/78 
main tomy 
31 53 F 270/130 IV + Right . 157 95 62 80 Nephrec- 18 ' 180/100 
mam tomy 
32 57 F 280/135 IV + Left 137 78 59 55 Nephrec- 9 170/ 80 
main tomy 
33 20 M 230/130 + Left 160 103 57 Angioplasty 8 135/70 
branch 
34 52 M 180/90 II Left 17 4 13 Nephrec- 18 150/ 80 
main tomy 
35 62 M 260/110 II Right 119 57 62 47 Died before 
surgery 
Mean 98.9 49.6 49.3 42.4 
(b) Patients Without Substantial Differences in Renin Activity Between the Two Renal Veins 
36 66 M 220/120 I + Left 29 23 6 20 Nephrec- 24 230/130 
main tomy 
37 63 F 250/120 Ill Left 20 18 2 14 Nephrec- 24 200/120 
main tomy 
38 64 M 230/120 II Left 30 28 2 17 Exploration; 18 260/130 
main no gradient 
39 58 M 160/ 90 II + Right 6 6 0 5 No surgery main 
40 13 M 140/90 Right 
branch 
3 4 3 Angioplasty 24 140/ 90 
41 52 F 170/120 II Left 3 3 0 No surgery 
main 
42 59 F 210/110 II Left 
main 
12 14 2 11 No surgery 
Mean 14.7 13.4 1.1 10.0 
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Nine of these patients were treated 
surgically. Seven patients responded with 
continued normotensive blood pressures 
after surgery. A patient with a strong 
family history of hypertension (case 32) 
had marked improvement in level of 
blood pressure, disappearance of head-
aches, and regression of retinopathy from 
grade IV to grade II without further 
medical therapy. Patient 31 had a ne-
phrectomy on the left side for occlusion 
of the left renal artery at the time of by-
pass for an occluded lower abdominal 
aorta. A cerebrovascular accident com-
plicated the postoperative course. The 
blood pressure remained at normal levels 
for a period of three months, following 
which moderate hypertension developed 
without recurrence of the severe hyper-
tensive retinopathy previously present. 
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SURGERY WITH BP. RESPONSE 
SURGERY WITHOUT RESPONSE 
NO SURGERY 
KIDNEYS OF EQUAL SIZE KIDNEYS OF UNEQUAL 
SIZE OR SHAPE 
WITHOUT RENOVASCULAR LESIONS 
(Table 3) represent averages of at least 
three readings at the end of the indicated 
·period of follow-up. 
Seven patients had small or no dif-
ferences in renin activity between the 
3. Renin .activity in plasma from right and left renal veins in pa-
tients with and without angiographic evidence of unilateral renal 
artery stenosis. Results of surgery are indicated, also observations 
in patient 12 during periods of high and low sodium intake. 
two renal veins (Table 3b). The differences 
ranged from O to 6 mµ.g angiotensin II per milliliter 
with a mean difference of 1.8 mµ.g. Renin activity 
in the vein of the kidney with the apparent stenosis 
averaged 14.7 mµ.g angiotensin II per milliliter; in 
the vein from the opposite side the average was 
13.4 mµ.g; and in the peripheral vein plasma, 10.0 
mµ.g. The difference between the two sides was not 
significant. 
Four of these patients came to surgery. Unilat-
eral nephrectomy was carried out in two without a 
reduction in blood pressure. A patient (case 40) 
with fibromuscular hyperplasia in a branch of the 
right renal artery had no change in blood pressure 
after angioplasty. Exploratory surgery was done on 
the fourth patient and no pressure gradient was 
found across the apparent stenosis. 
The observations of plasma renin activity in the 
two renal veins in patients with unilateral renal 
artery stenosis and patients without renovascular 
disease are compared graphically in Fig 3. Two 
populations are apparent among the patients with 
renal arterial disease, a group with and one without 
large differences in renal vein renin activity. Renal 
vein renin activity in the group without differences 
between the two sides resembles that of patients 
without renovascular disease. 
Patients With Bilateral Renal Disease (Table 4). 
-Four of the five patients in this group had athero-
sclerotic narrowing of both renal arteries, the fifth 
had bilateral fibromuscular hyperplasia. Two pa-
tients had large differences in renal vein renin ac-
tivity between the two sides. Patient 43 had a renin 
activity difference of 60 mµ.g angiotensin II be-
tween the plasmas from the two renal veins. A 
-renogram made after administration of sodium 
iodohippurate I 131 was abnormal bilaterally and 
the patient was azotemic. Reconstruction of the 
left renal artery was not technically feasible. Pa-
tient 44 had a positive split function test (Howard 
method). A surgical approach could not be under-
taken because of other severe vascular disease. 
Patients 45, 46, and 47 had differences of 2, 3, 
and 3 m,,.g, respectively, between the two sides. 
Table 4.-Plasma Ren in Activity in Patients With Bilateral Renal Artery Stenosis 
Case 
No. Age Sex BP 
43 65 M 210/105 
44 48 M 210/130 
45 41 F 230/110 
46 50 M 190/70 
47 51 M 270/170 





















Plasma Renin Activity 
(mµg Angio~sin II/ml/hr) 
Difference 
Left Between 
Renal Renal Peripheral 
Vein Veins Vein Remarks 
103 60 63 Diffuse narrowing on right. 
Stenosis, left, at origin 
22 16 Occlusion on left, with 
collaterals. Stenosis, right 
22 2 15 Bilateral fibromuscular 
hyperplasia 
11 3 10 Diffuse narrowing on left. 
Localized stenosis, right 
10 3 6 Narrowing at origin of right. 
Left diffusely narrowed 
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Renograms made after the administration of sodi-
um iodohippurate I 131 showed bilaterally flattened 
curves in the first two of these patients; the reno-
gram was normal in the third. Patient 42 had a 
wide pulse pressure without diastolic hypertension 
despite angiographically severe bilateral renal ar-
tery stenosis. None of these patients was ap-
proached surgically. 
Comment 
Renin is a protein stored in the juxtaglomerular 
cells of afferent arterioles of the kidney. It is 
secreted in health as well as in disease. It is the 
initiating enzyme in a system that may act homeo-
statically to defend blood pressure and extracellu-
lar fluid volume in such conditions as salt depletion 
or hemorrhage, and may contribute to the patho-
physiology of renal artery stenosis or certain edema 
states. Tobian has suggested that juxtaglomerular 
cells act as stretch receptors, stimulated to secrete 
renin in response to reduced pressure or volume in 
the renal arterial tree. 15 Small changes in mean 
renal arterial perfusion pressure have been shown 
to affect renin secretion. 16 The macula densa may 
also regulate renin secretion.17 
Renin acts enzymatically on a tetradecapeptide 
substrate in the a2 globulin fraction of plasma to 
elaborate a decapeptide, angiotensin I. Angiotensin 
I is not directly vasoconstrictor; it is split by a 
converting enzyme in plasma to an octapeptide, 
angiotensin II. This peptide has at least two ac-
tions, one as a vasoconstrictor, the other as a 
trophic hormone that stimulates the adrenal cortex 
to secrete aldosterone.' "· 10 Angiotensinases are pres-
ent in plasma and cells.'0 
Assays of Plasma Renin.-Assay of renin current-
ly requires biologic techniques. Several methods 
are in use. In this study the method of Helmer and 
Judson13 was used with modifications of the muscle 
bath and recording system. Catecholamines, hista-
mine, and preformed angiotensin are :·emoved by 
dialysis. To minimize angiotensinase activity in 
plasma, pH is adjusted to 5.5. Salt is added to per-
mit the action of converting enzyme. The angio-
tensin II elaborated by the actions of renin and 
converting enzyme during incubation of the dialy-
sate is determined by comparison of the vasocon-
strictor effect of the incubated dialysate with the 
effect of known amounts of a synthetic angiotensin 
octapeptide standard on the same strip of rabbit 
aorta. Boucher et aI1• and Pickens et al21 use the 
pressor response of a pentolinium tartrate treated 
or nephrectomized rat to determine the amount of 
angiotensin formed after incubation of the plasma 
following ion exchange chromatography or dialysis. 
In each of these methods the renin substrate is 
endogenous. By the method of Brown et al,22 renin 
is first isolated by diethylaminoethanol cellulose-
column chromatography; ox substrate is added, 
and the angiotensin formed during incubation is 
determined by a rat pressor assay. In the latter 
method, zero order kinetics have been demon-
strated. These methods differ in several respects, 
particularly the handling of substrate and angio-
tensinase, the duration of incubation, and the meth-
od of determining the amount of angiotensin II 
elaborated. Yet, in both physiologic and disease 
states, results of these methods have been qualita-
tively similar although quantitatively different. 
Previous studies in this laboratory were the first 
to show that peripheral and renal vein plasma renin 
activity increase sharply in normal and hyperten-
sive subjects in response to mild salt depletion by 
a diuretic or low sodium diet.23 •24 The rabbit aortic 
strip method of assay was used. These observations 
have been confirmed by the other methods of as-
say. 2 1 ·25·26 Plasma renin activity is also increased in 
Addison's disease,2 6 hemorrhage,21 the erect pos-
ture,'" pregnancy,2°· 30 and the latter half of the 
menstrual cycle30·"2 ; it is reduced in salt loading and 
primary aldosteronism. 25 •20 •2 " 
Renal Vein Renin.-In the present study renin 
activity was found equivalent in the right and left 
renal veins in hypertensive patients without renal 
artery stenosis, both in those patients with kidneys 
of equal size and in patients with unequal kidneys 
due to pyelonephritis, hypoplasia, or cysts. The 
largest difference in activity was 6 mp.g angiotensin 
II per milliliter of plasma per hour of incubation. 
Patients with unilateral renal artery lesions fell 
into two groups, one with and one without distinct 
differences in plasma renin activity between the two 
sides. In the former group there was an average of 
a twofold difference in renin activity between the 
two sides. The smallest difference was 13 mµg 
angiotensin II per milliliter of plasma. The higher 
concentration of renin activity in venous blood of a 
kidney with functionally significant renal artery 
stenosis may reflect both an increase in secretion of 
renin and a reduction in blood flow in this kidney. 
Further studies are necessary to determine the rela-
tive contribution of these factors. 
Nephrectomy or relief of the stenosis in patients 
with significant differences in plasma renin activity 
in the two renal veins reversed or strikingly modi-
fied the hypertension. Unilateral nephrectomy in 
patients with apparent stenosis, but without later-
alizing differences in renin activity in the renal 
veins failed to affect the blood pressure. Patients 
with bilateral renal arterial lesions also fell into 
groups with and without substantial differences in 
renal vein renin activity between the two sides. 
Peripheral Vein Renin.-Peripheral vein plasma 
renin activity in patients without functionally sig-
nificant renal artery stenosis was about 20% lower 
than the activity in each renal vein. This difference 
was statistically highly significant. In patients with 
renal artery stenosis and a distinct difference in 
renin activity between the two sides, peripheral 
vein plasma renin activity was at approximately 
the same level as that in the renal vein plasma of 
the unaffected kidney. Determination of plasma 
renin activity in the three sites, a peripheral vein 
and the two renal veins, provides patterns of activ-
JAMA, Oct 9, 1967 • Vol 202, No 2 
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ity that separate patients with from patients with-
out significant unilateral renovascular disease. 
High peripheral vein plasma renin activity is not 
specific for renovascular disease since such states 
as salt depletion or pregnancy are also associated 
with high levels. The assumption of the erect pos-
ture for four hours induces a twofold increase in 
peripheral vein plasma renin activity. From the be-
g-inning to the end of the menstrual cycle, there c.2n 
be an even greater increase. These observations 
indicate the need for control of these variables in 
the use of the peripheral venous plasma renin activ-
ity as a test for the detection of renovascular dis-
ease. In this series, while on normal salt intake, two 
patients with significant renal artery stenosis had 
renin activity levels of the same order as several 
patients without renovascular disease. 
Current observations do not permit the conclu-
sion that the high levels of renin activity account 
for the elevation in blood pressure in renovascular 
hypertension. Although salt depletion by a diuretic 
or low sodium diet is followed by a marked increase 
in renin and aldosterone secretion in hypertensive 
and normotensive patients, the blood pressure in 
the hypertensive patient gradually decreases while 
that of the normotensive individual is unaltered. 
In the course of normal pregnancy, the levels of 
renin activity and aldosterone secretion are high, 
but the blood pressure remains normal. Following 
experimental production of renal artery constric-
tion in dogs, blood pressure and renin activity are 
both high initially, yet persistent elevation of blood 
pressure is accompanied by a gradual decline in ren-
in activity. '"' Assessment of the activity of each of 
the components of the renin-angiotensin-angioten-
sinase system is required before conclusions can be 
drawn concerning relationships between the renin 
system and blood pressure. The recent demonstra-
tion by Smeby et al" ' of a phospholipid renin-inhib-
iting factor in plasma has introduced an additional 
factor that may be involved in the relationship 
between renin and blood pressure. 
The Detection of R enouascular Hypertension.-
In the search for patients with surgically curable 
renovascular disease among the large group of pa-
tients with hypertension, two approaches are used: 
screening to select patients for arteriography, and 
tests to determine whether a demonstrated stenotic 
lesion is the cause of the hypertension. 
The yield of two screening procedures, modified 
excretory mography and renography after admin-
istration of sodium iodohippurate I 131 is high and 
when the two tests are used in combination, more 
than 90% of patients with renovascular hyperten-
sion can be recognized. '"' The occurrence of false 
negative intravenous urograms was noted in two 
patients in this study; the sodium iodohippurate I 
131 renogram was abnormal in one. False positive 
tests are frequent with both procedures. The pres-
sor response to intravenously infused angiotensin 
has also been suggested as a procedure to detect 
renovascular hypertension. Conflicting results have 
JAMA. Oct 9 , 1967 • Vol 202, No 2 
been reported. ''' Salt depletion and malignant hy-
pertension must be excluded before this test is 
applied. 
Proof of the functional significance of an angio-
graphically visible renal artery stenosis may be 
obtained by the demonstration of increased water 
reabsorption by the involved kidney.'" Hypercon-
centration of contrast material and delayed disap-
pearance after induced diuresis during urography 
reflect this pathophysiological disturbance. The 
split renal function techniques detect these phe-
nomena by decrease in urine volume and sodium 
excretion· and increased urinary concentration of 
creatinine, inulin or p-amino hippuric acid (PAH)" 
on the affected side. These procedures are techni-
cally difficult and not devoid of risk. In a group of 
100 cases, urine collections were unreliable in 17."-· 
In our series, two patients with branch lesions of a 
renal artery had normal results from split function 
tests but abnormal findings from renal vein renin 
studies; surgery in each case was followed by a 
dramatic and persistent fall in blood pressure. 
In this study of comparative renal vein renin 
assays in the determination of the functional sig-
nificance of unilateral renovascular disease, false 
positives were not observed. Of the nine surgically 
treated patients with substantial differences in 
plasma renin activity in the two renal veins, seven 
became normotensive and two had marked improve-
ment. False negative results were also not encoun-
tered. Observations of renal vein renin activity in 
renovascular disease have been presented in sum-
mary fashion by Judson and Helmer " and by .Kirk-
endall et al."'' The results of their v~udies and our 
own appear similar, despite differences in the meth-
ods of assay. Differential renal vein renin assay 
thus provides information of diagnostic value in the 
determination of the functional significance of an-
giographically visible renal artery stenosis. 
Several aspects of the technique of renal vein 
renin studies require attention. A side hole, placed 
within 1 cm of the tip of t '.1e catheter, facilitates 
withdrawal of blood. The position of both apertures 
within the renal vein and distal to the testicular or 
ovarian branches should be established. Since the 
presence of iodine-containing dye has been ob-
served to interfere with renin activity, the catheter 
should be flushed with saline and be first 5 ml of 
blood withdrawn should be discarded. Excess hepa-
rin may cause loss of renin activity; an amount not 
exceeding 10 units/ml of blood appear.; suitable. 
This inves(iga(icn was suppor(e<l in par( hy l'uhlic H ealth 
Service research granls HE-06119, HE-06316. and J--1 ~ -05ii47 
from the Nalional H eart lnsti(u(e. 
Generic and Trade Names of Drugs 
Phe n(ola mine hydrochloride-Re{!iline H y drochloride. 
Phenoxybenzam ine hydrochloride-Dibenzy /i n e . 
Diphenhydramine hydroch lori<le-Bc11adry/. 
Sodium iodohippurate I 131-1-lippuran . Hippuran - 13 1. Hippuran-
1-131 . Hipputope. 
Methyldopa-A/dome/ . 
Diatrizoa(e meglumine-Cardiograf,n. Gastrogra{,n . ll enogra{,11 . 
Pentolinium (a rt ra te -Ansolysen 1'artrate. 
Angiolensin am ide -Hypertensin . 
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Antihypertensive Actions of Diuretics 
Comparative Study of an Aldosterone Antagonist and a Thiazide, Alone and Together 
Bertram M . W iner, MD; Wilhelm F. L ubbe, MB, ChB; and Theodore Colton, ScD 
Hydrochlorothiazide in a daily dose of 150 mg and 
spironolactone in a daily dose of 400 mg (100 mg of the 
currently available preparation) were found to have equiv-
alent antihypertensive effects-reducing basal blood pres-
sure, decreasing the pressor response to levarterenol 
bitartrate (norepinephrine) and angiotensin amide, and 
increasing the depressor response to a ganglion-blocking 
agent, trimethaphan camsylate-in a double-blind study 
of 11 hypertensive patients. The two diuretics, when given 
together, appear to act irdependently and additively in 
their antihypertensive effects. Serum potassium level, 
lowered by hydrochlorothiazide, was in the normal range 
during administration of spironolactone alone or in com-
bination with hydrochlorothiazide. Spironolactone can thus 
be a useful substitute for a benzothiadiazine derivative in 
the treatment of hypertension. The administration of a 
combination of these diuretics, a thiazide and an aldo-
sterone antagonist, can render hypertension more readily 
manageable. 
Benzothiadiazine derivatives and aldosterone an-tagonists, drugs that are diuretic by different 
mechanisms, are antihypertensive. Comparative 
studies of the antihypertensive effect of represen-
tatives of these two families of diuretics are few, 
and conflicting results have been reported.' ·" 
A double-blind study was undertaken to com-
pare, in the same group of hypertensive patients, 
the effects of hydrochlorothiazide and spironolac-
tone alone and together on basal blood pressure, 
serum electrolytes, plasma volume, and the blood 
pressure responses to infused pressor and depressor 
From the depa rtments of medicine (Drs. Winer and Lubbe) 
and p reven tive medicine (Dr. Colton), Harvard Medical School, 
Boston. Dr. Winer is also with the Department of Medicine and 
the Yamins Research Laboratory, Beth Israel Hospital, Bos ton. 
Reprint requests to 330 B rookline Ave, Boston 02115 (Dr. 
Winer ). 
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agents. The experimental design permits statistical 
approach to determine whether in the doses used 
hydrochlorothiazide and spironolactone have equiv-
alent antihypertensive activity and whether addi-
tive, synergistic, or antagonistic effects occur when 
the two diuretics are given together. 
Patients and Methods 
Eleven patients with sustained hypertension were 
studied; ten had essential hypertension and patient 
4 had chronic glomerulonephritis. All had grade 2 
(Keith-Wagner scale) fundal changes; none had 
congestive heart-failure or uremia. Sodium was not 
restricted in the diet, and there was no potassium 
supplementation during the periods of diuretic ad-
ministration. 
After a placebo had been administered for ap-
proximately four weeks, hydrochlorothiazide in tab-
lets similar in appearance to the placebo was sub-
stituted in a dosage of 50 mg three times a day, 
for a period of four weeks. At this time, the place-
bo was resubstituted for a similar period, after 
which spironolactone was added in a dosage of 100 
mg four times a day in the original form in which 
this agent was prepared for clinical use. (Subse-
quently another method of crystallization was adopt-
ed, resulting in increased gastrointestinal absorp-
tion.• Twenty-five milligrams of the currently avail-
able preparation is reported to be equivalent to 
100 mg of the material used in this study.) After 
one month, hydrochlorothiazide was agai~ substi-
tuted for the placebo in the same dosage as before, 
without knowledge by the patients of the change. 
All blood pressures were determined by the same 
technician, using the auscultatory technique. She 
was unaware which agents were being adminis-
tered. During each visit of the patients, blood pres-
sures were obtained at intervals of a few minutes 
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for at least 30 minutes, with the patient in a re-
cumbent position. The lowest two blood pressures 
obtained in a period of study were averaged to rep-
resent the basal blood pressure. 
The pressor response to levarterenol bitartrate 
(norepinephrine) was determined during an intra-
venous infusion of 5.5µ,g of base per minute de-
livered by a constant-rate infusion pump for 10 
minutes. After return of blood pressure to basal 
levels, an intravenous infusion of angiotensin amide 
was administered at the rate of lµ,g/min for 10 
minutes. Ten minutes later, trimethaphan camsy-
late was infused intravenously at the rate of 1 
mg/min for 10 minutes. An average of the blood 
pressure values obtained at intervals of one minute 
from the sixth to the tenth minute of each infusion 
was taken to represent the response to the drug. 
Similar routines were followed during the initial 
placebo and all subsequent drug therapy periods. 
Plasma volume was determined from two venous 
samples of blood drawn 12 and 18 minutes after 
intravenous injection of 5µ,c of 1 3 1 I-labeled normal 
human serum albumin. Serum sodium and potassi-
um values were determined by flame photometry 
with lithium internal standard. 
The data were analyzed statistically with a two-
way analysis of variance.7 In this analysis, the vari-
ation due to the four different periods of drug ad-
ministration was partitioned according to a two-by-
two factorial arrangement into the effects of hydro-
chlorothiazide, spironolactone, and interaction of 
the two drugs." After statistical comparison re-
vealed no difference between the two placebo periods, 
only the results of the first period of placebo ad-
ministration were used in the analysis. 
Results 
The basal blood pressures in the different periods 
of placebo and drug administration for each of the 
11 patients are shown in Table 1. The mean values 
for the basal measurements and the measurements 
obtained during levarterenol bitartrate, angiotensin 
amide, and trimethaphan camsylate infusions dur-
ing the initial placebo and the subsequent periods 
of drug administration are shown in Table 2. 
The two-way analysis of variance of basal systolic 
blood pressure is shown in Table 3. The subdivision 
of the variation due to treatments indicates that 
there are highly significant effects due to hydro-
chlorothiazide (P< 0.001) and spironolactone (P< 
0.001). Furthermore, the data are consistent with 
the hypothesis that spironolactone and hydrochloro-
thiazide in combination produce an effect equiva-
lent to the sum of the effects when each drug is 
given alone. Thus, the antihypertensive effect of 
hydrochlorothiazide was found unaffected by the 
presence or absence of spironolactone and vice versa, 
as evidenced by the lack of statistical interaction 
(P> 0.05) . 
The analysis of variance was conducted on the 
basal levels and the levels during levarterenol, an-
giotensin, and trimethaphan infusions for both sys-
Table 1.-Basal Blood Pressure During Administration of 















211 / 113 
210/112 
210/118 




177 / 113 
173 / 105 
170/ 112 
163 / 110 
190/108 




172 / 93 
196/108 
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197 / 98 
190/110 
192/91 
172 / 113 
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181 / 102 
189 / 116 
185/102 
163 / 85 
176/ 99 
189 / 86 
157 /1 05 
160/ 96 













141 / 86 
155/88 
173/76 
129 / 94 
137 / 90 
129 / 94 
139 / 86 
148/91 
" The sequence of administration was placebo, hydrochlorothiazide, 
placebo, combination of spironolactone and placebo, and combination 
of hydrochlorothiazide and spironolactone. 
tDosage of hydrochlorothiazide was 50 mg three t imes a day. 
tDosage of spironolactone was 100 mg four times a day. 
Table 2.-Mean Systolic and Diastolic Blood Pressure 
During the Four Periods of Drug Administration 
No. of 
Mean Systolic and Diastolic 
Blood Pressure (mm Hg) 
Hydro-
chbro- Spir.>nJ-1~fu"s"e~ Patients Placebo thiazide lactJne 
None (basal 11 190 166 167 
value) 108 - 97 - 98 
Levarterenol 11 226 198 195 
bitartrate 121 109 110 
Angiotensin 9 232 200 • 203 
amide 130 120• 117 
Trimethaphan 6 171 141 140 
camsylate 103 Tl 88 
• Based on seven patients. 
Table 3.-Analysis of Variance on 
Basal Systolic Blood Pressure 
Degrees 
of 
Source of Free- Sum of Mean 
Variation dom Squares Square F-Ratio 
Patients 10 10,156 1,015.6 
Treatments 3 9,852 
Hydrochlorothiazide 1 5,524 5,524 55.48 
effect 
Spi ronolactone effect 4,301 4,301 43.20 
Hydrochlorothiazide- 28 28 < l 
spironolactone 
"interaction" t 
Res idual 30 2,987 99.57 
Total 43 22,995 





















tThe test of interaction examines whether the effect of the two 
drugs in combination differs from the sum of the effects of either drug 
alone. 
tolic and diastolic blood pressure. The probability 
values for the resulting statistical t est s of signifi-
cance on the hydrochlorothiazide effect , the spirono-
lactone effect, and their interaction are shown in 
Taqle 4. The results are remarkably consistent with 
a highly significant hydrochlorothiazide and spirono-
lactone effect (P< 0.001) and persistently support 
the hypothesis of independent additive effects of 
these two drugs when given in combination. There 
is no evidence of drug synergism or antagonism, 
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Table 4.- Analysis of Variance on Level of Blood Pressure 
Basal 
Null Hypoth<?sis Tested Systolic Diastolic 
No hydrochlorothiazide effect < 0.001 < 0.001 
No spironolactone effect < 0.001 < 0.001 
Hydrochlorothiazide and spironolactone 
in combination is not different from 
the sum of the two alone NS 0 NS 
Residual mean square (mm Hg)• 99.57 29.5 
Degrees of freedom 30 30 
0 NS = not significant (P > 0.05). 
Table 5.-Estimates of Mean Systolic and Diastolic 
Blood Pressure Change Due to Hydrochlorothiazide, 










Mean Effectt (mm Hg) 
Hydrochlorothiazide Spironolactone 
- 22.4 ± 6.1 -19.8 ± 6.1 
- 9.1 ± 3.3 - 8.4 ± 3 .3 
-21 ± 8.5 -24.1 ± 8.5 
-10.3 ± 3 .5 - 9.2 ± 3 .5 
-29.1 ± 6.7 -22.3 ± 6.7 
-10.5 ± 3 .8 -13.2 ± 3.8 
-28.5 ± 8.4 - 23.2 ± 8 .4 
-10.7 ± 6 .8 -13.2 ± 6.8 
Combination 
-42.2 ± 8.6 
- 17.5 ± 4.7 
-45.1 ± 12 
-19.5 ± 4 .9 
- 51.4 ± 9.5 
-23.7 ± 5.4 
- 51.7 ± 11.9 
-23.9 ± 9.6 






Placebo thiazide lactone lactone 
Effect of -1 + 1 -1 + 1 
Hydrochlorothiazide 2 2 2 2 
Spironolactone 
-1 - 1 + 1 + 1 
2 2 2 2 
Combination -1 0 0 + 1 
• Estimates have 95 % confidence limits. 
t The mean effects are derived from the means in Table 2 by using 
the above weighte<l values. 
ie, no statistical interaction (P>0.05). Table 4 also 
indicates the residual mean square variance in blood 
pressure. The systolic as well as diastolic values 
are consistent for the different measurements. 
Table 5 gives estimates of the mean effects on 
blood pressure and their 95% confidence limits for 
hydrochlorothiazide, spironolactone, and their com-
bination during the basal state and during infu-
sions of levarterenol, angiotensin, and trimethaphan. 
The results indicate that hydrochlorothiazide and 
spironolactone, in the doses used, each reduced sys-
tolic blood pressure an average of 20 to 30 mm Hg 
during the various experimental situations. Since 
the combined effect of these two drugs is independ-
ent and additive, the drugs together produce a 
mean systolic blood pressure decrease of about 40 
to 50 mm Hg. The diastolic effects are similar for 
hydrochlorothiazide and spironolactone, with about 
a 10 mm Hg mean decrease for each and a mean 
decrease of about 20 mm Hg for the two together. 
The effects of hydrochlorothiazide and spirono-
lactone on serum potassium and sodium levels and 
plasma volume are given in Tables 6 and 7. Table 
6 exhibits the means for each of the four periods of 
drug administration, and Table 7 summarizes the 
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Probability Values 
Levarterenol Angiotensin Trimethaphan 
Bitartrate Amide Camsylate 
Systolic Diastolic Systolic Diastolic Systolic Diastolic 
< 0.001 < 0.001 < 0 .001 < 0.001 < 0.001 < 0.01 
< 0.001 < 0 .001 < 0.001 < 0.001 < 0.001 < 0.001 
NS NS NS NS NS NS 
190.23 33.1 94.77 30.95 92.33 60.87 
30 30 22 22 15 15 
Table 6.-Mean Serum Potassium and Sodium Levels, Plasma 
Volume During Four Periods of Drug Administration 
Mean Value in 11 Patients 
Hydro- Hydrochloro-
Measurement chloro- Spirono- thiazide and 
and Unit Placebo thiazide lactone Spironolactone 
Serum potass ium 
level (mEq/liter) 3.93 3.22 4 .44 4.32 
Serum sodium 
level (mEq/liter) 141.4 139.8 138.8 138.2 
Plasma volume (ml) 3,004 2,747 2,619 2,495 
Table ?.-Analysis of Variance on Other Effects 
Probability Values 
Serum Serum 
Potassium Sodium Plasma 
Null Hypothesis Tested Level Level Volume 
No hydrochlorothiazide effect < 0.001 < 0.05 < 0.001 
No spironolactone effect < 0.001 < 0.001 < 0.001 
Hydrochlorothiazide and 
spironolactone in combina· 
tion is not different from the 
sum of the two alone < 0.001 NS• NS 
Residual mean square 0.090917 2.1763 27,921 
Degrees of freedom 30 30 30 
Units (mEq/liter)• (m Eq/liter) • (ml)• 
0 NS = not significant (P > 0.05). 
two-way analysis of variance for these data (fol-
lowing the format in Table 2). For serum potassium, 
the results demonstrate a highly significant de-
crease due to hydrochlorothiazide (P<0.001), a 
highly significant increase due to spironolactone 
(P<0.001), and a significant interaction of the two 
drugs. The latter indicates that, with reference to 
serum potassium, the effect of one of the drugs, 
spironolactone or hydrochlorothiazide, depends on 
whether the other is or is not present. In combina-
tion, there is an increase in serum potassium similar 
to the increase with spironolactone alone. For serum 
sodium, there is a significant decrease attributable 
to spironolactone (P<0.001). With regard to plasma 
volume, a highly significant decrease can be attribut-
ed to each drug (P<0.001). For both serum sodium 
and plasma volume, there is no evidence of inter-
action when the two drugs are given together. 
Side effects were not observed during spironolac-
tone administration. During hydrochlorothiazide 
therapy, gout developed in one patient. During ad-
ministration of the two diuretics together, three 
patients had mild constipation and transient cramps 
of their calf muscles. 
Comment 
Four _measures of antihypertensive action were 
assessed in this study: decrease in blood pressure 
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in the basal state, alteration in the pressor response 
to levarterenol bitartrate and, separately, to an-
giotensin amide, and increase in the depressor ef-
fect of a ganglion-blocking drug, trimethaphan 
camsylate. The statistical analyses indicate that 
in the doses used, hydrochlorothiazide and spirono-
lactone had equivalent effects with reference to 
each of these measures. When the two diuretics 
were given together, their effects were additive. 
The antihypertensive effects of each of these 
diuretics closely resemble those of a low sodium 
diet. 0 ·' 0 Similar responses have also been described 
after other diuretics, including mercurials, ethacryn-
ic acid, and furosemide. Early in the course of salt 
depletion, plasma volume and cardiac output are 
reduced, and peripheral resistance is increased." 
Blood pressure begins to fall after several days. 
After months of such therapy, plasma volume and 
cardiac output return to normal, and peripheral 
resistance is decreased: 12 The observation that di-
azoxide, a nonsulfamylated benzothiadiazine,' 3 is 
both antihypertensive and salt-retaining has raised 
the question whether thiazides may be antihyper-
tensive by a mechanism additional to that of salt 
depletion. Facts opposing this view are the remark-
ably similar antihypertensive effects of hydrochloro-
thiazide and spironolactone shown in the present 
study, the reversal of the antihypertensive effect of 
hydrochlorothiazide by administration of salt, 1 • and 
differences in the actions of diazoxide and chloro-
thiazide when intravenously administered. Diazox-
ide reduces blood pressure within several minutes 
after intravenous administration' 3 ; it rapidly re-
duces peripheral resistance and increases cardiac 
output. In contrast, the antihypertensive effect of 
chlorothiazide does not occur before diuresis, and 
cardiac output is reduced, with an increase in per-
ipheral resistance in the initial weeks of administra-
tion of this drug. 
Previous studies in this laboratory,'"·'" confirmed 
by others,17 ' 18 show that salt depletion in normal 
and in hypertensive subjects is a strong stimulus to 
renin secretion. Plasma renin activity increases two-
fold to eightfold within 24 hours of administration 
of thiazide or phthalimidine diuretics. Angiotensin, 
elaborated by the enzymatic action of renin, can 
stimulate the adrenal cortex to secrete aldosterone. 
Aldosterone secretion is increased within a day of 
administration of a mercurial or a thiazide drug. 
The action of aldosterone at the distal renal tu-
bules fosters the reabsorption of sodium and the 
excretion of potassium. This action of the renin-. 
angiotensin-aldosterone system is homeostatic in 
the sense that it limits the saluretic effect of a 
diuretic such as hydrochlorothiazide; on the other 
hand, it fosters potassium depletion. The hypokale-
mic effect of hydrochlorothiazide in this study was 
marked. Five patients had decreases in serum po-
tassium levels to less than 3 mEq/liter. The dose 
was large and was given continuously for a month, 
without restriction of sodium in the diet. 
Spironolactone, competitively inhibiting the ac-
tion of aldosterone at the distal renal tubules, re-
duces the renal secretion of potassium and favors 
an increase in serum potassium. In this study, 
there was a statistically significant rise in serum 
potassium concentration attributable to spirono-
lactone. When spironolactone was given in combina-
tion with hydrochlorothiazide, serum potassium 
levels were about the same as when spironolactone 
was given alone. Drug interaction of an antagonistic 
nature was thus evident between spironolactone and 
hydrochlorothiazide during their combined admin-
istration with regard to serum potassium. Caution 
is indicated in the use of spironolactone in patients 
with chronic renal insufficiency. Hyperkalemia has 
been reported in several patients with azotemia 
during administration of spironolactone in combi-
nation with chlorthalidone or bendroflumethiazide.3 
Potassium supplements during administration of 
this drug should be avoided. Salt substitutes com-
monly contain potassium and may be an unrecog-
nized source of this ion. Spironolactone has not 
been found to affect glucose or uric acid metabol-
ism. It may cause gynecomastia, reversible upon 
withdrawal of the drug. 
The use of an orally effective continuously ac-
tive diuretic has become a cornerstone of the medi-
cal management of hypertension since the develop-
ment of chlorothiazide ten years ago. Administered 
alone, a sulfamylated benzothiadiazine or a phthali-
midine reduces systemic blood pressure approxi-
mately 10%. Such an agent also increases the hy-
potensive effects of other antihypertensive drugs. 
From the present and other studies, it appears 
clear that spironolactone can be used to obtain 
similar antihypertensive effects while avoiding the 
adverse effects of a thiazide on potassium, glucose, 
and uric acid levels. Indeed, the use of the two 
diuretics together, a thiazide and spironolactone, 
can provide a reduction in basal blood pressure 
equivalent to the sum of the reduction in basal 
blood pressure with either agent alone. In those 
patients in whom other drugs are required, a sig-
nificant reduction in the dose and side effects may 
be obtained by the use of such combined diuretic 
therapy. 
This work was supported by grants HE-06119 and HE-06316 
from the National Heart Institute, N ational Institute of Health. 
Hydrochlorothiazide, its placebo and angiotensin amide were 
supplied by Edgar Jack, MD, of Ciba Pharmaceutical Co., Sum-
mit, NJ. 
Spironolactone was supplied as Aldactone by I . C. Winter, MD, 
G. D . Searle & Co., Chicago. 
Generic and Trade Names of Drugs 
Hydrochlorothiazide-Esidrix, Hydrodiuril, Oretic, Hydril, Aquar-
ius. 
Angiotensin amide-Hypertensin. 






Levarterenol bitartrate-Levophed Bitartrate. 
Normal human serum albumin-Albumisol, Proserum. 
Trimethaphan camsylate-Arfonad Camsylate . 
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